Oral health and cognitive function in the Atherosclerosis Risk in Communities (ARIC) study by Naorungroj, Supawadee
  
ORAL HEALTH AND COGNITIVE FUNCTION IN  
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY 
 
 
 
Supawadee Naorungroj 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial 
fulfillment of the requirements for the degree of Doctoral of Philosophy in the Department of 
Epidemiology, Gillings School of Global Public Health. 
 
 
 
 
 
Chapel Hill  
2013 
                                                                                                                                                          
 
 
                     
Approved by:      
Victor J. Schoenbach 
Gerardo Heiss 
James D. Beck  
Lisa Miller Wruck 
Gary D. Slade
  
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©2013 
Supawadee Naorungroj 
ALL RIGHTS RESERVED
  
 
 
iii 
ABSTRACT 
SUPAWADEE NAORUNGROJ: Oral health and cognitive function in  
the Atherosclerosis Risk in Communities (ARIC) study 
(Under the direction of Gary D. Slade and Victor J. Schoenbach)  
Emerging evidence suggests possible links between poor oral health and cognitive 
dysfunction in older adults; however, it is unclear whether the association is present in midlife, and 
whether poor oral health in midlife increases risk of subsequent cognitive decline. The present study 
aimed to investigate whether a) periodontal disease and tooth loss were associated with low cognitive 
performance and b) periodontal disease and tooth loss were predictive of eight-year cognitive decline. 
The study used data collected from adults aged 52-75 years who participated in the dental health 
component of the Atherosclerosis Risk in Communities (ARIC) study.  
Cognitive function tests consisted of Delayed Word Recall (DWR), Digit Symbol 
Substitution (DSS), and Word Fluency (WF). At ARIC Visit 4 (1996-1998), 9,874 participants also 
answered dental screening questions, and 5,942 of the 8,554 dentate participants received 
comprehensive oral examinations, including periodontal probing. From 2004-2006, cognitive 
function for 911 participants was reassessed as part of the Brain MRI study; 785 of these participants 
were dentate, and 558 of them had received periodontal examinations at ARIC Visit 4. Models fit 
with multiple linear regression and generalized estimating equations (GEE) used dental status, 
number of teeth, or clinical periodontal conditions classified by the Biofilm-Gingival Interface (BGI) 
classification to predict Visit 4 cognitive scores and eight-year change in cognitive scores, 
respectively. In our cross-sectional study, complete tooth loss was consistently associated with 
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lower performance on all three measures of cognitive function. Number of teeth and periodontal 
disease were associated only with DSS and WF scores. In our cohort study, mean scores from all 
three cognitive measures slightly decreased. Although we found that complete tooth loss was 
associated with low performance on two cognitive tests, the DWR and WF, our data did not support 
the hypothesis that poor oral health predicted greater cognitive decline. In these late-middle aged 
adults, complete tooth loss was significantly associated with low cognitive performance but not with 
subsequent cognitive decline. Although differences in mean scores between BGI groups were small, 
greater extent of gingival inflammation tended to correlate with lower cognitive scores.
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LITERATURE REVIEW 
A. Introduction 
Dementia and cognitive impairment are major public health problems that are of growing 
concern in aging populations. Affected individuals become more dependent as cognitive impairment 
and dementia progress, disrupting their personal lives and those of their caregivers, as well as causing 
substantial expenditures for medical and long-term care services (1). At present, effective prevention 
or treatment is unavailable, and biological pathways contributing to cognitive impairment and 
dementia are not clearly understood.  
B. Dementia and cognitive decline 
Age-related cognitive decline, mild cognitive impairment, and dementia 
Cognitive decline is a decrease in the ability of the brain to perform regular functions such as 
judgment, reasoning, memory, learning, and understanding. Decline can be a result of 
neurodegenerative disease or the aging process (2). Neurodegenerative diseases that cause cognitive 
decline include Alzheimer disease (AD) and vascular dementia (VaD) (e.g., due to stroke). Cognitive 
aging is a result of aging-related changes in brain physiology, the cerebrovascular system, and 
neurochemical levels. The changes produce decreases in brain vascularization, reduction in 
neurotransmitter levels, and general brain atrophy (3). Mild cognitive impairment (MCI) is a level of 
cognitive decline which, although it does not affect the ability to lead an independent life, is more 
pronounced than cognitive aging. Cognitive decline and MCI can occur at any age but primarily 
affect the elderly. About 10% to 20% of people aged 65 years and older have MCI (1). 
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Older adults with MCI are at increased risk of developing dementia, a chronic and 
irreversible deterioration of cognition. Education is associated with lower rates of age-related 
cognitive decline because a high level of education may be a proxy indicator of cognitive reserve. 
Higher education level reflects better resilience and plasticity of cognitive networks that protect 
individuals from the negative effects of aging (3). Moreover, education attainment is related to risk 
factors for the underlying pathologic processes of dementia, such as lifetime patterns of health care 
use and health behaviors. Each year, about 10% to 15% of individuals with MCI are estimated to 
progress from MCI to dementia. In one study, progression rates from MCI to dementia were 2.3, 1.3, 
and 0.3/100 person-years for Alzheimer disease, vascular dementia, and other types of dementia, 
respectively (4). As the aging population is growing, attempts to identify MCI and predictors of 
progression from MCI to dementia become important, because MCI is treatable. Furthermore, the 
earlier the interventions occur, the greater the possibility to delay or stop the neurodegenerative 
process. Many studies, therefore, use brain imaging techniques and biomarkers in addition to 
neuropsychological testing to identify people who are likely to progress from MCI to dementia (5-7). 
Public health burden of cognitive decline and dementia 
Cognitive decline and dementia are major public health problems affecting older adults in the 
United States (U.S.) and worldwide. Incidence and prevalence of dementia rise substantially with age 
(1). In the U.S., the prevalence of all types of dementia ranges from approximately 2% in people aged 
65-69 up to more than 30% in people over 90 years of age (Figure 1-1). Incidence rates are between 
approximately 4 per 1000 person-years in people aged 65-69 and up to 60 per 1000 person-years 
among the group aged over 90 years old (8). The two most common types of dementia are AD and 
VaD, accounting for up to 75% of all dementia cases (4,8,9).  
As aging populations are growing and effective treatment and prevention are lacking, the 
costs and social burden associated with dementia are increasing. The number of people in the U.S. 
with AD will be as high as 13.5 million by 2050, almost three times the number in the year 2000 (10). 
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Furthermore, the 2012 report revealed that annual health care costs for patients with AD and other 
dementias were triple the health care costs for adults aged 65 and older without dementia (1). At the 
individual level, dementia results in physical disability, institutionalization, decreased quality of life, 
and increased risk of mortality. Therefore, it is essential to identify underlying mechanisms and 
treatable factors affecting clinical onset and progression of dementia. 
C. Determinants of cognitive decline, dementia, and structural brain abnormalities 
Advancing age and low education are prominent risk factors for age-related changes in 
cognitive function (1,3,8). Many observational studies have identified potential risk factors that may 
contribute to initiation and progression of dementia and cognitive decline, such as severe 
atherosclerosis, hypertension, diabetes mellitus, hyperlipidemia, and smoking (6,8,11-13). However, 
few factors have sufficient evidence to support a causal association with cognitive decline and 
dementia. Stroke and cardiovascular risk factors are consistently reported as risk factors for 
neurocognitive disease, particularly VaD. Several studies have also related genetic factors as well as 
systemic infection and inflammation to both AD and VaD (7,14-16). However, specific underlying 
mechanisms of AD and VaD have not been clearly characterized (8,9). Neurodegenerative changes 
(i.e., progressive brain atrophy and accumulations of cortical senile plaques and neurofibrillary 
tangles) in AD and cerebral infarction in VaD may lead to neuronal or axonal loss, impairing 
cognitive function. Since AD and VaD are the two most prevalent dementia subtypes, the following is 
a summary of major risk factors that may contribute to cognitive impairment caused by AD or VaD 
pathogeneses. Relevant findings from ARIC studies are summarized in Table 7-1. 
APOE genotype  
Despite uncertainty about the causes of cognitive impairment and dementia, genetic factors 
are accepted as part of the etiology, particularly the association between the apolipoprotein E (APOE) 
ε4 allele and sporadic AD (late-onset AD) (8,9,17). A higher frequency of the APOE ε4 allele was 
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found in demented compared to non-demented people, with an apparent dose-response relationship 
(16,18). Compared to individuals with the ε3/ε3 genotype, the risk of dementia hospitalization for 
persons with the ε4/ε4 genotype was highest, followed by those with ε3/ε4 genotype (19). Several 
longitudinal studies have shown a greater cognitive decline among non-demented people who are 
carriers of the APOE ε4 allele (11,14).  
In the ARIC cohort, associations between the APOE genotype and cognitive decline among 
middle-aged white participants have been reported. The greatest cognitive decline was found in 
participants with combinations of APOE ε4 with cardiovascular risk factors, particularly 
hypercholesterolemia or diabetes, suggesting a synergistic effect (14). Likewise, in a Dutch study, AD 
and VaD were associated with atherosclerosis, and the association was pronounced in participants 
with APOE ε4 (20). 
The relationships of APOE ε4 with cognitive decline and dementia are well-documented (18-
20); however, the underlying mechanisms are unknown. A possible mechanism is that APOE 
enhances proteolytic breakdown of peptide beta-amyloid protein in the brain, both within and 
between cells, and the isoform APOE ε4 is not as efficient as other isoforms in catalyzing this 
reaction. Consequently, individuals with the APOE ε4 variation tend to accumulate beta-amyloid 
protein, predisposing to AD. In addition to an increased risk of AD, APOE ε4 also increases risk of 
cardiovascular disease as a result of impaired cholesterol transport and metabolism (18,21).  
Stroke and cardiovascular risk factors   
Cross-sectional and longitudinal studies, including the ARIC study, have reported that stroke, 
coronary heart disease (CHD), and cardiovascular risk factors are related to a higher risk of dementia 
in elderly people (6,11,19,22). As for genetic factors, specific biological mechanisms linking these 
environmental factors to neurocognitive disorders remain unclear. Multiple infarcts and small vessel 
atherosclerosis in the brain caused by these risk factors can lead to subsequent cognitive decline and 
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VaD (16). The observed associations among stroke CHD, and cognitive decline may also be due to 
sharing several common risk factors such as low education, smoking, and diabetes mellitus 
(8,12,16,22). 
Stroke: Stroke causes cognitive and motor impairments that are both acute and chronic. 
History of stroke is also a risk factor for developing dementia (16). In ARIC, a follow-up study 
conducted over a 14-year period found that stroke was associated with a decline in performance on 
the DWR and WF test scores but not on the DSS test (11). 
CHD: Evidence from studies examining an association between CHD and cognitive 
performance is inconsistent. Two large epidemiologic studies have reported an association between 
CHD and lower cognitive scores (22,23)  Another study with fewer participants did not observe the 
association between CHD and dementia diagnosis (24). Low cardiac output, brain hypoperfusion, and 
cardiac microembolization after myocardial infraction have been proposed as possible causal 
pathways of cognitive impairment. 
Hypertension: Hypertension in midlife is a strong risk factor for cognitive decline, cerebral 
abnormalities, and dementia (12). In the ARIC cohort, baseline hypertension was associated with a 
decline only in the DSS test score (25). 
Diabetes: Studies have shown a clear association of diabetes with both cognitive decline and 
dementia (19). People with diabetes at baseline exhibited greater decline in cognitive function over 
the six-year interval. Of the three cognitive tests (DWR, DSS, and WF), change in the DSS scores 
was most strongly associated with diabetes (25). Associations between clinical signs or symptoms 
related to diabetes and cognitive disorders, however, were inconsistent (26,27). Cognitive decline was 
not correlated with hyperglycemia (26), but a relation was detected with hyperinsulinemia (27). 
High serum cholesterol: Many studies fail to show an association of elevated low-density 
lipoprotein (LDL) cholesterol or triglycerides with dementia, cognitive impairment, or abnormalities 
on brain imaging (4,28). Similarly, elevated LDL was not associated with cognitive decline in 
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middle-aged adults after follow-up for 6 years in the ARIC study (25). Nonetheless, 
hypercholesterolemia, elevated total cholesterol in midlife, was associated with dementia incidence in 
a longitudinal study with an average follow-up of 12.8 years (19). 
Smoking: A cross-sectional study reported a dose-response relation between cigarette 
smoking and silent cerebral infarction, in which infarction prevalence was highest for current 
smokers, followed by ex-smokers, persons exposed only to environmental tobacco smoking, and 
nonsmokers (29). A 14-year prospective study of the ARIC cohort found smoking to be the primary 
risk factor for dementia incidence (19). However, in another prospective study with a follow-up 
interval of 6 years in the same cohort, the most important risk factors for cognitive decline were 
diabetes and hypertension; the association of cognitive decline with cigarette smoking was not 
significant (25).  
Alcohol consumption: A previous study has shown a protective effect of low and moderate 
alcohol consumption on stroke (30). In the ARIC study, current drinkers had higher baseline scores 
for cognitive performance than nondrinkers (31). Alcohol intake was not associated with the presence 
of brain infarction lesions. However, a positive correlation between number of alcoholic drinks per 
week and brain atrophy was observed (32). 
Systemic infection and inflammation  
 Viral or bacterial pathogens and inflammation have the potential to cause neurocognitive 
disease; however, the specific mechanisms are unknown. Several types of data including post-mortem 
examinations have suggested that chronic infection and inflammation might contribute to the 
neurodegenerative process leading to dementia. High levels of inflammatory mediators (e.g. serum C-
reactive protein (CRP) and Interleukin-6 (IL-6)) have been linked to an increased risk of cognitive 
decline and dementia in epidemiological studies (7,15,33-40) (Table 1-1). Pro-inflammatory factors 
derived from immune responses to local chronic infection may reach the brain via the systemic 
circulation, exacerbating inflammatory processes or vascular pathologies (41). Herpes virus, bacteria 
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(e.g. C. pneumoniae), and periodontal pathogenic spirochetes (e.g., T. denticola, T. pectinovorum, T. 
vincenti, T. amylovorum, T. maltophilum, T. medium, and T. socrankii) have been detected in the 
brains of demented patients, suggesting other possible risk factors for AD (42-44).  Observational 
studies have also shown the benefits of using long-term, nonsteroidal anti-inflammatory drug 
(NSAIDs) to prevent or slow cognitive decline; however, results from clinical trials have failed to 
confirm any positive effect on cognition (7,13).  
D. Associations of oral health measures with cognitive function 
Public health burden of periodontal disease and tooth loss in adults 
Periodontal disease is defined as a chronic infectious disease that causes inflammation of 
periodontal tissues and destruction of the periodontal ligament that attaches the tooth to its bony 
socket. Periodontal disease is associated with increased systemic inflammatory markers such as CRP 
and local inflammatory levels such as gingival crevicular fluid (GCF) prostaglandin E2 (PGE2) 
(17,45). As a result of inconsistent case definitions for PD, there is a difficulty in comparing the 
disease prevalence and incidence estimates across epidemiologic studies (46). Overall, prevalence of 
periodontal disease has declined in the U.S. population. The Third National Health and Nutrition 
Examination Survey: NHANES III (1998-1994) estimated that 10% of adults (20-64 years) had 
moderate or severe periodontal disease compared with 5% in 1999-20041, using the same case 
definition. Moderate or severe periodontitis decreased from approximately 27% to 17% between 
1988-1994 and 1999-2004 among adults aged 65 years and older (47). However, these data, which 
                                                      
1The Centers for Disease Control and Prevention/ The American Academy of Periodontology (CDC/AAP) case definitions were applied. 
Severe periodontitis was defined as the presence of 2 or more interproximal sites with ≥ 6 mm attachment loss (not on the same tooth) and 1 
or more interproximal site(s) with ≥ 5 mm pocket depth . Moderate periodontitis was defined as 2 or more interproximal sites with pocket 
depth ≥ 4 mm attachment loss (not on the same tooth) or 2 or more interproximal sites with pocket depth ≥ 5 mm, also not on the same 
tooth. Mild periodontitis was defined as ≥ 2 interproximal sites with ≥ 3 mm attachment loss and  ≥ 2 interproximal sites with ≥ 4 mm  (not 
on the same tooth) or 1 site with ≥ 5 mm pocket depth.  
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obtained using a partial-mouth protocol (i.e. one maxillary and one mandibular quadrant), 
underestimate true prevalence observed when all periodontal tissues are assessed (48).  
A recent NHANES (2009-2010), which is the first national survey to use a full mouth protocol, 
reported that total prevalence of periodontitis ranged from 24.4% in adults 30-34 years old to 70.1% 
in adults aged 65 years and older. Prevalence of mild, moderate, and severe periodontitis in adults 
aged 30 years and older was 8.7%, 30.0%, and 8.5%, respectively (49). 
Advanced periodontal disease destroys the periodontal ligament, loosening the tooth and 
contributing to tooth loss. Tooth loss has been described as a clinically-meaningful outcome of dental 
caries and periodontal disease (50), although in all age groups, dental caries is a more common 
underlying cause of tooth loss (51). Complete tooth loss (edentulism) is common among older adults 
aged 65 or older worldwide. The positive association with age can be attributable primarily to 
elevated rates of tooth loss in generations born in the first half of the 20th century (52). At present, 
prevalence of complete tooth loss is declining in the U.S. For adults (20-64 years) the prevalence of 
edentulism decreased from approximately 6% during 1988-1994 to 4% during 1999-2004. For older 
adults (65-74 years), complete tooth loss was 24% in 1999-2004 compared with 29% in 1988-1994 
(47). The recent NHANES (2009-2010) reported that 15% of adults 65-74 years old and 22% of 
adults 75 years and older were edentulous (53). Tooth loss affects not only chewing ability and 
nutritional status (54,55), but also quality of life and self-sufficiency (21,56). Associations of tooth 
loss with an increased risk of stroke, mortality, and elevated inflammatory markers have also been 
shown (57,58).  
Bidirectional associations between oral health measures and cognitive function 
A number of both cross-sectional and longitudinal studies suggest an association between 
cognitive decline and poor dentition in the elderly (59-64), but it is not well established if the same 
relationship exists in middle-aged adults (65). The observed association may be confounded, since 
poor oral health and cognitive impairment share several common risk factors, such as low 
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socioeconomic status, smoking, and diabetes mellitus. Furthermore, the association likely is 
bidirectional and the underlying mechanisms remain unclear. 
There are several proposed explanations as to how cognitive decline might contribute to 
dental caries, severe periodontal disease, and tooth loss (66,67). First, older adults with impaired 
memory and reduced physical function lack the capacity to perform proper oral health care (66). 
Second, older individuals are less likely to receive regular dental care (68). Third, decreased saliva 
production is a side effect of many commonly prescribed medications used to treat depressive 
symptoms in demented people, thereby impairing oral clearance and neutralization of dental plaque 
acid (69). Recently, two large observational studies suggest that socioeconomic inequalities in oral 
health might explain the relationship between cognitive ability and oral health. The authors proposed 
that low cognitive ability limits education achievement and income, and thus impairs self-care, which 
may lead to poor oral health (60,70). 
Poor oral health resulting from cognitive impairment has been confirmed in many studies, but 
several findings have suggested that the reverse association is plausible. Periodontal disease and tooth 
loss in midlife may lead to early onset and rapid progression of cognitive decline (59,61,71). A 
longitudinal study of aging and AD suggested that a low number of teeth (0-9) was related to 
increased prevalence and incidence of dementia (72), and the decline in cognitive function was more 
rapid for those who carried the APOE ε4 allele (73). A case-control study in monozygotic twins 
discordant for probable AD showed that tooth loss early in life was associated with increased risk for 
dementia after adjusting for socioeconomic status. In that study, tooth loss occurred years before the 
diagnosis of AD, suggesting that oral disease and possibly antecedent PD might hasten progression of 
AD (74). Additionally, a case-control study showed that PD was a cause of tooth loss in most AD 
cases and occurred 20-30 years before dementia (75).  
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Several biologically plausible pathways have been proposed for a causal effect of oral disease 
on cognition. However, most evidence comes from cross-sectional studies (65,71,76,77), longitudinal 
studies with small sample size (61,73,78,79), and varieties of periodontal case definitions and 
cognitive tests (Appendix A). Potential mechanisms include inflammatory mediators produced in 
response to periodontal pathogens (76), dissemination of gram-negative bacteria to the brain, and 
increased risk of stroke and cerebrovascular injury (17,80-83).  
Contribution of periodontal disease and tooth loss to cognitive decline and dementia  
Periodontal pathogens can induce systemic inflammation. Previous studies have showed 
the involvement of inflammation in AD, though it remains unclear whether the inflammatory process 
is related specifically to initiation or progression of the disease. Elevation of inflammatory 
biomarkers, such as serum CRP, has been associated with periodontal pathogens, periodontitis, and 
dementia (76,80,82,84). NHANES III revealed a positive association between systemic exposure to P. 
gingivalis (measured as serum antibody to P. gingivalis) and poor cognition (85). Thus, it has been 
hypothesized that periodontal pathogens may influence neuropathogenesis of dementia via the 
inflammatory process (41). Lipopolysaccharide, a bacterial endotoxin, from periodontal pathogens 
can stimulate proinflammatory cytokines as well as CD14 activity, resulting in chronic elevation of 
systemic inflammatory markers. In addition, chronic periodontitis may result in long-term locally 
increased proinflammatory molecules that surround the trigeminal cranial nerve endings (6). 
Hypothetically, then, periodontal-derived cytokines could reach the brain by both systemic and neural 
pathways and amplify brain cytokine pools, contributing to the progression of dementia (33,41,81).  
Periodontal pathogens can invade brain tissue. Periodontal pathogens such as P. 
gingivalis, T. denticola, and A. actinomycetemcomitans are capable of invading multiple cell types. 
These bacteria have been found at distant sites, including atherosclerotic plaque and brain tissue (86). 
The Treponema species has been detected in the trigeminal ganglia, brainstem, and cortex of human 
brain. Several studies have shown that the brains of AD patients were more likely than controls to 
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have Treponema (42-44). These finding suggested that oral bacteria may be capable of invading brain 
tissue via peripheral nerve fibers. 
Periodontal disease may increase risk for CHD and stroke. Previous studies discussed 
several potential mechanisms relating periodontal disease and CHD, including bacteremia, systemic 
inflammation, and vascular injury (45,86). Periodontal pathogens have been found in atherosclerotic 
plaques, and they may induce vascular pathology through their cytotoxicity or inflammatory process. 
It has been shown that chronic, low-grade inflammation in response to periodontal infection may 
contribute to the development of atherosclerosis or CHD (45,83). Systemic inflammatory biomarkers, 
which are elevated in people with PD and CHD, include CRP, IL-6, tumor necrotic factor-alpha 
(TNF-α), and fibrinogen (45,87). Since PD is associated with elevated risk of stroke and CHD 
(83,87), which are risk factors for dementia (4,22), the elevated risk of dementia among people with 
periodontal disease may be mediated by CHD and stroke. Nonetheless, a recent review by Lockhart 
et.al. (2012) concluded that although current evidence suggests an independent association between 
periodontal disease and cardiovascular diseases, the evidence is insufficient to demonstrate the causal 
relationship (88). 
Tooth loss results in malnutrition. Weight loss and deficiency of vitamin B6 have been 
suggested as potential risk factors for dementia (8,89). Tooth loss can lead to impaired masticatory 
function, thereby influencing food choices and nutritional status. However, a review study found that 
most studies reported a weak association between tooth retention, masticatory function and nutrition, 
and thus a definite casual effect cannot be established (90). In an animal model, the loss of molar 
teeth resulted in reduced mastication and impairment of spatial memory (91,92).  
In summary, the association between poor oral health and cognitive impairment is complex 
and likely bidirectional, with poor dental health both a risk factor for and a consequence of cognitive 
impairment. To clarify the link between oral health and cognitive function will require a consistent 
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body of evidence from longitudinal studies with standardized measures of periodontal disease and 
tooth loss as well as careful follow-up. From a public health perspective, if further studies 
consistently identify periodontal disease as a risk factor for cognitive decline and dementia, the 
implications are significant since periodontal disease is treatable and preventable. Therefore, 
epidemiological studies investigating the relationship of periodontal disease as well as tooth loss with 
cognitive function are warranted. 
E. Cognitive assessments 
Changes in cognitive function may occur in one or more cognitive domains and those 
domains may change differentially within an individual (2). Cognitive screening assessments aim to 
objectively assess a patient’s history of cognitive deficits or chief symptoms (3). Many instruments 
and approaches are available to screen for cognitive impairment, but none covers all cognitive 
domains (93). In addition, patterns of impairment differ among subtypes of dementia, and thus, no 
single test can accurately screen for all forms of dementia. Most instruments focus on memory 
impairment, a common symptom of AD at the initial stage of disease. In addition to memory loss, AD 
can manifest as gradually progressive neuropsychological deficits with, for example, dysphasia or 
subtle abnormalities in executive function. A well-known instrument for AD screening, the Mini-
Mental State Examination (MMSE), is a brief and focused screen of cognitive domains most often 
affected in AD. This test includes items such as asking patients to name actual time and place of the 
test, repeat lists of words, perform arithmetic (e.g., serial sevens), and perform tasks involving 
language use and comprehension as well as basic motor skills. Possible scores range from 0 to 30, and 
scores between 21 and 24 indicate MCI. Since MMSE is very limited in evaluating executive 
function, additional tests for attention, language, praxis, visuomotor functioning, abstract reasoning, 
and executive functioning have been suggested as accompaniments to MMSE to improve screening 
sensitivity (3,94). 
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Each dementia subtype is characterized by different cognitive domain deficits. In comparison 
with people with AD, those with VaD tend to score lower on tests of executive function, such as 
verbal fluency, and their level of memory impairment is usually less severe. Similarly, people with 
frontotemporal dementia typically possess reduced letter fluency and executive function than people 
with AD, but their memory performance is often better. Individuals diagnosed as Lewy body 
dementia are even more dysfunctional in areas such as attention, visuospatial tasks, letter fluency, 
mental tracking, and abstract reasoning. Therefore, a comprehensive screening instrument should 
cover the following six core domains: a) attention/working memory; b) new verbal learning and 
recall; c) expressive language; d) visual construction; e) executive function; and f) abstract reasoning 
(93). 
There is no consensus regarding a standard screening test; using both formal and informal 
assessments may provide more information about people’s cognitive performance. A formal test 
provides a summary measure of cognitive performance, but that measure may be influenced by 
anxiety on the part of the subject. An informal evaluation, carried out through a conversation using 
simple questions, may permit a more realistic assessment of cognitive performance in relation to 
cognitive deficits, but will not provide a summary score. 
Cognitive function assessment in the ARIC study 
 The entire ARIC cohort completed two neurocognitive function assessments at both Visits 2 
and 4 (Figure 3-1). For those who participated in the Brain MRI study, cognitive function 
assessments were also carried out at Visit 3 and once between 2004 and 2006. Three standard 
cognitive tests (DWR, DSS, and WF) administered at every follow-up visit were used to quantify 
changes in cognitive function. The DWR measures verbal memory, whereas both the DSS and WF 
assess executive function. Higher test scores indicate better cognitive performance. Recently, the 
ARIC cohort has been undergoing the third cognitive function assessment (Visit 5), which included 
more neurocognitive tests. A total of seven core domains are examined: memory (verbal and 
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nonverbal), language, visuospatial, attention, executive function, motor function, and premorbid 
intelligence. However, Visit 5 data collection was not complete at the time of writing this dissertation. 
 A previous ARIC study reported that DWR, DSS, and WF scores at baseline were normally 
distributed and negatively associated with age (31). Participants aged 65-69 years had lower cognitive 
scores compared to those who were younger, and women had higher average scores than men for 
every age group. In addition to demographic characteristics, baseline cognitive function was also 
associated with cardiovascular risk factors, including smoking status, alcohol use, depressive 
symptoms, diabetes, and hypertension. A subset of ARIC participants was followed for fourteen 
years. An analysis found that stroke, diabetes, hypertension, metabolic syndrome, and APOE 
genotype predicted cognitive decline. However, the magnitude of changes for the DWR, DSS, and 
WF scores was relatively small (11) (Table 1-2). 
F. Neuroimaging 
Neuroimaging provides a sensitive and noninvasive method for detecting subclinical 
abnormalities in both cortical and subcortical brain structures. With the introduction of MRI, a 
number of recent studies have focused on assessing brain structural changes in normal aging, 
especially hippocampal-parahippocampal atrophy to detect early AD and MCI (5,95). Positive 
correlations between variation in brain structure and cognitive function have also been shown in 
healthy adults, particularly in domains such as processing speed, executive function, and memory 
(5,96). However, the basis for cerebral-cognitive relationships observed in current studies remains 
unclear.  
White matter hyperintensities (WMHs), which appear as “bright signals” on the MRI image, 
are common MRI findings that reflect demyelination, a deterioration of neural pathway. WMHs been 
associated with cognitive deficits in both AD and normal aging (96,97). White matter consists of glial 
cells and myelinated axons that are important for signal transmission in the nervous system. 
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Atherosclerosis of arteries and arterioles supplying blood to white matter may cause neurovascular 
changes as well as a reduction in myelination. The degradation and disruption of these white matter 
pathways will then result in cognitive deficits. Greater brain volume has been thought to be a 
protective factor for neurocognitive disorders, including cognitive aging. Ventricular and sulcal size 
as measures of brain volume have been associated with reduced cognitive function in both normal 
aging and AD (5,96,98). A longitudinal study in AD patients suggested that greater ventricular size 
measured on MRI might be a marker for preclinical AD neuropathology (98). Several pathologies 
such as neuronal loss, brain tissue density reduction, white matter degeneration, and microvascular 
pathology can result in decreased brain volume or brain atrophy (5,95,97). 
Brain MRI assessment in the ARIC study 
A study using ARIC Visit 3 data reported prevalence of brain neurodegenerative changes by 
comparison subjects’ MRI images with standardized images that successively increased from barely 
detectable (score 1) to extensive change (score 8). Studies with no change received score 0, and those 
with changes worse than score 8 received score 9. A high-grade abnormality was defined as 
ventricular grade 4 or higher (14%), sulcal size grade 3 or higher (26%), and WMHs grade 3 or 
higher (11%). Associations between these abnormalities and cognitive test scores have been reported 
(high grade WMHs with DWR, DSS, and WF; high ventricular grade with DWR and DSS; and high 
sulcal grade with DWR scores) (96). Two other ARIC studies reported that brain atrophy was 
correlated with diabetes (99) and alcohol consumption (32). Although they did not find an association 
of brain atrophy and hypertension, Knopman et al. (2005) did find a strong association between 
hypertension and the level of WMHs (99). Similar to findings from other studies, diabetes was a risk 
factor for brain atrophy in a 10-year follow up of this cohort. Worsening of sulcal widening was 
associated with diabetes, and incident infarcts were associated with both diabetes and hypertension 
(12). It is possible that microvascular effects of diabetes may result in decreased cerebral perfusion 
and subtle microinfarction, which can in turn lead to brain volume loss and cognitive decline (99). 
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G. Periodontal disease assessments 
Clinical measures used to define periodontal disease  
Previous literature reviews highlighted methodological problems in studying periodontal 
epidemiology, particularly a lack of uniform criteria used to define periodontitis (48,100,101). Most 
periodontal indices are developed by using clinical signs and symptoms of gingival inflammation, 
such as bleeding on probing (BOP) and destruction of periodontal supporting tissue, as measured by 
alveolar bone loss or attachment loss (AL)1. Other clinical measures that may be included are 
gingival recession (GR) and pocket probing depth (PPD2). Attachment loss is considered to be the 
gold standard for measuring the history of periodontal disease and its progression, as opposed to 
current disease activity (102). Inconsistencies in the use of disease indicators and a threshold for 
quantifying severity of periodontitis lead to multiple case definitions of periodontal disease. These 
methodological issues also arise from a difference in areas of the mouth surveyed (e.g., full-mouth, 
partial-mouth, or index teeth), periodontal probes, and techniques used to measure PPD and AL 
(100,101,103). As a result, it is very difficult to compare PD occurrence across studies.  
Centers for Disease Control/ American Academy of Periodontology (CDC/AAP) classification 
In 2003, a working group appointed by the CDC and AAP developed a standardized clinical 
case definition for population-based studies of periodontitis based on measurements of PPD and AL. 
The case definition for moderate periodontitis requires at least two sites on different teeth have 
interproximal AL > 4 mm or interproximal PPD > 5 mm. Severe periodontitis was defined as two or 
more interproximal sites with AL ≥ 6 mm, not on the same tooth, and at least one interproximal site 
with PPD ≥ 5 mm.(104). Nonetheless, validity of prevalence or incidence estimation largely depends 
on examination protocols, where the full mouth approach serves as “a gold standard”. A recent 
                                                      
1AL is the distance in millimeters form the cemento-enamel junction (CEJ) to the base of sulcus or periodontal pocket.  
2PPD is the distance in millimeters from the gingival margin to the base of the gingival sulcus or periodontal pocket. 
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validation study demonstrated that partial mouth protocols using the CDC/AAP definition 
underestimated the prevalence of severe and moderate periodontitis by 63% and 59%, respectively 
(48). Using this case definition, prevalence of severe periodontitis in Dental ARIC was 16.9% (83). 
The Dental ARIC study used the full mouth protocol to measure periodontal disease in the ARIC 
cohort. Thus, the estimated periodontal disease prevalence is unlikely to be underestimated due to the 
examination protocol. 
Biofilm-Gingival Interface (BGI) index 
 Unlike attachment loss or tooth loss that are historical markers of periodontal disease and 
treatment, the BGI index has been developed based on a concept that clinical disease classification 
should reflect an underlying biological process of periodontal disease that involves a complex 
interaction of the microorganisms with host inflammatory and immune response. Two clinical signs 
of disease, PPD and BOP, were used to create this case definition. The concept underlying the BGI is 
that periodontal disease represents pathology at the biofilm-gingival interface, which is bordered on 
the gingival tissue side by the epithelium and subgingival plaque within the pocket. Five levels of 
BGI were defined based on the extent of PPD (e.g., no periodontal pockets; PPD ≤ 3 mm vs. had 
periodontal pockets; PPD ≥ 4 mm) in combination with bleeding scores (e.g., low, LB; moderate, 
MB; or severe, SB) (Table 3-2). A study showed that levels of inflammatory mediators within the 
periodontal pockets (e.g., Interleukin 1-beta (IL-1β) and PGE2) were lowest among those with healthy 
periodontal tissue and increased significantly among subjects with gingivitis and periodontitis. The 
higher levels of gingival crevicular fluid (GCF) inflammatory markers were related to severe BOP 
conditions. In addition, the presence of periodontal pathogens was associated with each BGI group. 
For example, C. rectus was associated with gingivitis, BGI-DL/MB and BGI-DL/SB; P. gingivalis 
was associated with BGI-deep lesions (17). In the present study,BGI index was used as a measure of 
periodontal disease. 
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Gingival crevicular fluid (GCF) inflammatory markers 
Evidence from epidemiological and microbiological studies reveal that microorganisms 
associated with periodontal disease are also found in healthy individuals and at sites where 
periodontal disease is not progressing. Moreover, an individual’s disease severity or extent is not 
associated with levels of plaque control. These findings led to the current concept that periodontal 
disease progression is highly dependent upon inflammatory host response to localized microbial 
plaque challenge (17,105,106). Lipopolysaccharide, a cell-wall component of gram negative bacteria, 
triggers monocytes to release inflammatory mediators that increase local destruction of the 
periodontium. Therefore, levels of monocyte inflammatory mediators in GCF, such as PGE2, IL-1β, 
IL-6, IL-8, TNF, and collagenase can be markers of periodontal disease activity at the site level. It has 
been demonstrated that GCF composition reflects the nature and amplitude of the inflammatory host 
response to bacterial plaque and periodontal status (17,102,107). A systemic host response to 
periodontal disease is evidence by serum antibodies to common oral bacteria such as P. gingivalis 
(85,106), and elevation in serum inflammatory markers such as serum CRP and sICAM 
(17,80,82,83).  
The Dental ARIC study reported levels of GCF-inflammatory markers in association 
withBGI index (Table 1-3). Compared to healthy subjects (BGI-H), all four categories had 
significantly increased GCF-levels of IL-1b  and PGE2. Increased expression of the GCF-
inflammatory markers appeared to be related to the extent of gingival bleeding among individuals 
PPD ≤ 3 mm or PPD ≥ 4 mm (17). Inflammatory response to chronic local infection may trigger a 
more generalized systemic response in tissues remote from the periodontium (e.g., the liver), thereby 
increasing systemic levels of inflammatory markers, which may impair neurogenesis or damage 
existing neurons in the brain. Consequently, people with elevated levels of inflammatory markers 
may at an increased risk of cognitive decline.  
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H. Tables 
Table 1-1. Inflammatory markers associated with cognitive decline and dementia in epidemiologic 
studies 
Study n Inflammatory markers Outcomes 
Framingham study (35) 619 IL-1 
Tumor necrosis factor alpha (TNF-α) 
Dementia 
 
MacArthur studies (36) 779 IL-6 Cognitive decline 
Health ABC study (37) 3,031 IL-6 
CRP 
TNF-α 
Cognitive decline 
 
Rotterdam study (38)  188  cases  
727 controls 
 
IL-6 
CRP 
α-1 antichymotrypsin (ACT) 
Dementia 
 
 
Leiden 85+ study (39) 599 TNF-α 
IL-10 
Cognitive decline 
 
Honolulu-Asia Aging study (33)  1,050 CRP Dementia 
Longitudinal aging study Amsterdam 
(40) 
1,284 α-1 antichymotrypsin (ACT) Cognitive decline 
Greek community (15) 37 cases 
33 controls 
CRP 
Intracellular adhesion molecule (ICAM-1) 
Vascular cell adhesion molecule (VCAM-1) 
Cognitive decline 
Table was modified from Watts A, Crimmins EM, Gatx M.  Inflammation as a potential mediator for the association between periodontal 
disease and Alzheimer’s disease. Neuropsychiatric Disease and Treatment 2008;4(5):865-76.(81) 
 
 
 
Table 1-2. Test scores in the ARIC MRI study among participants who completed cognitive tests on 
all four follow-ups 
Cognitive assessment   Visit 2 
(1990-1992) 
 Visit 3 
(1993-1995) 
 Visit 4 
(1996-1998) 
 2004-2006 
Delayed word recall  6.6 (1.4)  6.6 (1.6)  6.7 (1.5)  6.0 (1.7) 
Digit symbol substitution  41.1 (13.2)  40.7 (14.4)  40.4 (14.0)  36.7 (13.2) 
Word fluency  33.3 (12.1)  33.2 (12.8)  33.4 (12.8)  31.6 (12.3) 
Means (standard deviations) of test scores for 1,018 participants. 
Table was adapted from Knopman DS, Fourteen-year longitudinal study of cardiovascular risk factors, APOE genotype, and cognition: The 
ARIC study. Alzheimer’s & Dementia 2009(5):207-14. (11) 
 
 
Table 1-3. Gingival crevicular fluid-mediator levels and Biofilm-Gingival Interface categories  
GCF-mediator 
(ng/mL)  
PPD ≤ 3 mm  PPD ≥ 4 mm 
BOP ≤ 10% BOP >10%  BOP ≤10% 10%< BOP <50% BOP ≥50% 
 BGI-H BGI-G  BGI-DL/LB BGI-DL/MB BGI-DL/SB 
IL-1b ,  mean ± SE 104.1 ± 4.8 148.7 ± 4.7  122.5 ± 4.3 141.4 ± 2.9 194.7 ± 5.3 
PGE2, mean ± SE 198.9 ± 6.3 249.0 ± 6.3  218.1 ± 5 .3 234.7 ± 3.6 254.4 ± 6.8 
Table was modified from Offenbacher S, Barrons SP, Singer RE, et.al. Periodontal Disease at the Biofilm-Gingival Interface. J 
Periodontal 2007;78;1911-1925.(17) 
 20 
 
I. Figures 
 
 
 
 
 
 
Figure 1-1. Age-specific prevalence of all types of dementia (per 100 population) across continents 
and countries (8) 
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SPECIFIC AIMS 
A. Rationale 
Maintenance of cognition is important to preserve good health and quality of life, particularly 
in adults with advancing age. Knowledge concerning etiology and associated risk factors of cognitive 
decline and dementia is accumulating, but biological mechanisms remain uncertain. Several studies 
have reported associations of cognitive decline and certain inflammatory markers with vascular 
diseases and stroke (1-12). In addition, a link has been shown between impaired cognition and 
periodontitis, a common chronic infection associated with elevations of systemic inflammatory 
markers (13-15). It has also been proposed that chronic periodontal disease can contribute to early 
onset and rapid progression of cognitive decline (13,15,16). At present, however, there is evidence to 
show that there may be a reversed causal relationship, meaning that a decline in cognition can lead to 
poor oral health in older adults (17-19). If infection and inflammation from periodontal disease are 
associated with an increased risk of cognitive decline, periodontal disease can be a pivotal modifiable 
risk factor to delay onset or slow progression of cognitive decline among the aging population, since 
periodontal disease is treatable and preventable.  
Hypotheses for the present study were developed based on a conceptual framework that 
systemic inflammation related to periodontal disease could be a potential biological pathway by 
which periodontal disease can lead to cognitive decline. We hypothesized that poor oral health was 
cross-sectionally associated with cognitive decline in late middle-aged adults. We also hypothesized 
that poor oral health in midlife was associated with progressive cognitive decline with advancing age. 
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B. Specific aims 
Aim 1: Estimate associations of oral health status measures (i.e., dental status, tooth loss, and 
periodontal with cognitive function1 at ARIC Visit 4.  
Hypotheses: a) complete tooth loss or fewer teeth is associated with lower scores of 
cognitive function, and b) severe periodontal disease is associated with lower scores of cognitive 
function.  
Overview: We evaluated the associations of oral health measures with the three cognitive 
tests (DWR, DSS, and WF) in late-middle aged adults after controlling for socio-demographic 
characteristics. We also assessed whether diabetes mellitus was an effect modifier of the 
associations. Participants included the subset of the ARIC cohort who completed cognitive 
assessment and dental screening or comprehensive dental examination at Visit 4 (1996-1998).  
Rationale: An association between poor oral health and cognitive impairment has been 
reported primarily in older (e.g., age 65+ years) populations (16,20-22). It is not fully established 
whether this association is present in midlife as well. The association could arise from an effect of 
impaired cognitive function on oral health or from an effect of poor oral health on cognitive decline. 
Several mechanisms have been proposed to support both of these possibilities. Older adults with 
cognitive decline are susceptible to poor oral health since they are unable to perform proper oral care 
and receive routine dental care less often (19). Moreover, decrease in saliva production, a common 
side effect of neurological medication, leads to impaired oral clearance and neutralization of dental 
plaque acid (23). Explanations for the reverse association are that impaired masticatory function 
resulting from complete tooth loss may influence food choices and affect nutritional status, which in 
turn, may cause cognitive decline (24). In addition, it has been claimed that periodontal disease can 
result in an elevation of systemic inflammatory molecules such as serum CRP and can play an 
                                                      
1Cognitive function test consists of the Delayed Word Recall (DWR) test, the Digit Symbol Substitution Subtest (DDS) of the Wechsler 
Memory Scale-Revised, and the first-letter Word Fluency (WF) test. 
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important role in the pathogenesis of dementia (16,25,26). Lastly, cardiovascular disease and 
dementia share pathophysiology as well as several common risk factors (10,27,28). Since 
periodontal disease is a predictor of cardiovascular diseases (29-31), a link between periodontal 
disease and dementia could be mediated through cardiovascular diseases. However, it is unclear to 
what extent the association may be accounted for by other factors that contribute to cognitive decline 
and are associated with poor oral health status or elevated levels of inflammatory markers, such as 
low education and cardiovascular risk factors. The present study sought to elucidate the associations 
of poor oral health with developing cognitive impairment by verifying that the association exists in 
midlife and was not attributable to confounding.  
Associations between periodontitis and diabetes have been consistently reported in 
epidemiologic studies (32-34). Both diseases share a common pathogenesis that involves an 
increased systemic inflammatory response. In addition, the relationship between diabetes and 
periodontal disease could be diabetes predisposing to periodontal infection, and once that infection is 
established, periodontal infection may exacerbate progression of diabetes. A recently ARIC study 
found that among people with diabetes, periodontal disease was associated with the increased oods 
for suclinical atherosclerotic heart disease and CHD compared to those with without diabetes or 
periodontal disease (35). Therefore, we further determined whether diabetes modify the association 
of periodontal disease with cognitive function. 
Elevated levels of inflammatory markers were hypothesized as a mediator of the association 
between periodontal disease and cognitive function. We justified not adjusting for the mediator to 
decompose a total effect of periodontal disease on cognitive function into a controlled direct effect 
(i.e., the effect of periodontal disease on cognitive function not due to inflammation) and an indirect 
effect (i.e., the effect of periodontal disease on cognitive function that occurs via inflammation) in 
regression analyses because the adjustment may lead to bias in the estimates. Valid estimation of the 
direct and indirect effects using the classical approach requires the following assumptions: a) 
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absence of unit-level exposure-mediator interactions, b) no confounding of the mediator-outcome 
association, and c) collapsibility of the association measures. In the context of the present study, 
assumptions a) and b) are major concerns. There must be no individuals for whom periodontal 
disease status and level of inflammation interact to influence the risk of cognitive decline. This 
situation is unlikely to occur in real life because the degree of systemic inflammatory marker is a 
complex interaction of microbiological components and host inflammatory response. If this 
assumption does not hold, it is impossible to derive a single direct effect of periodontal disease by 
adjusting for the level of inflammatory biomarkers. Additionally, to adjust for a causal intermediate 
along with controlling for other confounders of intermediate-outcome association may induce 
selection biases. Marginal structural models (MSM) fit using inverse probability weights (IPWS) 
may be an alternative to the classical mediation analysis. MSM can be used to control for 
confounders and mediators while avoiding selection biases due to conditioning on the causal 
intermediate (36,37). However, causal explanation of our results was largely constrained by 
temporality of periodontal disease-inflammatory mediator-cognitive function associations (i.e., no 
clear evidence of temporal relationships between the exposure, the causal intermediate, and the 
outcome). For these reasons, only the total effect of periodontal disease on cognitive function was 
estimated. 
Aim 2: Using data from two ARIC sites, estimate associations of oral health measures with eight-
year changes (between ARIC Visit 4:1996-1998 and 2004-2006) in cognitive function. 
Hypotheses: a) greater number of missing teeth is associated with greater degrees of 
cognitive decline, and b) severe periodontal disease is associated with greater degrees of cognitive 
decline. 
Overview: The study included ARIC participants who answered dental screening questions 
at ARIC Visit 4 (1996-1998) and participated the 2004-2006 Brain MRI substudy in two ARIC 
study sites (Forsyth County NC and Jackson MS). We evaluated associations between oral health 
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measures and the changes on three cognitive function scores after controlling for socio-demographic 
factors. For each hypothesis, we also assessed whether combined effects of periodontal disease with 
diabetes were associated with greater cognitive decline.  
Rationale: Periodontal infection in late middle-aged adults may contribute to onset and 
progression of cognitive decline. However, few longitudinal studies have investigated the 
association between oral health and cognitive function or dementia (13,20,38,39). It is also not clear 
whether impaired oral health begins to affect cognitive performance in midlife or if the impact of 
poor oral health is delayed. The present study investigated the relationship between poor oral health 
status in late middle-aged adults and changes in cognitive function over the eight years of follow-up. 
Periodontal infection can possibly manifest as tooth loss (i.e. an ultimate outcome of untreated 
severe periodontal infection). Therefore, we also studied if tooth loss in late-middle-age adults 
predicted cognitive decline. Since host defense mechanisms in diabetic individuals have been 
altered, facilitating bacterial persistence in the periodontal pockets, increasing production of pro-
inflammatory cytokines, thus we also examined the potential modifying effect of diabetes on the 
association between periodontal disease and cognitive decline. With longitudinal study data, 
standardized measures of periodontal disease, and careful follow-up, we were able to establish clear 
evidence that poor oral health in midlife predicted changes in cognitive function.  
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RESEARCH METHODS 
A. Study design 
We tested our hypotheses by using ARIC data from Visit 4 (1996-1998) to 2004-2006. ARIC 
is a prospective, population-based study of vascular diseases in a biracial cohort of middle-aged 
adults followed from Visit 1 (1987-1989) to Visit 5 (2011-2013). Analyses for each study aim were 
based on existing data from: (a) main ARIC, (b) Dental ARIC, and/or (c) brain MRI substudy (Figure 
3-1). The associations between oral health measures with cognitive function were evaluated after 
controlling for socio-demographic characteristics and putative confounders. Potential effect 
modification by diabetes mellitus was also examined.  
B. Source of population 
At inception (1987-1989), probability samples of men and women, 45 to 64 years of age, 
were constructed in four different U.S. communities: Forsyth County NC, Jackson MS, suburban 
Minneapolis MN, and Washington County MD. African Americans were sampled exclusively in 
Jackson and were oversampled in Forsyth County. The baseline examination included 15,800 men 
and women, with response rates of 46% in Jackson and 65-67% in the other three communities (1). 
Follow-up visits occurred every three years through Visit 4, which was completed between 1996 and 
1998. Follow-up at Visit 5 will continue through 2013. 
C. Data sources and participants’ involvement 
In the present study, the exposures were obtained from Dental ARIC, a cross-sectional 
investigation performed at Visit 4 (1996-1998) on a subset of the dentate ARIC cohort, Dental ARIC 
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consisted of interviews, oral examinations, and collections of GCF, dental plaque and serum. Levels 
of inflammatory markers related to periodontal disease were identified from GCF and serum samples. 
A total of 11,656 ARIC participants were seen for Visit 4. Participants were excluded from the Dental 
ARIC study if they required antibiotics prior to the dental examination (n = 1,621), because pocket 
depth could not be measured or if they had no natural teeth (n = 1,651). Of the 8,384 individuals 
eligible to participate in the Dental ARIC study, 6,976 underwent a dental examination (2). 
The main outcomes, cognitive test scores, were obtained from ARIC Visit 4 and from the 
2004-2006 Brain MRI substudy. Brain MRI studies were carried out among participants from two 
study sites (Forsyth County NC and Jackson MS) on two separate visits (Visit 3 and 2004-2006) to 
investigate cerebral abnormalities (e.g., WMHs, SW, and VS). Of the 2,891 participants screened for 
eligibility during Visit 3, 1,949 participants (67%) received initial brain MRI scan (3). Of those 
received the initial brain MRI scan, 1,112 participants (57%) underwent a second brain scan and 
cognitive assessment during 2004-2006 after excluding those who refused and were ineligible (4). 
Socio-demographic characteristics and related medical histories were abstracted from the ARIC data 
sets. 
Participants were included in the analysis for each study aim if they had received a dental 
screening or periodontal examination at Visit 4. Data for periodontal status and number of remaining 
teeth were available only for dentate participants who had an oral examination in Dental ARIC. The 
dental screening questionnaires were used to identify ARIC participants who were edentulous 
(complete tooth loss) at Visit 4. Eligible participants were also required to complete cognitive 
function assessment: a) at Visit 4 for Aim 1 and b) at the Visit 4 and 2004-2006 for Aim 2. (Figure 4-
3, 5-7) 
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D. Sample size and power  
Sample sizes that address each aim are shown in Table 3-1. A statistical power analysis was 
carried out with periodontal status as an exposure (dichotomy) and cognitive function (continuous) as 
a primary outcome. For aim 1, we used the available sample size for complete case analysis (n ~ 
6,400). A two-sided alpha of 0.05 and power of 0.80 were used to calculate minimum-detectable 
differences in cognitive function at Visit 4, expressed as unit normal deviates for a two-sample t test. 
Calculated effect sizes represent group differences as the number of standard deviations. Unequal size 
risk groups were specified (BGI-DL/SB vs. others = 1:7). Calculations with the SAS power procedure 
showed that the minimum detectable mean difference was 0.11 standard deviations  (Figure 3-2). By 
way of comparison, there was a reduction of 0.27 in standard deviations in mean DSS test scores 
between 1996-1998 and 2004-2006. Therefore, the present study has sufficient power to detect an 
association of periodontal disease with a difference in cognitive function of a magnitude similar to the 
declining occurring in the entire cohort with the passage of nine years. For aim 2, the effect of 
periodontal status on cognitive function were tested using a longitudinal study design in which 
cognitive scores were repeatedly measured at Visit 4 and 2004-2006. Given the smallest available 
samples size for complete case analysis (n ~ 500) and an assumed correlation between repeated 
measures of 0.5-0.6, the present study has 80% power to detect minimal effect size of 0.3-0.4. 
E. Assessment of exposures, outcomes, and covariates 
Exposure variables 
For the present study, the following oral health measures were used as exposure variables 
indicative of oral disease burden: a) dentate status; b) number of remaining teeth; and c) periodontal 
status.  
Periodontal disease status: Severity of periodontal disease was classified by using BGI, a 
clinical index reflecting biologic phenotype of periodontal disease based on measures of PPD and 
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extent of BOP (Table 3-2)(6). Trained examiners (n = 6) recorded periodontal assessments according 
to Dental ARIC examination protocol. In summary, the periodontal examination included 
measurements of PPD and gingival recession (GR) at six sites per tooth for all teeth present. PPD was 
determined with a UNC-15 periodontal probe and recorded in millimeters, with fractions of 
millimeters rounded to the next lower millimeter. After each quadrant of PPD measures was 
completed, BOP was assessed and recorded. BOP was determined as either present or absent for each 
site in a given quadrant. The extent of BOP was expressed as a percentage of all sites. At the same 
sites, GR was the distance from the cemento-enamel junction (CEJ) to the free gingival margin, and 
recorded in millimeters with fractions of millimeters rounded to the next lower millimeter. 
Attachment loss was calculated during data analysis as the sum of PPD and GR. Periodontal 
examiners at the ARIC centers were calibrated to a standard examiner, and the percent agreement for 
attachment loss (within 1 mm) between each examiner and the standard examiner, ranged from 83.2% 
to 90.2%. Weighted Kappa statistics ranged from 0.76 to 0.86, indicating excellent to outstanding 
agreement (2).  
Number of remaining teeth: Examiners recorded the number of permanent teeth including 
root fragments (range 1-32). 
Dentate status: For ARIC participants who received dental screening, we created a binary 
variable, dentate status (edentulous vs. dentate) from two self-reported screening questions: “Do you 
have any natural teeth?” and “Do you have any dental implants?”. People were classified as dentate, 
if they had any natural teeth. If they had no natural teeth, they were classified as edentulous, even if 
they had dental implants. 
Outcome variables  
The main outcome variables for Aims 1 and 2 were continuous measures of three cognitive 
function tests. 
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Cognitive function scores: We quantified changes in cognitive function scores measured at 
the eight-year intervals. Cognitive function assessment consisted of the DWR, DSS, and WF tests. 
Details of the cognitive assessment protocol have been described elsewhere (3,5). In brief, the DWR 
is a test of verbal learning and recent memory. Study participants were asked to recall a list of ten 
common nouns, one at a time. After a five-minute delay, the participant was asked to recall these 
words by composing a sentence with each one. The DWR score received was the total recalled 
correctly (score ranges from 0 to 10). The DSS test is a test of concentration and psychomotor speed. 
Participants were required to translate numbers to symbols using a key within 90 seconds. The total 
number of correct translations determined the score (a range from 0 to 93). The WF test is a test of 
expressive language. The participants were asked to generate words beginning with “F”, “A”, and 
“S”, not including proper names or places, within 60 seconds for each trial. The total score included 
the combined total of correct words generated for the three trials. Trained examiners administered all 
assessments in a standardized order during one session in a quiet room. Examiners’ performance was 
monitored by audiotaped recordings. These tapes were reviewed to ensure that the testing procedure 
was consistent across the study centers.    
Covariates 
Covariates presumed to modify or confound the associations between oral health and 
cognitive decline are presented in directed acrylic graphs (DAGs) according to hypothesized causal 
pathways (Figures 7-1, 7-2). These covariates were and entered as time-independent variables in 
regression models. Variables at similar levels in the causal paths were grouped to facilitate the 
identification of causal intermediates and simplify the graphic representation. The following are 
selected covariates and their coding for the analyses.  
Socio-demographic factors were assessed by standard interview at Visit 1.  They included 
gender (male, female), age in years, race (White and African American), education (<12 years, less 
than high school; 12-16 years, high school completion; or ≥17 years, post-secondary education), and 
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income (Refused, <$25,000, $25,000-50,000, and >$50,000). A variable representing race and ARIC 
filed centers was created to control for the racial, regional, and examiner differences in the ARIC 
cohort as the following: Forsyth/White (FW), Forsyth/Black (FB), Jackson/Black (JB), 
Minnesota/White (MW), and Washington/White (WW). 
APOE genotyping was performed using the TaqMan assay (Applied Biosystems, Foster City, 
CA). The APOE variants at codons 112 and 158 were detected separately. Data from these two 
codons were combined to generate the six APOE genotypes as ε2/2, ε2/3, ε3/3, ε4/2, ε4/3, and ε4/4. 
A binary variable was created to represent the presence or absence of the ε4 allele (5). 
Prevalent CHD at Visit 4 was defined as adjudicated myocardial infarction on the 
electrocardiogram at baseline or prior self-reported history of myocardial infarction, coronary artery 
bypass surgery, or angioplasty. 
Prevalent stroke at Visit 4 was defined as a self-reported history of physician-diagnosed 
stroke or stroke validated by an ARIC clinician through a review of medical records. 
Cardiovascular risk factors at Visit 4 were self-reported hypertension (yes, no), diabetes 
mellitus (yes, no), hyperlipidemia (yes, no), body mass index (BMI) in kg/m2, smoking status (never, 
former, and current), and alcohol use (never, former, and current). 
Hypertension was defined as systolic blood pressure ≥ 140 mm Hg, diastolic BP ≥ 90 mm 
Hg, or hypertensive medication usage in the previous two weeks. Systolic and diastolic blood 
pressures were measured three times using a random zero sphygmomanometer in the right arm of 
seated participants; the mean of the last two measurements was calculated for each individual. 
Diabetes mellitus was defined as a fasting glucose level of ≥126 mg/dL, nonfasting glucose ≥ 
200 mg/dL, self-reported history of diabetes, or regular pharmaceutical treatment for diabetes. 
Participants were asked to fast for 12 hours before the clinic visit. Blood was drawn from the 
antecubital vein of seated participants, and serum glucose was assessed by the hexokinase method. 
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Hyperlipidemia was defined as LDL cholesterol of ≥140 mg/dL or the use of cholesterol-
lowering agents. Plasma lipids and lipoproteins were determined by enzymatic methods in a 
laboratory standardized by the CDC. LDL cholesterol was estimated by the Friedewald equation1. 
BMI was calculated as weight in kilograms divided by the square of height in meters. A 
continuous measure of BMI will be used for the analyses.  
Smoking was self-reported as never smoked, former smoker, or current smoker. 
Alcohol drinking was assessed from subject self-report and described as never, former, or 
current drinker. 
F. Statistical analyses 
Overview of analytical approach 
All analyses were performed using SAS version 9.3 (SAS Institute, Inc., Cary, North 
Carolina). We primarily used a complete case analysis for the outcome variables, and assessed 
frequency and pattern of missing independent variables. Candidate variables were eliminated if their 
distributions were too narrow to be meaningfully predictive or they had a substantial proportion of 
missing values (> 20%). Initial descriptive statistics and plots were generated. Means and percentages 
for each outcome variable were assessed in bivariate and stratified analyses. 
Study hypotheses were evaluated using generalized linear models (GLMs) fit with the SAS 
PROC GENMOD procedure to examine associations between oral health measures and cognitive 
function. GLMs are flexible and well suited to a wide range of situations, including traditional general 
linear regression. For a normally distributed continuous variable (e.g., cognitive test scores), we used 
least-squares linear regression, for which the “identity” link function was specified. In addition, we 
used an extension of GLMs, marginal generalized estimating equations (GEE) models, for a repeated 
                                                      
1Friedewald formula: LDL = TC – HDL- TG/0.5 (mg/dL) 
TC, Total cholesterol (mg/dL); HDL, High-density lipoprotein (mg/dL); TG, Triglycerides (mg/dL) 
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outcome (cognitive function scores), where a within-subjects correlation was taken into account. In 
this case, the GENMOD procedure offers a “REPEATED” statement to analyze such correlated 
outcomes data. 
DAGs and the change-in-estimate procedure were used for adjustment-variable selection. We 
selected explanatory variables based on published studies and biological plausibility of the 
relationships. DAGs showed the selected covariates and their relationships with the exposures and 
outcomes in the causal paths. We also used results of bivariate, stratified, and collinearity analyses to 
guide the selection of variables for model building.  
Descriptive statistics 
Descriptive analyses were initially performed on selected variables to study data distributions 
as well as identify missing values, impossible values, and outliers for outcomes, exposures, and 
covariates. We used PROC UNIVARIATE to examine mean, median, mode, standard deviation, 
range, skewness, and kurtosis for each continuous variable (e.g., cognitive score, number of teeth, and 
levels of inflammatory markers). In addition, data distributions were visualized using graphical 
displays such as box plots and scatterplots. Frequency distributions were evaluated using PROC 
FREQ for ordinal and categorical variables (e.g., periodontal disease status, CHD, and stroke). The 
number, percentage, and type of missing data were recorded for each variable.  
Bivariate and multivariate analyses 
We conducted bivariate analyses to investigate the nature and strength of the following 
associations: (a) between explanatory variables and both outcomes, and (b) among explanatory 
variables. These analyses helped to identify potential cofounders, effect modifiers, and collinearity for 
regression model building. First, we calculated a crude estimate of the association between the 
exposure and the outcome using general linear regression for continuous outcomes (mean ± SE).  
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Second, we examined stratum-specific estimates for the presumed effect modifier (diabetes mellitus). 
If the stratified estimates were substantively different from each other and a likelihood ratio test for 
homogeneity suggests strong effect modification (p < 0.10), then we included an interaction term 
between the effect modifier and the exposure in the regression model. Next, we determined whether a 
covariate was a potential confounder by assessing a magnitude and the 95% confidence interval along 
with the p-value between the covariate and the exposure or outcome. Then, we compared magnitude 
and precision of the estimates for the exposure-outcome association with and without adjustments for 
that covariate. If the estimate adjusted for a selected variable differed from the crude estimate by 
more than 10%2, we considered that covariate to be a potential confounder. 
Collinearity and multicollinearity among continuous and ordinal explanatory variables were 
investigated using PROC REG with options VIF, TOL, and COLLIN in SAS. For nominal or 
categorical independent variables, the same approach was applied. We created dummy variables for 
each category and use our outcome of interest as the dependent variable in the linear regression. We 
examined tolerance3 and variance inflation factor (VIF) for each variable. The VIF is 1/Tolerance; it 
is the number of times the variance of the corresponding parameter estimate is increased due to 
multicollinearity as compared to as it would be if there is no mulitcollinearity. Values of VIF 
exceeding 10 suggest multicollinearity. If the variables were correlated covariates, coding choices 
were reconsidered or one variable may be dropped from the analyses. 
Analysis plan for specific aim 1 
We estimated associations of the following oral health measures with cognitive function:  
a. Dental status 
b. Tooth loss 
                                                      
2The change in estimate is the absolute difference between the crude estimate and the adjusted estimate divided by the adjusted estimate:  
(βcrude - βadjusted) x 100. A priori criterion for a potential confounder is that the change in estimate is greater than 10%. 
 
3 For each independent variable, tolerance = 1-Rsq, where Rsq is the coefficient of determination for the regression of that variable on all 
remaining independent variables, low values indicate high multivariate correlation. 
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c. Periodontal disease classified by BGI 
The conceptual basis for these analyses was that poor oral health can be predictive of low 
cognitive performance. The main hypothesis was that persons who are edentulous, have lost most of 
natural teeth, or have severe periodontal disease have lower cognitive scores. We also investigated 
whether diabetes mellitus was an important modifier of the relationship between each predictor and 
cognitive function. Separate regression models were applied for each outcome-exposure association. 
Independent variables included an ordinal measure of periodontal disease (five levels forBGI index), 
continuous measures of remaining teeth, and a binary measure of dental status (edentulous or 
dentate). Dependent variables were continuous measures of three cognitive functions. Thus, linear 
regression was used to analyze the data. The linear trend across the periodontal status categories was 
tested. First, we evaluated the primary effect for each main outcome, adjusting for age, gender, race-
center, education, and income. Second, we developed a fully adjusted model by including all potential 
confounders and effect measure modifiers based on DAGs and bivariate analyses. A reduced model 
was also created using the minimally sufficient set of covariates for adjustment used in the multiple 
analyses included age, race, gender, study sites, education, income, smoking, alcohol use, and 
diabetes. Covariates in fully adjusted models consisted of variables from the reduced model and 
variables that were significantly associated with exposures or outcomes, namely body mass index 
(BMI), hyperlipidemia, hypertension, and APOE ε4. Significance of effect modification by diabetes 
was assessed with likelihood ratio tests by comparing the -2log-likelihood of the fully adjusted model 
(i.e. model included the interaction term between the exposure and diabetes) with that of the nested 
model (i.e. model excluded the interaction term). The interaction term was removed if its p-value was 
greater than 0.10. Third, the change-in-estimate approach was used to select the final model. 
Regression coefficients for oral health measures (i.e., dental status, the number of teeth, and BGI) 
from the reduced model and those from the fully adjusted model were compared. If the change-in-
estimate was less than 10% or ± 0.1, the more parsimonious model or the reduced model was 
selected. 
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Analysis plan for specific aim 2  
We used data from two ARIC sites to estimate associations of oral health status measures 
(e.g.,BGI index, tooth loss, and complete tooth loss) with the eight-year change in cognitive function 
between ARIC Visit 4:1996-1998 ("baseline") and 2004-2006 ("follow-up"). A longitudinal analysis 
using the GEE method was applied for the cognitive function measures. The dependent variables 
were continuous measures of three cognitive function scores (DSS, DWR, and WF). We created an 
indicator variable, namely time (t), to identify whether the scores represented a baseline or follow-up 
measurement. We assumed unstructured correlation for all pairs of within-subject outcomes (i.e., 
cognitive score); therefore, working correlation matrix as “unstructured” was specified for the 
correlated responses in the analyses. In the model, the main effect of time indicated if the cognitive 
scores significantly changed over the 8-year follow-up. The interaction term between time and the 
exposure was added to determine whether there was a significant difference in the change of 
cognitive scores between participants who had poor oral health and those who did not. 
 
Above is the fully adjusted model where Yit is an observation for subject i at time t;  β0 is the 
intercept; x is the oral health measure; β1 is the regression coefficient for the oral health measure x; β2  
is the regression coefficient for time; x* t is an interaction term between Visit 4 oral health measure 
and time; β3 is the regression coefficient for the interaction term; Gim are the values of the m  time-
independent covariates for subject i; β4m  are the regression coefficients for the time-independent 
covariates; M is the number of time-independent covariates; and εit is the error for subject i at time t. 
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Since GEE fits models using a quasi-likelihood method, not a maximum likelihood, “Quasi-
likelihood under the independence model information criterion” (QIC) was used to assess the model 
fit. A smaller QIC suggests a better fit of the model. 
G. Protection of human subjects  
Human subjects involvement, characteristics, and study design 
The present study was a secondary analysis of the ARIC, a prospective, population-based 
study of vascular diseases. The final datasets for the analyses were derived from three main 
measurements: a) cognitive function assessments; b) Brain MRI; and c) dental screening and 
examination at ARIC Visit 4. Our primary hypotheses were that: a) poor oral health was predictive of 
early cognitive decline and rapid progression of the decline over time; and b) the magnitude of 
change in cognitive test scores was greater among individuals with few teeth or an extensive form of 
periodontal disease.  
Participants were from four geographic areas in the US, which were Forsyth County NC, 
Jackson MS, the suburbs of Minneapolis MN, and Washington County MD. We used ARIC data 
from Visit 4 through 2004-2006. To address each study aim, eligible study subjects for the analyses 
were ARIC participants who underwent a dental examination or screening and cognitive or Brain 
MRI assessment. Estimated samples sizes are presented in Table 3-1. 
Sources of materials 
Statistical analyses were based on data available from the ARIC Coordinating Center at 
UNC-Chapel Hill. Information obtained from participants included socio-demographic status (age, 
gender, race, study site, education, and marital status), cognitive performance (DWR,  DSS, and WF), 
oral health measures (dentate status, number of teeth, and periodontal disease), cardiovascular risk 
factors (hypertension, diabetes, smoking status, alcohol use, etc.), CHD, stroke, and APOE genotype. 
Strict data confidentiality procedures have been established for the ARIC study. They are applicable 
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to all ancillary studies and are followed here. Only the ARIC study principal investigators have access 
to individually identifiable information of subjects. The principal investigator for the present study 
received de-identified files from the ARIC Coordinating Center for data analyses. 
Potential risks and adequacy of protection against risks 
  This study is based on an existing dataset, and there is no direct interaction with subjects. 
Therefore, risk of physical harm to subjects is not applicable and potential for psychological harm 
limited to breach of confidentiality. After merging data from all study visits, personal identifiers was 
removed from the dataset for each visit by ARIC Coordinating Center staff. The final dataset is a de-
identified dataset and, thus, the risk of disclosure is minimal. For security purposes, the final dataset 
is stored in the School of Dentistry research database, which is password enabled and backed up 
periodically. Only authorized personnel have access to the dataset, and the password is changed 
periodically.  
Potential benefits of the proposed research to human subjects and others 
Since the study involved no direct interaction with study participants, there was no direct 
benefit to the individual subjects. However, results from the study can provide important medical 
information to society as a whole. The study allowed us to assess whether tooth loss and periodontitis, 
based on clinical measurements of periodontal status are independently associated with cognitive 
decline in later life. If the association exists, periodontal treatment or prevention may be a promising 
strategy to reduce the incidence of cognitive impairment and dementia.  
Importance of knowledge to be gained 
The costs and social burden resulting from cognitive impairment and dementia are increasing 
in the U.S. and worldwide. This project contributes novel scientific knowledge that addresses a major 
public health concern in older adults. To our knowledge, this is the first study to examine associations 
between periodontal disease (BGI index) and cognitive function using prospective longitudinal data. 
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H. Tables 
Table 3-1. Numbers of subjects participating in the ARIC study from Visit 1 through Visit 4, Dental 
ARIC, and Brain MRI  
 
 
Table 3-2. Definition and prevalence of periodontal disease classified by Biofilm-Gingival Interface 
(BGI) system in adults aged 52 to 74 years at ARIC Visit 4 
 
  
Study/Examination 
1987-1989 
Visit 1 
1990-1992 
Visit 2 
1993-1995 
Visit 3 
1996-1998 
Visit 4 
2004-2006 
Main ARIC  15,800 14,348 12,887 11,656  
Cognitive function  14,201 2,077 11,343 1,112 
ARIC Brain MRI   1,949  1,112 
Dental ARIC: Dental screening  11,378  
Dental ARIC: Dental examination  6,967  
Proposed study: Expected number of participants for each study aim and exposure 
 Aim 1                
 (a) Dental status  
 
~10,000 
 
(b) Tooth loss 
 
~6,400 
 
(c)  PD  
 
~6,400 
 
Aim 2 
(a)  Dental status 
 
~900 
(b)  Tooth loss 
 
~500 
(c)  PD  
 
~500 
Periodontitis Classification (6) Definition Prevalence 
No pockets/ Low bleeding (BGI-H) All PPD ≤ 3 mm, BOP < 10% 14.3% 
No pockets/ Moderate-Severe bleeding (BGI-G) All PPD ≤ 3 mm, BOP ≥ 10% 15.1% 
Pockets/Low bleeding (BGI-DL/LB) One or more PPD ≥ 4 mm, BOP < 10% 18.0% 
Pockets/Moderate bleeding (BGI-DL/MB) One or more PPD ≥ 4 mm,10% ≤ BOP < 50% 39.7% 
Pockets/Severe bleeding (BGI-DL/SB) One or more PPD ≥ 4 mm, BOP ≥ 50% 12.9% 
PPD, periodontal probing depth; BOP, bleeding on probing 
Offenbacher S, Barrons SP, Singer RE, et.al. Periodontal Disease at the Biofilm-Gingival Interface. J Periodontal 2007;78;1911-
1925.(6) 
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Table 3-3. Summary of candidate variables, coding, and analytic approach 
 
Variables  Coding  Aim 1  Aim 2 
 Visit 4 DWR, DSS, WF  Continuous  Outcome  Outcome 
 2004-2006 DWR, DSS, WF  Continuous  Not used  Outcome 
 BGI  Categorical  Exposure  Exposure 
 Number of teeth  Continuous   Exposure  Exposure 
 Dentate status (Yes / No)  Binary  Exposure  Exposure 
 Stroke (Yes / No)  Binary  Covariate  Covariate 
 CHD (Yes/ No)  Binary  Covariate  Covariate 
 Age  Continuous  Covariate  Covariate 
 Gender (Female / Male)  Binary  Covariate  Covariate 
 Education (<12, 12-16, ≥ 17 years)  Categorical  Covariate  Covariate 
 Income (< $25,000, $25-50,000, >$50,000, 
refused) 
 Categorical  Covariate  Covariate 
 Race-center (FB, FW, MW, WW, JB)  Categorical  Covariate  Covariate 
 APOE ε4 genotype (Yes / No)  Binary  Covariate  Covariate 
 BMI   Continuous  Covariate  Covariate 
 Hyperlipidemia (Yes / No)  Binary  Covariate  Covariate 
 Hypertension (Yes / No)  Binary  Covariate  Covariate 
 Diabetes mellitus (Yes / No)  Binary  Covariate  Covariate 
 Smoking (Current/ Former/Never)  Categorical  Covariate  Covariate 
 Alcohol (Current/ Former/Never)  Categorical  Covariate  Covariate 
 Time (Baseline/Follow-up)  Binary  not used  Covariate 
Interaction terms       
 BGI x Diabetes    Yes  Yes 
 (BGI, number of teeth, dentate status) x Time    Not used  Yes 
Models 
 General linear regression   Yes  No 
 GEE   No  Yes 
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I. Figures 
 
Figure 3-1. Data sources, key variables, and study design for each specific aim 
 
Figure 3-2. Power plot for detectable difference in means between BGI-DL/SB vs. others (Difference 
is expressed as a number of standard deviations.)  
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STUDY 1: RESULTS 
Associations between oral health measures and cognitive function in late middle-aged adults: A 
community-based study 
A. Overview 
Associations between tooth loss, periodontal disease, and cognitive function have been 
reported primarily in older adults. It has not been established whether this association is present in 
late middle-aged adults as well. The purpose of this investigation was to determine whether tooth loss 
and periodontal disease were associated with lower cognitive function in adults aged 52-75 years who 
participated in the Atherosclerosis Risk in Communities (ARIC) study. Cognitive function was 
assessed in 11,097 participants between 1996 and 1998 (Visit 4) by three cognitive tests: Delayed 
Word Recall (DWR), Digit Symbol Substitution (DSS), and Word Fluency (WF). At Visit 4, 9,874 
answered dental screening questions, and 5,942 of the 8,554 dentate participants received 
comprehensive oral examinations, including periodontal probing. Multiple linear regression models 
used dental status, number of teeth, or clinical periodontal conditions classified by the Biofilm-
Gingival Interface (BGI) index to predict cognitive scores, adjusting for socio-demographic factors, 
smoking, alcohol use, and diabetes. Approximately 13 % of participants were edentulous. 27.3% of 
dentate participants had < 20 teeth and 12.4 % had pocket depth ≥ 4 mm with severe bleeding. 
Compared to dentate participants, edentulous subjects had lower scores for all cognitive tests. Among 
the dentate, fewer teeth and gingival bleeding were associated with lower DSS and WF scores, 
although periodontal pocket depth was not. Complete tooth loss and gingival bleeding were markers 
of poorer cognitive function. These findings indicate that association between periodontal  
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inflammation and cognition that has been observed in older adults is present in late middle-aged 
adults. The association with tooth loss suggests that oral disease earlier in life might be a marker of 
future cognitive decline in late middle-age. The association with gingival inflammation illustrates the 
potential for bi-directional relationships between oral disease and cognitive decline.  
B. Introduction 
 
 
As the populations age, cognitive impairment and dementia are becoming challenging public 
health problems because they adversely affect older adults’ quality of life and health care costs (1). 
Many studies, primarily in older adults have linked oral diseases and/or previous tooth loss with low 
cognitive performance and dementia onset (2-10). However, although the associations are clear, they 
could arise from various mechanisms. For example, persons with cognitive impairment have reduced 
ability for oral hygiene, which would lead to poor oral health (11). Cross-sectional studies, which are 
typically unable to establish the temporal sequence underlying causal associations, have provided 
most of the evidence to date. 
In addition, if the mechanism behind the association begins with cognitive impairment, an 
extended interval would be needed for the subsequent decline in oral health to translate into tooth loss 
and edentulism, making that scenario less probable. Therefore, a more likely reason for the 
association may be that poor oral health leads to cognitive decline. Several studies suggest that 
periodontal infection and increased inflammatory levels in early life could be responsible for later 
cognitive decline (6,7,12-14). For example, a case-control study found oral bacteria more frequently 
in the brains of Alzheimer’s disease (AD) than non-AD subjects (15). A recent pilot study using high 
throughput DNA sequencing reported higher levels of Prevotellaceae from subgingival plaque in 
participants with dementia (16). It is also possible that periodontal disease may affect cognition in 
midlife (17). 
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Many studies of the association between cognitive performance and periodontal disease have 
used a wide range of indicators of past and current periodontal disease, including tooth loss 
(3,5,6,8,18), presence of microorganisms (15), immunological biomarkers (13,14,16,19), and clinical 
signs of periodontal destruction and inflammation (3,5,7,8,12). Tooth loss is an imperfect indicator of 
periodontal disease since tooth loss can result from non-inflammatory causes (e.g., caries and 
trauma). More direct evidence comes from studies using oral bacteria burdens and systemic antibody 
levels, which strongly suggest that periodontal disease contributes to the pathogenesis of 
neurodegenerative diseases and cognitive decline. Although most of these studies are small, high 
levels of immunoglobulin G antibody against the periodontal pathogen P. gingivalis were found to be 
associated with cognitive impairment in a large U.S. national health survey, NHANES (13). In 
addition, a recent longitudinal study, with an average follow-up of 10 years, showed that individuals 
who developed Alzheimer’s disease (AD) had higher baseline levels of serum antibodies to F. 
nucleatum and P. intermedia (14).  
These two studies provide important evidence, but they examined only two of the dozens of 
known periodontal pathogens. Studies that have investigated associations between cognitive decline 
and clinical signs of periodontal disease (e.g., pocket depth, gingival bleeding, or attachment loss) 
have reported inconsistent results (2,5,7,8,12,17,19). Possible reasons are that many of these studies 
are small (7,12,19) and have relied on measures of periodontal disease based on partial examinations 
(8,17) or self-report (2). In addition, attachment loss, often used as an indicator of past periodontal 
disease, may also reflect non-inflammatory processes such as gingival recession from physical injury 
from tooth brushing or flossing.  
The purpose of the present study, therefore, was to examine associations between cognitive 
performance in midlife adults and periodontal disease assessed with an index that reflects current 
state of probing depth and inflammation. Toward that end we related three measures of cognitive 
performance to three indicators of oral health – dental status, number of teeth, and periodontal disease 
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classified by the Biofilm-Gingival Interface (BGI) classification–among middle-aged adults in the 
Atherosclerosis Risk in Communities (ARIC) study. We hypothesized that lower cognitive 
performance was associated with edentulism, tooth loss, and severity of periodontal disease. 
C. Methods 
Design and study population 
The present cross-sectional study used ARIC and Dental ARIC data collected between 1996 
and 1998 (Visit 4). Details regarding the study designs and protocols have been reported elsewhere 
(20-22). Briefly, ARIC is a prospective, community-based study of middle-aged adults (age 45-64 
years at inception) followed since 1987-1989 (Visit 1). Dental ARIC, an ancillary study of the parent 
ARIC study, was conducted at Visit 4. We confined our analysis to African American and white 
participants who received a cognitive assessment and dental screening interview at that visit. A subset 
of screened dentate participants also underwent comprehensive dental examination, which included 
periodontal probing. Of 11,097 participants who completed Visit 4 cognitive battery tests, 9,874 
answered dental screening interviews that asked about tooth loss. Of the 8,554 dentate respondents, 
5,942 received a dental examination (Supplemental Figure 4-3).   
Oral health measures 
Exposures included dental status, number of teeth, and clinical classification of periodontal 
disease. An individual’s dental status was obtained from answers to the following two items on a self-
administered questionnaire: “Do you have any natural teeth?” and “Do you have any dental 
implants?” Participants with only dental implants (n = 21) were excluded from the study. During the 
dental examination, the number of teeth present was recorded. Periodontal probing depth (PPD) and 
bleeding on probing (BOP) were assessed at six sites on all remaining teeth by trained examiners.  
The BGI system has been developed based on a concept that clinical disease classification 
should reflect an underlying biological process of periodontal disease that involves a complex 
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interaction of the microorganisms with host inflammatory and immune response.BGI index, based on 
measures of PPD (≤ 3 mm or ≥ 4 mm)  and the extent of BOP (<10%, low; 10-50%, moderate; or ≥ 
50 %, severe), was used to classify periodontal status into five levels. Subjects with PPD ≤ 3 mm (no 
periodontal pockets) were defined as periodontal healthy if BOP was less than 10% or gingivitis if 
BOP was 10% or more. Subjects with one or more PPD ≥ 4 mm (had periodontal pockets) were 
divided into low, moderate bleeding, or bleeding. During the dental examination, the number of teeth 
present was recorded (23). 
Cognitive function 
Outcomes of interest were scores from the following cognitive tests: a) Delayed Word Recall 
(DWR); b) Digit Symbol Substitution (DSS); and c) Word Fluency (WF). The DWR tests verbal 
learning and recent memory. The WF, a test of expressive language, and the DSS, a test of 
concentration and psychomotor speed, assess executive function. Higher scores on each of the three 
tests indicate better cognitive ability. All cognitive tests were administered by trained examiners. 
Cognitive test protocols from ARIC have been reported elsewhere (21). 
Covariates 
Covariates included socio-demographic factors (age, race, gender, educational level, income, 
and study sites), cardiovascular risk factors, APOE genotype, stroke, and coronary heart disease 
(CHD). Educational levels were classified as less than high school, high school completion, and post-
secondary education. Household income was coded as <$25,000, $25,000-$50,000, > $50,000, and 
refused (1996-1998 dollars). The four ARIC communities are Forsyth County, NC; Jackson, MS; the 
northwest suburbs of Minneapolis, MN, and Washington County, MD. A variable representing race 
and ARIC filed centers was created to control for the racial, regional, and examiner differences in the 
ARIC cohort as the following: Forsyth/White, Forsyth/Black, Jackson/Black, Minnesota/White, and 
Washington/White. Cardiovascular risk factors included smoking and alcohol use (each recorded as 
never, former, or current), diabetes, hypertension, hyperlipidemia, and body mass index. 
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Apolipoprotein E (APOE) genotype was dichotomized as presence or absence of the APOE ε4 allele 
(Supplemental methods).  
Statistical analyses 
Gender- and race-specific distributions of covariates and self-reported dental history were 
examined. Bivariate analyses were used to assess associations of covariates with cognitive scores and 
oral health measures. Cognitive scores were analyzed as continuous measures using multiple linear 
regression models. We used directed acyclic graphs (DAGs) and the change-in-estimate procedures to 
select the adjustment variables in this study. CHD and stroke were considered mediators of the 
exposure-outcome association and were therefore not included in the regression models. Models fit 
with a minimally sufficient set of covariates, identified in the DAGs, included age, race, gender, study 
sites, education, income, smoking, alcohol use, and diabetes (DAG models). Fully adjusted models 
included these variables along with body mass index (BMI), hyperlipidemia, hypertension, and APOE 
ε4. The regression coefficient for the oral health measure (i.e., dental status, number of teeth, or BGI) 
from the DAG model was compared with that from the fully adjusted model. If the estimate changed 
by less than 10 % or ± 0.1, the more parsimonious (DAG) model was selected for the primary 
analysis. Supplementary analyses used other clinical measures of periodontal disease including the 
extent of attachment loss and CDC/AAP classification as predictor variables. The effect of BGI 
components (PPD and BOP) on cognitive scores was also determined separately. The statistical 
package SAS version 9.3 (SAS Institute, Cary NC) was used for all analyses.  
D. Results 
Characteristics of study participants 
The majority of the study sample was female (56 %). About 80% of all participants were 
whites, but all Jackson participants and about 9 % Of Forsyth participants were African Americans. 
About half of the participants were current drinkers, and 14% were current smokers. Compared to 
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white participants, African American subjects had less education, lower incomes, more medical 
problems, and lower scores on all cognitive tests. Of 9,874 dentally screened participants, 13.4 % 
(1,320) were edentulous. More than two-thirds of participants who received a comprehensive dental 
exam had periodontal pockets (PPD ≥ 4 mm), and 12% were classified as periodontitis with severe 
bleeding (Table 4-1). About 70% of edentulous and dentate participants reported past tooth loss due 
to caries. Edentulous participants were two times higher (32 % vs. 11%) than dentate participants to 
report past tooth loss due to “gum disease,” and 42% of edentulous participants had an initial “gum 
disease” diagnosis more than 30 years ago (Table 4-2).  
In the multiple regression analyses, hypertension, body mass index, hyperlipidemia, and 
APOE ε4 were not confounders for any of the associations between oral health measures and 
cognitive scores. Therefore, results from the DAG models are presented in Table 4-3. 
Tooth loss and cognitive function  
Complete tooth loss was significantly associated with lower DWR, DSS, and WF scores 
(Table 4-3, Figure 4-1). Regression coefficients for complete tooth loss were greatly attenuated after 
adjusting for socio-demographic factors (unadjusted associations are shown in Supplemental Table 4-
5). The associations remained significant after controlling for smoking, alcohol, and diabetes. Among 
the dentate participants, a larger number of teeth present were associated with higher cognitive scores 
for all tests. However, the number of teeth was no longer associated with DWR scores after adjusting 
for socio-demographic factors. The adjusted associations with DSS (b = 0.069 per tooth, p-value = 
0.0003) and WF (b= 0.087, p-value 0.0002) were significant in the final models (Table 4-3).  
Periodontal disease and cognitive function  
In the crude analyses, periodontal disease was associated with all cognitive test results, and 
the severe periodontitis groups had the lowest cognitive scores (Table 4-5). As with the analysis for 
number of teeth, the association with DWR scores was not evident after adjustment for socio-
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demographic factors. In the final models, BGI was significantly associated with DSS (p-value = 
0.0464) and WF (p-value = 0.0015); however, there was no clear dose-response relationship across 
the five levels of the BGI index. The lowest cognitive scores were found in participants with 
gingivitis or periodontitis with severe bleeding (Table 4-3, Figure 4-2). 
Supplementary analyses showed that BGI index was correlated with the extent of attachment 
loss. In other word, periodontitis with severe bleeding group had the greatest extent of attachment loss 
(Table 4-7, Figure 4-5). For each of the three cognitive tests, low scores were correlated with greater 
plaque deposit and attachment loss, but not with CDC/AAP classification and pocket depth (Table 4-
8). 
E. Discussion 
In this late middle-aged cohort, participants with no teeth had lower cognitive scores on all 
three tests. The other two indicators of poor oral health—decreases in number of teeth and 
periodontal disease—were associated with lower DSS and WF scores, but not with lower DWR 
scores. We did not observe a dose-response relationship between five levels of periodontal disease 
created by the combination of PPD and BOP with cognitive performance. Instead, cognitive scores 
were likely to be related to the extent of BOP.  
Strengths of this study include its large population-based sample and high quality control for 
periodontal and cognitive function assessments. Clinical examination for periodontal disease, coded 
based on biological systems at the biofilm-gingival interface, (23) allowed us to investigate the 
association between cognitive function and degree of periodontal infection and inflammation. A 
fundamental limitation of our study is that our data are cross-sectional data, so associations could 
reflect effects of poor oral health on low cognitive performance or the reverse process. Furthermore, 
the Dental ARIC study enrolled only people with no contraindication to periodontal probing (i.e., a 
requirement for antibiotic prophylaxis). If people who require antibiotic prophylaxis have medical 
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conditions that are associated with severe periodontal disease, this exclusion could cause the 
association with cognitive function to be underestimated. Another limitation is that our cognitive tests 
cover only two cognitive domains, memory (DWR) and executive function (DSS and WF).  
Although tooth loss and cognitive function were measured cross-sectionally, multiple tooth 
loss in this study sample typically occurred early in life, likely before the beginning of age-related 
cognitive decline (Table 4-2). Thus, the association between edentulism and lower cognitive 
performance seems more likely to reflect an effect of past periodontal disease on cognitive function 
rather than the development of inflammation from current low cognitive performance.  On the other 
hand, at least part of the positive association between tooth loss and cognitive function may be 
attributable to socio-demographic factors. Having no teeth remained a significant term in the multiple 
regression model for low cognitive function that included terms for health behaviors and medical 
conditions, but residual confounding by socioeconomic status is a distinct possibility. By contrast, the 
authors of a large cross-sectional study which included middle-aged adults (45 years and older) 
suggested that an association they observed between tooth loss and word list recall test scores was 
likely due to confounding because it disappeared after they controlled for socioeconomic status (24).  
Our results are consistent with those from studies that suggest that loss of multiple teeth early 
in life increases the risk of cognitive decline (2,3,7,10). For instance, a case-control study in 
monozygotic twins reported that only history of tooth loss before age 35 years was a significant risk 
factor for AD (10). A cross-sectional study in Japanese older adults reported an association between 
having an extended edentulous period (15 years or longer) and increased risk of low cognitive scores 
(3). However, both of these studies were retrospective and relied on self-reports of tooth loss.  
Two possible biological pathways whereby tooth loss could accelerate cognitive decline have 
been proposed: a) systemic infection and resultant inflammation (7,25); and b) nutritional deficiency 
(4,26). Even though we did not measure nutritional status, that mechanism is unlikely to explain the 
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association between tooth loss and low cognitive performance in our study. In the study of older 
Japanese adults having few teeth without dentures increased the risk of dementia onset (Hazard ratio 
= 1.85; 95% CI 1.04, 3.31) (4). But virtually all ARIC edentulous participants (98%) had dentures 
and also tended to have BMIs higher than those for dentate participants (data not shown).  
Among the dentate participants in our study, both number of teeth and periodontal disease 
were associated with DSS and WF scores, but these associations were relatively weak. Examination 
of cognitive scores in relation to the levels of the BGI index indicated that lower cognitive function 
was related primarily to the extent of gingival bleeding rather than to periodontal pocket depth. Our 
finding was consistent with a previous cross-sectional study analyzing the NHANES data, where the 
extent of gingival bleeding was associated with low scores on two cognitive tests (i.e., symbol digit 
substitution and serial digit learning test) in young and middle-aged adults (20-59 years)(17).  
The BGI index reflects both the current and the cumulative burden of inflammatory 
periodontal disease. Both gingivitis and deep pockets were associated with lower cognitive scores, 
suggesting two causal scenarios. In the first scenario, deep pockets are a marker of chronic 
inflammatory periodontal disease which is a cause of cognitive decline. In this scenario, gingivitis 
represents a marker of current inflammation and periodontal pockets represent a marker of previous 
inflammation.  Participants with both gingivitis and deep pockets therefore are expected to have the 
lowest cognitive scores because of longer period of infection and elevated inflammatory levels. 
However, the effect of periodontal pockets probably is underestimated in this scenario because teeth 
with very deep pockets are likely to be extracted, thereby underestimating the estimated effect of 
periodontal pockets.  . Likewise, periodontal treatment is likely to reduce pocket depth, but it will not 
reduce inflammation unless oral hygiene or host-response to inflammation also improves.  Hence, the 
gingivitis group could represent people whose periodontal disease has been treated. In our study 
sample, about half of dentate participants reported less than 10 years of having “gum disease” and 
about 11 % have lost teeth because of “gum disease” (Table 4-2). A longitudinal study in older men 
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found that additional tooth loss with progression of alveolar bone loss or progression of pocket depth 
per decade predicted low cognitive function after a 32-year follow-up interval (5).  
In the second scenario, a reverse causal process may be possible. Gingivitis represents the 
consequences of poor oral hygiene, which itself is a consequence of cognitive decline.  Specifically, 
an early decline in executive function domain (DSS and WF tests) may alter individuals’ cognitive 
processes (e.g. planning, reasoning, initiation, or making decisions) and perception toward health 
care, resulting in non-compliance with oral hygiene behavior. Our previous study (27) revealed that 
six-year changes (between 1990-1992 and 1996-1998) in executive function were associated with 
infrequent tooth brushing, plaque deposit, and Löe and Silness gingival index. 
The clinical method used to measure gingivitis casts some doubt on the second scenario. 
Unlike Löe and Silness gingival index, BOP detects bleeding anywhere in the pockets, including 
ulceration of deepest tissue in the pocket. In principle, we expect that BOP in sites with deep pockets 
is influenced less by supragingival plaque deposits than BOP in shallow lesions or gingivitis group. 
However, counter to this expectation, Offenbacher et.al (2007) (23) reported  higher prevalence of 
infrequent tooth brushing in severe periodontitis than that of gingivitis groups. Given discrepancies 
between these expectations and the observed relationships, and given the cross-sectional nature of 
study, it is difficult to evaluate the merits of these two scenarios.   
Further relevance and interpretation of supplementary analyses were discussed in Chapter 6. 
F. Conclusion 
Our study findings add to the evidence that complete tooth loss, low number of teeth, and the 
inflammatory stage of periodontal disease are associated with lower cognitive performance. Because 
in our study severe periodontal disease and edentulism apparently occurred many years before data 
collection, we believe that the process through which these conditions developed preceded rather than 
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followed age-related cognitive decline. However, the association of poorer cognitive function with 
gingivitis could reflect an effect of cognitive decline, so the association between oral health and 
cognitive function could reflect causal processes in either – or both – directions. 
G. Human participants protection 
No protocol approval was necessary because this study involved the analysis of secondary data 
only. 
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H. Tables 
Table 4-1. Race- and gender- specific of ARIC Visit 4 characteristics of study samples 
Characteristics African American White  
All Female Male Female Male 
(n = 1,301) (n = 693) (n = 4,209) (n = 3,671) (n = 9,874) 
Age at Visit 4,  mean ± SD 61.6 ±  5.6 61.7 ± 5.8 62.7 ± 5.6 63.5 ± 5.6 62.8 ± 5.7 
Study sites, %      
 Forsyth 11.7 12.1 28.8 28.7 25.4 
 Jackson 88.3 87.9 0 0 17.8 
 Minneapolis 0 0 36.1 37.0 29.1 
 Washington 0 0 35.1 34.3 27.7 
Education, %      
 Less than high school 32.4 32.0 13.4 14.6 17.6 
 High school completion 31.6  27.9 51.3 39.5 42.7 
 Post-secondary education 36.0 40.1 35.3 45.9 39.7 
Income, %      
 Refused 2.5 2.7 2.1 2.1 2.2 
 <$25,000 64.1 44.6 28.0 17.9 30.2 
 $25-<$50,000 22.9 27.4 37.4 38.0 35.0 
 $50,000 or more 10.5 25.3 32.5 42.0 32.6 
Cigarette use, %      
 Current 13.5 22.2 13.9 13.9 14.4 
 Former 28.9 49.9 35.2 58.2 43.9 
 Never 57.6 27.9 50.9 27.9 41.6 
Alcohol use, %      
 Current 18.2 40.4 51.6 62.2 50.4 
 Former 36.9 43.6 25.5 28.8 29.5 
 Never 44.9 16.0 22.9 9.0 20.1 
Diabetes mellitus, % 26.6 23.9 11.1 15.7 15.8 
Hypertension, % 70.1 59.9 41.0 42.3 46.6 
Coronary heart disease, % 4.5 9.5 3.8 14.7 8.4 
Stroke, % 2.2 4.5 1.4 2.3 2.1 
Hyperlipidemia, % 35.7 36.9 41.1 40.8 40.0 
Body mass index (kg/m2), mean ± SD 31.7 ± 6.7  28.7 ± 4.9  28.2 ± 5.9  28.4 ± 4.3  28.7 ± 5.6  
APOE ε4, % 39.0 42.1 27.2 27.4 29.9 
Oral health conditions      
Edentulous, % 22.5 14.0 10.9 12.8 13.4 
Number of teeth1, mean ± SD 17.2 ± 7.4  18.3 ± 7.8  23.0 ± 6.4  22.8 ± 6.8  21.9 ± 7.1  
Periodontal disease1, %      
Had periodontal pockets      
 BOP > 50% 14.4 31.0 8.2 13.3 12.3 
 BOP 10- ≤ 50% 21.9 27.4 39.6 47.4 39.5 
 BOP < 10% 8.7 12.4 19.9 20.5 18.5 
No periodontal pockets      
 BOP ≥ 10% 22.8 16.0 16.0 11.4 14.9 
 BOP < 10%  32.2 13.2 16.3 7.4 14.4 
Cognitive functions      
Delayed word recall, mean ± SD 6.3 ± 1.6 5.6 ± 1.7 7.0 ± 1.5 6.3 ± 1.5 6.6 ± 1.6 
Digit symbol substitution, mean ± SD 32.3 ± 13.2 28.9 ± 13.2 49.7 ± 11.0 43.9 ± 10.7 43.8 ± 13.3 
Word fluency, mean ± SD 29.1 ± 12.7 27.4 ± 14.1 36.1 ± 11.6 33.5 ± 12.3 33.6 ± 12.5 
n, total number of study group; SD, standard deviation; BGI, Biofilm-Gingival Interface   
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP).  
1Only among dentate participants who received periodontal examination (n = 5,942)  
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Table 4-2. Comparisons of self-reported causes of tooth loss, the use of prosthesis, and gum disease 
of study participants who were edentulous and those who were dentate  
 
Self-reported  Dental status 
Edentulous (n = 1,320)  Dentate (n = 8,554) 
Causes of tooth loss    
Loss due to cavities1, % 73.6  71.8 
 Unknown 1.9  3.4 
 Missing 0.08  0.01 
Loss due to gum disease1, % 32.5  11.1 
 Unknown 3.3  2.0 
 Missing 0.08  0.01 
Loss due to wisdom teeth1, % 75.9  75.1 
 Unknown 2.6  3.4 
 Missing 0.08  0.05 
Loss due to overcrowding1, % 9.2  18.6 
 Unknown 2.0  2.2 
 Missing 0.08  0.01 
Loss due to other reasons1, % 18.6  14.8 
 Unknown 1.2  0.6 
 Missing 0.2  0.1 
Prosthesis use    
Had false teeth1, % 97.8  50.5 
 Missing 0.2  0.05 
Age when got first false teeth2     
 Mean ± SD 36.0 ± 13.7  38.6 ± 14.6 
Gum disease    
Ever noticed any loose teeth, % 26.1  15.7 
 Unknown 1.8  0.2 
 Missing 2.2  1.0 
Had gum disease, % 22.0  22.3 
 Unknown 0.3  0.5 
 Missing 0  0.06 
Years of having gum disease3    
 Mean ± SD 24.3 ± 12.9  11.1 ± 10.1 
 <10 years, % 10.7  51.0 
 10- <20 years, % 23.1  27.0 
 20- <30 years, % 24.1  14.8 
 ≥ 30 years, % 42.1  7.2 
n, total number of study group; SD, standard deviation 
1Of 1,290 edentulous and 7,698 dentate participants who reported history of tooth loss. 
2Of 1,261 edentulous and 3,886dentate participants who had prosthesis, 1,202 edentulous and 3,683 dentate participants 
reported age when they got first false tooth. 
3Of 291 edentulous and 1,907 dentate participants who had gum disease, 290 edentulous and 1,985 dentate participants 
reported duration since they were firstly diagnosed. 
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Table 4-3. Regression coefficients for the associations between oral health measures and Visit 4 
cognitive scores 
 
 
 
  
  Delayed word recall Digit symbol substitution Word fluency  
 n  b (SE) P-value b (SE) P-value b (SE) P- value 
Dental status  9,874       
 Edentulous 1,320 -0.16 (0.046) 0.0004 -2.18 (0.30) <0.0001 -1.87 (0.35) <0.0001 
 Dentate 8,554 Ref  Ref  Ref  
         
Periodontal disease 5,942       
Had periodontal pockets       
 BOP > 50% 733 0.047( 0.076) 0.4493 -0.44 (0.48) 0.0464 -0.78 (0.59) 0.0015 
 BOP 10- ≤ 50% 2,374 0.069 (0.060)  0.26 (0.38)  0.12 (0.46)  
 BOP < 10% 1,097 0.047 (0.069)  0.21 (0.44)  1.31 (0.53)  
No periodontal pockets       
 BOP ≥ 10% 884 0.13 (0.071)  -0.84 (0.45)  -0.78 (0.55)  
 BOP < 10%  854 Ref  Ref  Ref  
         
Number of teeth 5,942       
 1-tooth increase  0.0024 
(0.003) 
0.4252 0.069 (0.019) 0.0003 0.086 (0.023) 0.0002 
b, regression coefficient; SE, standard error; BGI; Biofilm-Gingival Interface   
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP).  
Covariates in models included age, gender, race-center, education, income, smoking, alcohol use, and diabetes. 
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I. Figures 
a. Delayed word recall 
 
b. Digit symbol substitution 
 
c. Word fluency 
 
Figure 4-1. Crude and adjusted means with 95% confidence intervals of three cognitive scores, 
comparing edentulous participants with dentate participants (n = 9,874) 
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a. Delayed word recall 
 
b. Digit symbol substitution 
 
c. Word fluency 
 
Figure 4-2. Crude and adjusted means with 95% confidence intervals of three cognitive scores, 
comparing among five levels of periodontal conditions (n = 5,942)  
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J. Supplemental materials 
Covariates definition and classification 
Diabetic status was determined by fasting plasma glucose ≥ 126 mg/dL, non-fasting plasma 
glucose ≥ 200 mg/dL, self-reported- history of physician-diagnosed diabetes or current medication for 
diabetes. Hypertension was defined as a previous diagnosis of hypertension, taking hypertensive 
medication, or having a current systolic blood pressure of 140 mmHg or higher or a diastolic blood 
pressure 90 mmHg. Stroke was defined as a self-reported history of physician-diagnosed stroke or 
stroke validated by an ARIC clinician through a review of medical records. Coronary heart disease 
was defined as adjudicated myocardial infraction on the electrocardiogram at baseline, or prior self-
reported history of myocardial infarction, coronary artery bypass surgery or angioplasty.  
Effect measure modification 
We also tested whether diabetes and APOE ε4 were the effect measure modifiers by 
examining likelihood ratio for type 3 analysis and stratum-specific estimates. If the p-value is less 
than 0.10 or stratum-specific estimates were substantially difference, the interaction terms between 
oral health measures and diabetes or APOE ε4 are included in the regression model. In this study 
sample, no effect measure modification by diabetes and APOE ε4 was observed. 
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K. Supplemental Tables 
Table 4-4. Self-reported causes of tooth loss, prosthesis use, gum disease, oral hygiene care, and 
dental visits of dentally-screened participants  
Self-reported  African American White  
All Female Male Female Male 
(n = 1,301 ) (n = 693) (n = 4,209) (n = 3,671) (n = 9,874) 
Causes tooth loss 95.4 94.8 88.8 91.3 91.0 
Lost any natural teeth, %      
 Missing 3.4 3.6 0.6 0.4 1.1 
Loss due to cavities1, % 86.3 85.3 66.3 70.3 72.0 
 Unknown 1.5 1.9 3.6 3.5 3.1 
 Missing 0 0.1 0.03 0 0.02 
Loss due to gum disease1, % 22.4 18.7 11.9 12.8 14.2 
 Unknown 2.7 5.6 1.5 2.2 2.2 
 Missing 0 0.1 0.03 0 0.02 
Loss due to wisdom teeth1, % 80.5 70.6 75.4 74.0 75.2 
 Unknown 2.4 2.6 3.0 4.1 3.3 
 Missing 0.1 0.3 0.05 0 0.1 
Loss due to overcrowding1, % 4.9 6.2 21.9 18.9 17.3 
 Unknown 1.7 2.3 2.1 2.5 2.2 
 Missing 0 0.1 0.03 0 0.02 
Loss due to other reasons1, % 6.9 7.3 19.4 15.4 15.3 
 Unknown 0.4 0.9 0.7 0.7 0.7 
 Missing 0.08 0.1 0.1 0.09 0.1 
Prosthesis use      
Had false teeth1, % 71.0 53.8 55.0 55.3 57.3 
 Missing 0 0.1 0.1 0.03 0.07 
Age when got first false teeth2       
 Range (years) 72 - 13 72 - 14 73 - 10 74 - 8 74 - 8 
 Mean ± SD 41.4 ± 12.7  45. 7 ± 13.9 37.0 ± 14.2 38.0 ± 15.4 38.6 ± 14.6 
Ever noticed any loose teeth, % 21.5 27.4 13.7 17.5 17.1 
 Unknown 0.8 0.3 0.4 0.5 0.4 
 Missing 3.5 3.7 0.7 0.5 1.2 
Gum disease      
Had gum disease, % 22.4 20.9 22.5 22.2 22.3 
 Unknown 0.5 0.4 0.5 0.4 0.5 
 Missing 0.1 0.1 0.02 0.03 0.05 
Years of having gum disease3      
 Range (years) 0 - 48 0 - 53 0 -53 0 - 55 0 - 55 
 <10 years, % 57.1 62.1 43.4 41.4 45.7 
 10- <20 years, % 22.8 22.1 26.0 29.1 26.5 
 20- <30 years, % 11.1 8.6 16.7 18.3 16.0 
 ≥ 30 years, % 9.0 7.1 13.8 11.2 11.8 
Oral hygiene care      
Brushing teeth4      
 None 1.6 2.5 0.5 2.7 1.6 
 Once a day 22.9 40.8 17.9 37.8 27.5 
 Twice or more a day 72.7 53.5 81.0 59.0 69.9 
 Missing 2.8 3.2 0.6 0.5 1.0 
Dental flossing4      
 None 43.5 59.7 22.0 43.9 35.4 
 Once a week 7.7 8.6 6.6 9.7 8.0 
 Twice or more a week 45.9 28.4 70.8 45.9 55.6 
 Missing 2.8 3.3 0.6 0.5 1.0 
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Dental visits      
Last time saw dentist4      
 > 36 months  24.3 24.3 4.9 7.5 9.5 
 12-<36 months 24.6 24.0 8.3 11.7 12.6 
 <12 months 47.8 48.2 86.1 80.3 76.8 
 Missing 3.3 3.5 0.7 0.5 1.1 
Reasons to see dentist4      
 Do not see a dentist 4.2 4.7 0.6 0.5 1.3 
 Only when having problems 57.5 61.7 13.4 22.5 25.4 
 A regular basis 35.5 30.2 85.4 76.5 72.3 
 Missing 2.8 3.4 0.6 0.5 1.0 
n, total number of study group; SD, standard deviation 
1Of 8,988 participants who reported tooth loss. 
2Of 5,147 participants who had prosthesis, 4,885 reported age when they got first false tooth. 
3Of 2,198 participants who had gum disease, 2,185 reported duration since they were firstly diagnosed. 
4Only among dentate participants (n = 8,554) 
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Table 4-5. Cognitive scores at Visit 4 in relation to selected study characteristics (n = 9,874)  
Characteristics Col % Delayed word recall Digit symbol substitution Word fluency 
  b (SE) P-value b (SE) P-value b (SE) P-value 
Age at Visit 4 (years)        
 > 65 34.3 -0.73 (0.038) <0.0001 -7.52 (0.31) <0.0001 -2.49 (0.30) <0.0001 
 60-65 31.8 -0.24 (0.039)  -2.70 (0.32)  -1.42 (0.31)  
 51-59 33.9 Ref  Ref  Ref  
Gender        
 Male 44.2 -0.67 (0.031) <0.0001 -4.12 (0.27) <0.0001 -1.90 (0.25) <0.0001 
 Female 55.8 Ref  Ref  Ref  
Race        
 African American 20.2 -0.64 (0.039) <0.0001 -15.87 (0.29) <0.0001 -6.35 (0.31) <0.0001 
 White 79.8 Ref  Ref  Ref  
Study sites        
 Forsyth 25.3 0.21 (0.043) <0.0001 0.20 (0.32) <0.0001 -0.57 (0.34) <0.0001 
 Jackson 17.8 -0.54 (0.048)  -14.99 (0.36)  -5.80 (0.37)  
 Minneapolis 29.1 0.17 (0.042)  3.79 (0.31)  2.51 (0.33)  
 Washington 27.7 Ref  Ref  Ref  
Education        
 Less than high 
school 17.6 -0.90 (0.045) <0.0001 -16.70 (0.34) <0.0001 
-14.44 
(0.33) <0.0001 
 High school 
completion 42.7 -0.20 (0.034)  -4.16 (0.26)  -6.28 (0.25)  
 Post-secondary 
education 39.7 Ref  Ref  Ref  
Income        
 Refused 2.2 -0.67 (0.11) <0.0001 -9.40 (0.85) <0.0001 -6.41 (0.84) <0.0001 
 <$25,000 30.2 -0.74 (0.04)  -13.61 (0.31)  -9.00 (0.30)  
 $25-< $50,000 35.0 -0.32 (0.038)  -5.20 (0.30)  -3.57 (0.29)  
 $50,000 or more 32.6 Ref  Ref  Ref  
Cigarette use        
 Current 14.4 -0.24 (0.049) <0.0001 -4.16 (0.41) <0.0001 -1.87 (0.38) <0.0001 
 Former 43.9 -0.19 (0.034)  -0.58 (0.29)  0.40 (0.27)  
 Never 41.6 Ref  Ref  Ref  
Alcohol use        
 Current 50.4 0.28 (0.042) <0.0001 7.96 (0.34) <0.0001 5.95 (0.32) <0.0001 
 Former 29.5 -0.015 (0.046)  1.42 (0.37)  1.54 (0.36)  
 Never 20.1 Ref  Ref  Ref  
Diabetes mellitus        
 Yes 15.8 -0.45 (0.044) <0.0001 -6.29 (0.36) <0.0001 -3.86 (0.34) <0.0001 
 No 84.2 Ref  Ref  Ref  
Hypertension        
 Yes 46.6 -0.31 (0.032) <0.0001 -5.33 (0.26) <0.0001 -2.57 (0.25) <0.0001 
 No 53.4 Ref  Ref  Ref  
Coronary heart disease       
 Yes 8.4 -0.51 (0.057) <0.0001 -4.70 (0.48) <0.0001 -2.69 (0.45) <0.0001 
 No 91.6 Ref  Ref  Ref  
Stroke        
 Yes 2.1 -1.04 (0.11) <0.0001 -10.84 (0.93) <0.0001 -5.08 (0.87) <0.0001 
 No 97.9 Ref  Ref  Ref  
Hyperlipidemia        
 Yes 40.0 -0.045 (0.032) 0.1689 -0.31 (0.27) 0.2554 -0.53 (0.26) 0.0391 
 No 60.0 Ref  Ref  Ref  
Body mass index         
 ≥ 30 kg/m2 34.4 -0.088 (0.034) 0.0092 -2.54 (0.28) <0.0001 -1.62 (0.26) <0.0001 
 < 30  kg/m2 65.6 Ref  Ref  Ref  
APOE ε4        
 Yes 29.9 -0.17 (0.035) <0.0001 -2.27 (0.29) <0.0001 -0.57 (0.27) 0.0385 
 No 70.1 Ref  Ref  Ref  
 74 
 
Oral health conditions       
Edentulous        
 Yes 13.4 -0.58 (0.046) <0.0001 -9.39 (0.38) <0.0001 -6.86 (0.36) <0.0001 
 No 86.6 Ref  Ref  Ref  
Number of teeth1        
 1-24 50.4 -0.39 (0.04) <0.0001 -6.66 (0.31) <0.0001 -4.25 (0.31) <0.0001 
 ≥ 25 49.6 Ref  Ref  Ref  
Periodontal disease1         
Had periodontal pockets       
 BOP > 50% 12.3 -0.30 (0.078) <0.0001 -3.58 (0.62) <0.0001 -2.71 (0.61) <0.0001 
 BOP 10- ≤ 50% 39.9 -0.012 (0.062)  2.01 (0.49)  0.73 (0.49)  
 BOP < 10% 18.5 0.024 (0.071)  3.20 (0.56)  2.78 (0.56)  
No periodontal pockets       
 BOP ≥ 10% 14.9 0.096 (0.075)  -1.16 (0.59)  -1.51 (0.59)  
 BOP < 10%  14.4 Ref  Ref  Ref  
n, total number of study group; BGI, Biofilm-Gingival Interface  
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP).  
1Only among dentate participants who received periodontal examination (n = 5,942) 
 
  
  
 
Table 4-6. Study centers-specific estimates for association between oral health measures and cognitive function 
  
Forsyth County Jackson Minneapolis Washington County All 
    b	  	   SE P-value b	  	   SE P-value b	  	   SE P-value b	  	   SE P-value b	  	   SE P-value 
Delayed word recall     
   n = 2,503 n = 1,758 n = 2,878  n = 2,375    
Edentulous -0.27 0.10 0.0055 -0.12 0.10 0.2366 -0.071 0.12 0.5533 -0.20 0.08 0.0077 -0.16 0.046 0.0004 
                 BGI n = 1,568 n = 901 n = 1,974 n = 1,499 
   
 
BGI-DL/SB -0.057 0.14 0.4040 0.16 0.16 0.1845 -0.28 0.27 0.3399 0.053 0.18 0.9192 0.047 0.076 0.4493 
 
BGI-DL/MB 0.012 0.12 
 
0.34 0.15 
 
-0.08 0.10 
 
0.072 0.16 
 
0.069 0.06 
 
 
BGI-DL/LB -0.09 0.17 
 
0.29 0.19 
 
-0.04 0.10 
 
-0.045 0.22 
 
0.047 0.069 
 
 
BGI-G 0.14 0.12 
 
0.24 0.15 
 
0.29 0.21 
 
-0.0031 0.19 
 
0.132 0.076 
 Number of teeth -0.045 0.0068 0.2074 0.0001 0.01 0.9918 0.006 0.006 0.3352 0.002 0.005 0.7132 0.0024 0.003 0.4252 
Digit symbol substitution       
 n = 2,503 n = 1,758 n = 2,878  n = 2,375    
Edentulous -2.65 0.62 <0.0001 -1.34 0.64 0.0383 -1.84 0.77 0.0167 -2.40 0.4879 <.0001 -2.18 0.30 <0.0001 
                 BGI n = 1,568 n = 901 n = 1,974 n = 1,499 
   
 
BGI-DL/SB -1.93 0.86 0.0411 0.51 1.04 0.7117 -1.81 1.71 0.0255 -0.24 1.12 0.7203 -0.44 0.48 0.0464 
 
BGI-DL/MB 0.043 0.73 
 
0.80 0.94 
 
0.14 0.62 
 
-0.07 1.03 
 
0.26 0.38 
 
 
BGI-DL/LB 0.78 1.06 
 
0.87 1.21 
 
-0.04 0.62 
 
-1.17 1.38 
 
0.21 0.44 
 
 
BGI-G -0.60 0.73 
 
-0.43 0.96 
 
-3.98 1.38 
 
-0.84 1.18 
 
-0.84 0.45 
 Number of teeth 0.17 0.04 <0.0001 0.038 0.045 0.3933 0.046 0.037 0.2089 0.061 0.035 0.0794 0.069 0.019 0.0003 
Word fluency       
 n = 2,503 n = 1,758 n = 2,878  n = 2,375    
Edentulous -2.47 0.73 0.0007 -2.37 0.69 0.0006 -1.73 0.91 0.0573 -1.01 0.583 0.0828 -1.87 0.35 <0.0001 
                 BGI n = 1,568 n = 901 n = 1,974 n = 1,499 
   
 
BGI-DL/SB -1.40 1.05 0.3248 0.30 1.15 0.4707 -5.00 2.09 0.0061 -0.97 1.41 0.3496 -0.78 0.59 0.0015 
 
BGI-DL/MB 0.15 0.88 
 
0.91 1.04 
 
-0.09 0.76 
 
-0.89 1.30 
 
0.12 0.46 
 
 
BGI-DL/LB 0.41 1.29 
 
2.19 1.34 
 
1.23 0.75 
 
0.87 1.73 
 
1.31 0.53 
 
 
BGI-G -0.84 0.89 
 
-0.059 1.06 
 
-0.34 1.68 
 
-2.02 1.49 
 
-0.78 0.55 
 Number of teeth 0.15 0.045 0.0007 0.015 0.049 0.7611 0.083 0.045 0.0664 0.10 0.043 0.0286 0.086 0.023 0.0002 
b , regression coefficient; SE, standard error; BGI, Biofilm-Gingival Interface  
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP). Five levels of BGI were the followings: BGI-DL/SB (deep lesion/severe 
bleeding), BGI-DL/MB (deep lesion/moderate bleeding), BGI-DL/LB (deep lesion/low bleeding), or BGI-G (gingivitis), and BGI-H (healthy).  
75 
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Table 4-7. Prevalence of periodontal disease classified by CDC/AAP index and other clinical 
measures of periodontal disease in relation to five levels of Biofilm-Gingival Interface  
 
 
 
  
 
 
Biofilm-Gingival Interface BGI) classification2   All 
(n = 5,942) No periodontal pockets Had periodontal pockets 
BOP = < 10% ≥ 10% BOP = < 10% 10- ≤ 50% > 50%  
CDC/AAP (n, col %)            
Healthy/ Mild 705  82.5 723 81.8 377 34.4 618 26.0 51 7.0 2,474 41.6 
Moderate 149 6.2 161 18.2 588 53.6 1,239 52.2 297 40.5 2,434 41.0 
Severe 0 0 0 0 132 12.0 517 21.8 385 52.5 1,034 17.4 
Other clinical measures (mean, SD)        
Probing pocket depth 1.5 0.2 1.5 0.3 1.8 0.3 2.0 0.4 2.7 0.8   
Extent of BOP  3.3 3.2 30.2 18.9 4.6 3.0 26.1 11.0 70.8 16.1   
Attachment loss (AL) 1.4 0.7 1.4 0.7 1.6 0.8 1.7 0.8 2.9 1.5   
Extent of AL  ≥ 3 mm   11.9 16.5 13.3 17.9 21.1 19.4 23.3 19.8 48.1 28.1   
Extent of plaque 
deposit  30.5 39.2 45.2 41.3 25.7 29.4 42.7 34.6 71.3 33.8   
CDC/AAP: The Centers for Disease Control and Prevention/ The American Academy of Periodontology; BOP, bleeding on probing 
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Table 4-8. Regression coefficients for associations of CDC/AAP periodontal disease classification 
and clinical signs of periodontal disease with three measures of cognitive function at Visit 4  
  
  Delayed word recall Digit symbol substitution Word fluency  
 n (%) b (SE) P- 
value 
b (SE) P- 
value 
b (SE) P- 
value 
CDC/AAP1 5,942       
 Severe 2,474 (41.6) -0.03 (0.06) 0.7704 -0.49 (0.36) 0.1717 -0.58 (0.44) 0.3791 
 Moderate 2,434 (41.0) 0.008 (0.04)   -0.48 (0.27)   -0.31(0.33)   
 Healthy / Mild 1,034 (17.4) Ref  Ref  Ref  
         
Extent of AL 
 ≥ 3 mm 
5,642 -0.002 (0.0009) 0.0271 -0.021 
(0.006) 
0.0004 -0.014 
(0.007) 
0.0461 
        
Pocket depths  5,942       
 ≥ 4 mm 3,945 (70.0) -0.02 (0.04) 0.6495 0.37 (0.28) 0.1869 0.54 (0.34) 0.1135 
 < 4 mm 1,693 (30.0) Ref  Ref  Ref  
         
Gingival bleeding 5,942       
 ≥ 50% 859 (14.5) 0.038 (0.06)  0.4363 -0.95 (0.41)  0.0325  -1.51 (0.50)  0.0073 
 10- < 50% 3,132 (52.7) 0.057 (0.04)  0.019 (0.28)  -0.75 (0.34)  
 0 - < 10% 1,951 (32.8) Ref  Ref  Ref  
         
Plaque deposit1 5,638       
 ≥  80% 1,346 (23.9) -0.14 (0.06) 0.0085 -1.95 (0.40) <0.0001 -1.93 (0.48) 0.0002 
 30-<80% 1,508 (26.7) -0.0077 (0.05)  0.63 (0.34)  -0.12 (0.41)  
 10-<30% 1,117 (19.8) 0.096 (0.06)    0.13 (0.36)   0.057 (0.43)   
 0-<10% 1,667 (29.6) Ref  Ref  Ref  
b , regression coefficient; SE, standard error;  CDC/AAP: The Centers for Disease Control and Prevention/ The American Academy of 
Periodontology; AL, attachment loss 
1Extent of plaque deposit was defined as a percentage of visible plaque on buccal surfaces. 
Covariates in the models included age, gender, race-center, education, income, smoking, alcohol use, and diabetes. 
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Table 4-9. Regression coefficients for associations between dental status (complete tooth loss vs. 
dentate) and three cognitive scores at Visit 4 (n = 9,874) 
  
  Delayed word recall   Digit symbol substitution   Word fluency  
  b	  	   SE P-value   b  SE P-value   b  SE P-value 
Crude  -0.573 0.047 <0.0001 
 
-9.394 0.382 <0.0001 
 
-6.844 0.363 <0.0001 
Model A1 -0.201 0.046 <0.0001 
 
-2.776 0.297 <0.0001 
 
-2.096 0.344 <0.0001 
Model B2 -0.163 0.046 0.0004 
 
-2.176 0.298 <0.0001 
 
-1.868 0.347 <0.0001 
Model C3 -0.162 0.046 0.0004 
 
-2.166 0.298 <0.0001 
 
-1.848 0.347 <0.0001 
            Change (%)4 -0.10 
   
-1.06 
   
-2.02 
  b , regression coefficient; SE, standard error 
Linear regression models estimated associations between complete tooth loss and cognitive scores. 
1Adjusting for socio-demographic factors (age, gender, race-center, education, and  income) 
2Adjusting for socio-demographic factors, smoking, alcohol use, and diabetes (a minimally sufficient adjustment set) 
3Adjusting for socio-demographic factors, smoking, alcohol use, diabetes, hypertension, hyperlipidemia, body mass index, and 
APOE ε4 
4Absolute changes in estimates = (b model B – b model C) x 100  
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Table 4-10. Regression coefficients for associations between periodontal disease classified by 
Biofilm-Gingival Interface (BGI) classification1 and three cognitive scores at Visit 4 (n = 5,942)  
  BGI Delayed word recall Digit symbol substitution Word fluency  
    b 	   SE P-value b  SE P-value b  SE P-value 
Crude  DL/SB -0.302 0.079 <0.0001 -3.583 0.619 <0.0001 -2.709 0.615 <0.0001 
 
DL/MB -0.012 0.062  2.015 0.491  0.729 0.487  
 
DL/LB 0.024 0.071  3.202 0.561  2.787 0.557  
 
G 0.096 0.075  -1.162 0.590  -1.509 0.586  
Model A2 DL/SB 0.024 0.076 0.5107 -0.810 0.487 0.0302 -1.003 0.586 0.0003 
 
DL/MB 0.085 0.069  0.116 0.384  0.070 0.462  
 
DL/LB 0.039 0.069  0.030 0.443  1.302 0.533  
 
G 0.119 0.071  -0.926 0.454  -0.999 0.547  
Model B3 DL/SB 0.047 0.076 0.4493 -0.435 0.483 0.0464 -0.779 0.586 0.0015 
 
DL/MB 0.069 0.060  0.260 0.381  0.122 0.461  
 
DL/LB 0.047 0.069  0.213 0.439  1.306 0.532  
 
G 0.132 0.076  -0.841 0.451  -0.783 0.546  
Model C4 DL/SB 0.055 0.076 0.4199 -0.369 0.484 0.0483 -0.708 0.586 0.0027 
 
DL/MB 0.074 0.060  0.295 0.381  0.164 0.461  
 
DL/LB 0.045 0.069  0.177 0.439  1.269 0.532  
 
G 0.136 0.071  -0.827 0.451  -0.769 0.546  
Change (%)5 DL/SB -0.80 
  
-6.64 
  
-7.11 
  
 
DL/MB -0.51 
  
-3.44 
  
-4.21 
  
 
DL/LB 0.19 
  
3.63 
  
3.63 
  
 
G -0.36     -1.39     -1.46     
b , regression coefficient; SE, standard error 
1Biofilm-gingival interface (BGI) classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on 
probing (BOP). Linear regression models estimated the effects of BGI-DL/SB (deep lesion/severe bleeding), BGI-DL/MB (deep 
lesion/moderate bleeding), BGI-DL/LB (deep lesion/low bleeding), or BGI-G (gingivitis) compared to BGI-H (healthy). 
2Adjusting for socio-demographic factors (age, gender, race-center, education, and income) 
3Adjusting for socio-demographic factors, smoking, alcohol use, and diabetes (a minimally sufficient adjustment set) 
4Adjusting for socio-demographic factors, smoking, alcohol use, diabetes, hypertension, hyperlipidemia, body mass index, and APOE ε4 
5Absolute changes in estimates = (b model B –b model C) x 100 
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Table 4-11. Regression coefficients for associations between number of teeth and three cognitive 
scores at Visit 4 (n = 5,942) 
  Delayed word recall   Digit symbol substitution   Word fluency  
  b 	   SE P-value   b  SE P-value   b  SE P-value 
Crude  0.0275 0.003 <0.0001 
 
0.531 0.022 <0.0001 
 
0.332 0.022 <0.0001 
Model A1 0.0038 0.003 0.1967 
 
0.099 0.019 <0.0001 
 
0.090 0.022 <0.0001 
Model B2 0.0024 0.003 0.4252 
 
0.069 0.019 0.0003 
 
0.086 0.023 0.0002 
Model C3 0.0021 0.003 0.4894 
 
0.066 0.019 0.0005 
 
0.082 0.023 0.0003 
            Change (%)4 0.03 
   
0.27 
   
0.38 
  b , regression coefficient; SE, standard error 
Linear regression models estimated the effect of 1-unit increase in the number of teeth on cognitive scores.  
1Adjusting for socio-demographic factors (age, gender, race-center, education, and  income) 
2Adjusting for socio-demographic factors, smoking, alcohol use, and diabetes (a minimally sufficient adjustment set) 
3Adjusting for socio-demographic factors, smoking, alcohol use, diabetes, hypertension, hyperlipidemia, body mass index, and APOE ε4 
4Absolute changes in estimates = (b model B – b model C) x 100 
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L. Supplemental figures 
 
 
1Covariates: age, race, gender, study sites, education, income, smoking, alcohol use, body mass index, hyperlipidemia, diabetes, coronary 
heart disease, stroke, and APOE genotype. 
Figure 4-3. Flow chart of ARIC participants who completed three cognitive function tests, dental 
screening, and comprehensive dental examination between 1996 and 1998 
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Figure 4-4. Extent of probing pocket depth by five levels of Biofilm-Gingival Interface classification 
(n = 5,942)  
 
 
Figure 4-5. Extent of attachment loss by five levels of Biofilm-Gingival Interface classification          
(n = 5,942)  
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STUDY 2: RESULTS 
Tooth loss, periodontal disease, and cognitive decline in the ARIC study 
A. Overview 
It is inconclusive whether poor oral health in midlife increases risk for subsequent cognitive 
decline in later life because the majority of evidence comes from cross-sectional studies of older 
adults, whose cognitive function has already declined. The purpose of the present prospective study 
was to investigate whether poor oral health in midlife predicted eight-year cognitive function change 
in adults aged 52-75 years at Visit 4 (1996-1998) in the Atherosclerosis Risk in Communities (ARIC) 
study. Participants included a subset of ARIC participants from two study sites: Forsyth County NC 
and Jackson MS. All subjects completed cognitive function assessments from Visit 4 and 2004-2006 
as part of the Brain MRI study, and the same subjects received a dental examination at Visit 4. 
Cognitive assessment consisted of Delayed Word Recall (DWR), Digit Symbol Substitution (DSS), 
and Word Fluency (WF) tests. At Visit 4, 4,737 participants answered screening questions, and 2,728 
of 4,004 dentate participants received comprehensive oral examinations, including periodontal 
probing. Measures of oral health included dental status, number of teeth, and periodontal disease 
classified by the Biofilm-Gingival Interface (BGI) classification. From 2004-2006, cognitive function 
for 911 dentally screened participants was reevaluated. The generalized estimating equations (GEE) 
method was used to analyze repeated measures of cognitive scores with adjustment for socio-
demographic characteristics and cardiovascular risk factors. Of 911 study participants, 126 (13.8%) 
were edentulous and 558 of 785 dentate participants received periodontal examination. About 13 % of 
dentally examined participants had deep periodontal lesions with severe bleeding.
 86 
 
At Visit 4 DWR and WF scores were lower in edentulous compared to dentate people, whereas other 
oral health measures were not associated with cognitive function. Mean values declined over time for 
all three cognitive measures, although oral health measures were not associated with degree of decline 
in cognitive function. In these late-middle aged adults, complete tooth loss was significantly 
associated with lower cognitive performance. However, neither edentulism, number of teeth, nor 
periodontal disease predicted greater subsequent cognitive decline.  
B. Introduction 
Cognitive function changes throughout one’s life. These changes can be physiological or 
pathological in one or more cognitive domains (1,2). Emerging evidence has linked tooth loss and 
periodontal disease to a greater age-related cognitive decline and to neurodegenerative diseases, such 
as Alzheimer’s disease (AD) (3-9). An inflammatory model, based on the fundamental theory that 
chronic periodontal disease is a complex interaction between bacterial pathogens and the host 
inflammatory response, has been proposed to explain the observed associations (10). 
However, there is considerable uncertainty concerning the mechanisms that could lead to 
associations between poor oral health and cognitive function, since most studies have been cross-
sectional and conducted primarily in older adults (4,8,9,11-17). For example, poor nutritional status 
resulting from tooth loss may affect cognitive ability (17,18). Cognitive dysfunction may lead to 
poorer self-care, thereby worsening oral health status (19). Low cognitive ability in early life may 
lead to socioeconomic inequalities in oral health (20). 
Whereas many studies report associations of fewer teeth and complete tooth loss with poorer 
cognitive function (3,5,13,21-23), evidence regarding the association between periodontal disease and 
cognitive ability is mixed (3,6-8,13,14). Furthermore, periodontal disease exposure in earlier studies 
was defined based on clinical signs that do not provide much information about the underlying 
biology of periodontal disease. For instance, Stein et al. (2007) found that a low number of teeth (0-
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9), but not alveolar bone loss, was associated with the incidence of dementia during 12 years of 
follow-up (5). In contrast, another prospective study in dentate men found that a higher rate of tooth 
loss, along with the progression of alveolar bone loss or probing pocket depth, increased the risk of 
low cognitive scores. In that study, however, baseline cognitive status was unavailable (3). Recently, 
a 15-year follow-up study in French older adults found a lower risk of dementia associated with fewer 
teeth among lower educated participants but noted that their surprising finding might have arisen if 
lack of teeth protected them from a source of chronic inflammation. In that study, the risk of dementia 
was not associated with masticatory function or community periodontal index (CPI) (7).  
The purpose of the present study was to determine whether tooth loss and current 
inflammatory state of periodontal disease, as classified by the Biofilm-Gingival Interface (BGI) 
classification, predicted eight-year changes in cognitive function among community-dwelling, late 
middle-aged adults in the Atherosclerosis Risk in Communities (ARIC) study. We hypothesized that 
multiple tooth loss and severity of periodontal disease would predict low cognitive performance and 
subsequent cognitive decline.  
C. Methods 
Data and participants 
Participants were members of the ARIC study, a prospective investigation of the etiology and 
natural history of atherosclerosis and clinical cardiovascular disease in four U.S. communities 
(Forsyth County, NC; Washington County, MD; suburban Minneapolis MN; and Jackson, MS). The 
Jackson cohort was comprised exclusively of African Americans. In this study, we used data from 
ARIC Visit 4 (1996-1998) and two ARIC ancillary studies: a) the Dental ARIC study; and b) the 
Brain Magnetic Resonance Imaging (MRI) study. Details on sampling and data collection procedures 
used in ARIC, including its ancillary studies, have been described elsewhere (24-26).  
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Cognitive function of ARIC participants was initially assessed between 1990 and 1992 (Visit 
2), and has been repeatedly evaluated approximately every three years until Visit 4. Dental ARIC was 
a cross-sectional study conducted at Visit 4. From 2004-2006, a subset of participants from two study 
sites (Forsyth County NC and Jackson MS) received another cognitive function assessment as part of 
the Brain MRI study. For the present study, analyses were restricted to subjects who participated in 
the dental study at Visit 4 and the Brain MRI study with two cognitive assessments separated by eight 
years (between 1996-1998 and 2004-2006). 
At Visit 4, 4,737 participants from the Forsyth County and Jackson study sites received 
cognitive functional assessments and a dental screening questionnaire, and 15.5% (n = 733) of these 
subjects reported complete tooth loss. Of 4,004 dentate participants, 2,728 (68.1%) underwent a 
comprehensive dental examination. From 2004-2006, the cognitive function of 911 participants was 
reevaluated (Figure 5-3). 
Oral health measures 
The cross-sectional Dental ARIC study consisted of a comprehensive dental examination, 
which included periodontal probing; collection of gingival crevicular fluid (GCF), dental plaque, and 
serum; and an interview. Persons requiring antibiotic prophylaxis for periodontal probing were 
excluded from the Dental ARIC study. Periodontal probing depth (PPD) and bleeding on probing 
(BOP) were assessed at six sites on all teeth by trained examiners.  
The BGI index, based on measures of PPD (PPD ≤ 3 mm or PPD ≥ 4 mm) and extent of BOP 
(low, <10%; moderate, 10-<50%; and severe , ≥ 50%), were used to classify periodontal status into 
five levels. Subjects with PPD ≤ 3 mm were defined as periodontal healthy if BOP was less than 10% 
or gingivitis if BOP was 10% or more. Subjects with one or more periodontal pockets or PPD ≥ 4 mm 
were divided into low, moderate, or severe bleeding. BGI index, in contrast to traditional definitions 
of periodontal status, creates subgroups that share some common clinical signs, but they differ in 
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microbial components and inflammatory biomarker levels (27). This unique characteristic of the BGI 
enables us to study whether infection and inflammatory components of periodontal disease are related 
to cognitive function. The number of teeth present was also recorded during the dental examination. 
An individual’s dental status was obtained from answers to the following items on a self-administered 
questionnaire: “Do you have any natural teeth?” and “Do you have any dental implants”? Participants 
who had only dental implants (n = 21) were excluded from the study. 
Cognitive function 
Outcomes of interest were scores from the following cognitive tests: a) Delayed Word Recall 
(DWR); b) Digit Symbol Substitution (DSS); and c) Word Fluency (WF). The DWR tests verbal 
learning and recent memory (28). The DSS, a test of concentration and psychomotor speed (29), and 
the WF, a test of expressive language, assess executive function (30). Higher scores in each of the 
three tests indicate better cognitive ability. All cognitive tests were administered by trained 
examiners. Cognitive test protocols for ARIC have been reported elsewhere (24). 
Covariates 
Covariates included socio-demographic factors (age, race, gender, educational level, income, 
and study sites), cardiovascular risk factors, apolipoprotein E (APOE) genotype, stroke, and coronary 
heart disease (CHD). Educational levels were classified as less than high school (<12 years), high 
school completion (12-16 years), or post-secondary education (17-21 years). Household income was 
coded as <$25,000, $25,000-$50,000, > $50,000, or refused (1996-1998 dollars). A variable 
representing race and ARIC filed centers was created to control for the racial, regional, and examiner 
differences in the ARIC cohort as the following: Forsyth/White, Forsyth/Black, and Jackson/Black. 
Cardiovascular risk factors included smoking and alcohol use (each recorded as never, former, or 
current), diabetes, hypertension, hyperlipidemia, and body mass index (BMI). APOE genotype was 
dichotomized as presence or absence APOE ε4 allele (Supplemental Methods).  
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Statistical analyses 
Race- and gender-specific descriptive statistic and bivariate analyses were conducted. We 
used generalized estimating equations (GEE) to analyze eight-year changes in the three cognitive 
scores. The dependent variables were repeated measures of the DWR, DSS, and WF scores. Since 
time intervals between baseline and follow-up were slightly different among study participants (mean 
± s.d. = 7.6 ± 1.0 years; median = 8 years), we used an indicator variable (time (t)) to identify whether 
the scores represented a baseline (t = 0) or follow-up (t = 1) measurement rather than using actual 
time intervals. The unstructured working correlation matrix was used to correct within-subject 
correlations in the analysis.  
The hypothesis that oral health predicted cognitive decline involved testing the interaction 
between time and oral health measures, i.e., a model of E (Yit ⏐Oral health predictorit) = b 0 ± b 1*Oral 
health predictor ± b 2*t ± b 3*(Oral health predictor*t), where the hypothesis H0: b 3 = 0 was tested. If 
p-value was greater than 0.10 for b 3, we concluded that oral health measures did not significantly 
predict cognitive decline over time.  
Potential confounders were identified based on previous literature and bivariate analyses 
assessing the association between exposures and outcomes. We used directed acyclic graphs (DAGs) 
and the change-in-estimate procedure to select the adjustment variables in this study. The minimally 
sufficient set for adjustment included socio-demographic factors, smoking, alcohol use, and diabetes 
(i.e., the reduced model). Fully adjusted models consisted of variables from the reduced model, BMI, 
hyperlipidemia, hypertension, and APOE ε4. All covariates were included in the GEE models as 
time-independent factors. If regression coefficients of the reduced models did not differ from those 
for the fully adjusted models by greater than 10% or ± 0.1, the regression coefficients from the 
reduced models were presented in table results. Supplementary analyses addressed questions 
concerning cross-sectional associations between oral health measures and baseline cognitive scores in 
this study samples, study center-specific associations of oral health indicators and the 8-year change 
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in cognitive scores, as well as, impact of including participants with history of stroke in study sample. 
All statistical analyses were performed using SAS 9.3 (Cary, NC).  
D. Result 
Characteristics of study participants 
The final sample contained 911 individuals with an average age of 64.7 ± 4.3 at baseline. 
Forty-nine percent of participants were African American and 61% were female. About half of study 
participants have never smoked and one-third have never used alcohol. There were notable 
differences between racial and gender groups in socio-demographic characteristics and in the 
prevalence of hypertension, diabetes, CHD, and stroke. About one-third of African American 
participants who primarily from Jackson study site compared to about 10% of whites, had less than 
12 years of education. African Americans also had lower income and a higher prevalence of diabetes 
and hypertension. CHD and stroke were more prevalent among African American males compared to 
other three race-gender groups. Overall, African American subjects had poor oral health as indicated 
by fewer teeth, higher prevalence of complete tooth loss, or severe periodontal disease. However, 
gingivitis was more common among white subjects (Table 5-1). 
Cognitive function  
Older age, male sex, low education, low income, diabetes, hypertension, current smoking, 
CHD, stroke, APOE ε4, and poor oral health (complete tooth loss, few teeth, and periodontitis with 
severe bleeding) were associated with a low cognitive profile. The differences in cognitive scores 
were generally greater for race, educational attainment, and income. There was, as expected, a strong 
association between dental status and overall cognitive performance. On average, individuals with 
complete tooth loss had cognitive scores 0.62, 9.08, and 8.30 points lower than dentate participants 
for the DWR, DSS, and WF tests, respectively. The associations of other covariates with repeated 
measures of cognitive scores are summarized in the Supplemental Table 5-9. 
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Over a median interval of eight years between the two examinations, most participants 
experienced a relatively small cognitive decline with substantial between-subjects variability. Mean 
change in DWR, DSS, and WF scores were -0.7, -3.6, and -1.8 points, with 53.5%, 67.8%, and 58.2% 
declining and 23.7%, 6.5%, and 5.2% unchanged. In general, white females tended to have a greater 
decline in DSS scores while African Americans (males, and females) exhibited a greater decrease in 
WF scores. The decline in DWR scores was similar across race- and gender-specific groups (Table 5-
2).   
Oral health measures and cognitive function  
Table 5-3 shows the regression coefficients (b ) for oral health measures, time, and their 
interactions; parameter estimates for the first-order effects of each oral health measure can be 
interpreted as the magnitude of association between the Visit 4 oral health measure and cognitive 
decline, while interaction terms indicate the difference between oral health status groups in degree of 
change in cognitive function over eight years. At Visit 4, lower levels of all three cognitive function 
test scores were seen in subjects with complete tooth loss when compared to dentate subjects, 
although the differences did not reach statistical significance for the DSS test in the fully adjusted 
model. In contrast, periodontal disease and the number of teeth were not significantly associated with 
cognitive performance, either as first-order effects or as interactions with time. 
Generally, cognitive decline among dentate participants tended to be slightly greater than that 
of edentulous subjects. However, oral health measures did not significantly modify the time-related 
degree of cognitive decline (Figures 5-2 – 5-6), except for the association between edentulism and 
DWR scores, which was marginally significant (p-value 0.0855 - Table 5.3). Individuals with 
complete tooth loss had adjusted DWR scores that declined from 6.1 (95% CI 5.8, 6.4) at baseline to 
5.7 (95% CI, 5.4, 6.0) at the follow-up visit compared with 6.6 (95% CI, 6.3, 6.7) at baseline and 5.8 
(95% CI, 5.6, 6.0) at the follow-up visit for dentate subjects (Figure 5-1).  
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Supplementary analyses showed dental status was associated with lower DWR and DSS at 
baseline (Table 5-4). Neither fewer teeth nor periodontal disease was associated with baseline 
cognitive scores of three tests. Associations between edentulism and change in cognitive scores in 
Forsyth study center was slightly stronger than that of Jackson study center (Table 5-6). The results 
were generally unchanged after excluding participants with history of stroke at baseline (Table 5-7). 
E. Discussion  
Four possible mechanisms have been proposed for the relation between poor oral health and 
lower cognitive function: (a) residual confounding by socio-demographic factors or other 
environmental factors; (b) nutritional deficiency resulting from tooth loss; (c) increased systemic 
inflammatory response (tooth loss is often a consequence of severe periodontal disease) (10,15,16); 
and (d) an adverse impact of cognitive decline on oral hygiene. 
Our study found complete tooth loss, though not periodontal disease and number of teeth, to 
be associated with low performance on two cognitive tests (DWR and WF) at baseline (Visit 4). 
However, although all three cognitive scores declined over time, we did not find that complete tooth 
loss, periodontal disease, and few teeth at baseline predicted a greater cognitive decline. We also 
observed a smaller decline in memory function among edentulous participants compared to dentate 
subjects. 
The most important strengths of the present study are the large population-based cohort of 
community-dwelling, predominantly late middle-aged adults and the quality of examination data. 
Cognitive assessment and periodontal examination, using a full-mouth protocol, were carried out by 
trained examiners. Several limitations are also relevant. Our study followed participants in only two 
of the four ARIC sites (Forsyth County and Jackson), and these differed greatly in regard to racial 
composition, socioeconomic characteristics, edentulism, and baseline cognitive scores (especially 
DSS and WF test scores).  
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Another limitation of our study is that oral health indicators were measured only at Visit 4, so 
that information was unavailable on the trajectory of oral health (i.e., additional tooth loss or 
periodontal disease progression). Thus, we cannot assess whether low cognitive performance 
influences oral health. Furthermore, assessments at two time points provide limited ability to 
differentiate true change from changes due to learning effects, random fluctuations, and measurement 
errors. Lastly, our study examined only three cognitive function tests, evaluating two cognitive 
domains. Thus, our failure to observe more rapid cognitive decline in participants with worse oral 
health provides limited evidence against the existence of a relationship. 
Complete tooth loss: 
Our findings of lower scores on Visit 4 DWR and WF for edentulous participants are 
consistent with previous studies which found that people with few teeth or complete tooth loss have 
lower cognitive function in the memory or executive function domains (3,6,13). We also observed a 
marginally-significantly lower score on the DSS for edentulous participants in the Forsyth County 
site but no association among Jackson site participants, whose cognitive function, education, and oral 
health measures were all markedly lower (Supplemental Tables 5-5, 5-6).  
Our findings are not consistent, however, with previous studies that found edentulism to 
predict more rapid cognitive decline and greater incidence of dementia (6,23). In fact, our study found 
a slower cognitive decline in edentulous participants. The many differences between the communities 
studied in the previous studies and in ours could conceivably account for the different findings. 
However, when we carried out separate analyses in the Forsyth and Jackson sites, which differ 
substantially in numerous characteristics, we observed a smaller decline in memory function in 
edentulous participants in both sites; it was, if anything, stronger in Forsyth (Supplemental Table 5-
6). The previous studies followed older participants, who experienced substantial cognitive declines, 
whereas our study population was predominantly late middle-aged adults, who had only modest 
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cognitive declines during the follow-up period. The smaller overall decline may have limited the 
opportunity to see a difference by oral health status.  
Other possible explanations for why our study did not observe greater cognitive decline for 
participants with poorer oral health – and for our observation of a smaller decrease in DWR scores for 
edentulous participants than for dentate participants – relate to the narrow time window under 
observation. Cognitive function of edentulous participants, who were older and had poorer socio-
demographic characteristics than dentate participants, may have begun to decline earlier in life, before 
our study baseline, and had now reached a stable level. Other possible explanations relate to the 
heterogeneity of age-related cognitive decline, where some cognitive domains decline earlier (i.e., 
memory function) and more rapidly than others, and inter-individual variability increases during the 
aging process (31). A longitudinal study in French elderly has reported a lower risk of dementia in 
lower educated participants with extensive tooth loss. The authors suggested that the observed 
association was possibly a result of greater tooth extraction in people with lower educational 
attainment, leading to better periodontal health (7). Such suppression of a source of chronic 
inflammation could conceivably explain why we observed a smaller decrement in cognitive function 
among edentulous persons. 
Yet another possibility is that the cross-sectional association between poorer oral health and 
worse cognitive function reflects an adverse effect of low cognitive function on oral health status. 
One longitudinal study has suggested that the observed association between complete tooth loss and 
cognitive impairment in older adults results from lower cognitive ability in early life predisposing 
individuals to edentulism (21).  
Periodontal disease: 
Previous findings regarding periodontal disease and cognitive function are mixed. Some 
studies, including our previous cross-sectional study (Study #1), have found a significant association 
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between periodontal disease and low cognitive ability (3,8,14-16), whereas others have not (5-7,13). 
Interpretation of these findings is complicated by differences in the definition and measurement of 
periodontal disease. A wide range of periodontal disease measures have been used, including 
biological markers (14,32), attachment loss (16), periodontal pocket depth (3,13), and self-reported 
periodontal status (6). Also, many study populations are highly selected, and results from them may 
not be indicative of what would be seen in other populations (3,5,7,8,13).  
In our study, BGI index was selected based on the concept that if periodontal infection and 
inflammation truly affect cognitive decline, we should observe a dose-response trend in the 
association because BGI reflects the underlying biology of periodontal disease (27). However, as 
noted in Chapter 4, the expected dose-response pattern might be masked by the nature of the clinical 
periodontal measures and effects of past treatments, none of which can be discerned given that 
periodontal measurements were recorded only a one visit. Furthermore, although different bacterial 
species are linked to gingivitis and severe periodontitis, both conditions have been correlated with 
elevated levels of gingival bleeding, inflammatory markers, and plaque scores.  
We found some indication that participants with a greater extent of bleeding (i.e., gingivitis 
and severe periodontitis) at baseline (Visit 4) had lower cognitive function than those who were 
healthy or had a lesser extent of bleeding, but we did not observe differences in the rate of cognitive 
decline to be related to the value of the BGI index. Our study may have been underpowered to detect 
an association between BGI and cognitive decline because cognitive change during the eight-year 
follow-up was modest, and the mean differences between the two extreme BGI groups were relatively 
small. However, it is also possible that subtle changes in cognitive function occurring prior to study 
baseline resulted in poor oral hygiene care, thereby increasing plaque level and the extent of bleeding 
on probing at baseline.  
Further relevance and interpretation of supplementary analyses were discussed in Chapter 6. 
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F. Conclusion 
We have not observed a relationship between edentulism, number of teeth, or periodontal 
disease in middle-aged adults and cognitive decline over the subsequent 8 years. Our study may have 
had insufficient statistical power given the low rate of observed cognitive decline, or the relationship 
may manifest only at older ages and/or in relation to more severe levels of impaired cognition. 
G. Human participants protection 
No protocol approval was necessary because this study involved the analysis of secondary 
data. 
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H. Tables 
Table 5-1. Race- and gender-specific socio-demographics, health conditions, and cognitive function 
at baseline (1996-1998) of study participants from Forsyth County, NC and Jackson, MS study sites  
 
Characteristics 
African American  White   
All Female Male  Female Male  
(n = 291 ) (n = 151)  (n = 268) (n = 201)  (n = 911) 
Age at Visit 4,  mean ± SD 64.0 ± 4.3 63.8 ± 4.5  65.4 ± 4.3 65.5 ± 4.1  64.7 ± 4.3 
Study sites, %        
 Forsyth  10.0 13.2  100 100  56.9 
 Jackson 90.0 86.8  0 0  43.1 
Education, %        
 Less than high school 32.0 31.8  8.6 9.0  20.0 
 High school completion 27.5 19.2  51.5 34.8  34.8 
 Post-secondary education 40.5 49.0  39.9 56.2  45.2 
Income, %        
 Refused 3.1 0.7  3.0 2.0  2.4 
 <$25,000 62.9 45.7  26.5 13.9  38.5 
 $25-<$50,000 23.7 29.1  38.0 35.3  31.4 
 $50,000 or more 10.3 24.5  32.5 48.8  27.7 
Cigarette use, %        
 Current 12.0 15.9  16.0 8.5  13.1 
 Former 27.8 47.0  26.5 65.2  38.8 
 Never 60.2 37.1  57.5 26.3  48.1 
Alcohol use, %        
 Current 18.9 34.4  40.3 55.2  35.8 
 Former 35.1 48.3  25.4 33.3  34.0 
 Never 46.0 17.2  34.3 11.4  30.2 
Diabetes mellitus, % 25.1 21.9  7.1 13.4  16.7 
Hypertension, % 67.0 51.7  32.8 39.8  48.4 
Coronary heart disease % 3.1 3.3  1.9 11.1  4.6 
 Missing 1.4 2.0  2.2 1.5  1.8 
Stroke, % 2.7 0.7  0.7 3.0  1.9 
 Missing 0 0.7  0 0  0.1 
Hyperlipidemia, % 35.0 31.8  35.1 36.3  34.8 
Body mass index (kg/m2), mean ± SD 30.6 ± 5.4  28.2 ± 4.5   26.1 ± 4.7  27.0 ± 3.6   28.1 ± 5.0  
APOE ε4, % 37.5 37.1  25.0 23.4  30.6 
Oral health conditions        
Edentulous, % 23.4 15.2  7.1 8.0  13.8 
Number of teeth1, mean ± SD 16.3 ± 7.3  18.9 ± 7.9   23.7 ± 5.5  22.1 ± 7.3   20.6 ± 7.5  
Periodontal disease1, %        
Had periodontal pockets        
 BOP > 50% 12.2 27.8  3.7 19.0  13.3 
 BOP 10- ≤ 50% 27.9 38.0  29.5 35.9  31.9 
 BOP < 10% 6.8 8.9  8.4 6.3  7.5 
No periodontal pockets        
 BOP ≥ 10% 24.5 13.9  39.5 25.4  28.3 
 BOP < 10%  28.6 11.4  18.9 13.4  19.0 
n, total number of study group; SD, standard deviation; BGI, Biofilm-gingival index 
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP).  
1Only among dentate participants who received periodontal examination  (n = 558 )  
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Table 5-2. Cognitive scores at Visit 4 and the eight-year changes in cognitive scores 
  
 African American White  All 
(n = 911) Cognitive scores, mean ± SD Female Male Female Male  
 (n = 291 ) (n = 151) (n = 268) (n = 201)  
Cognitive scores at Visit 4       
Delayed word recall  6.5 ± 1.5 5.8 ± 1.6 7.2 ± 1.3  6.8 ± 1.5  6.7 ± 1.6 
Digit symbol substitution 34.3 ± 12.5  30.0 ± 12.7 50.1 ± 9.9 44.6 ± 40.5  40.5 ± 14.0 
Word fluency 30.8 ±12.6 28.9 ± 14.4  37.0 ± 11.4 35.1 ± 12.1  33.3 ± 12.9 
       
Change in cognitive scores1       
Delayed word recall  -0.7 ± 1.8 -0.6 ± 1.7 -0.6 ± 1.7 -0.8 ± 1.6  -0.7 ± 1.7 
Digit symbol substitution -3.1 ± 9.1 -3.4 ± 6.9 - 4.9 ± 6.7 -2.9 ± 6.8  -3.6 ± 7.6 
Word fluency -2.5 ± 7.1 -2.5 ± 9.4 -1.6 ± 7.4 -0.7 ± 6.9  -1.8 ± 7.6 
1Changes  in cognitive scores =  Scores at follow-up – Scores at baseline 
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Table 5-3. Regression coefficients for the effects of time, oral health measures, and their interaction 
on three cognitive scores  
 
  
 n 
Delayed word recall Digit symbol substitution Word fluency 
 b (SE) P-value b (SE) P-value b (SE) P-value 
Dental status1,2 911       
Time (F/U vs. Baseline) -0.74 (0.06) <0.0001 -3.76 (0.26) <0.0001 -1.91 (0.28) <0.0001 
Edentulous  -0.42 (0.16) 0.0357 -1.47 (1.08) 0.2438 -3.03 (0.02) 0.0014 
Edentulous x Time  0.29 (0.17) 0.0855 0.89 (0.93) 0.3389 0.46 (0.60) 0.4512 
        
Periodontal disease1 558       
Time (F/U vs. Baseline) -0.98 (0.18) <0.001 -3.38 (0.84) <0.0001 -1.32 (0.80) <0.0001 
BGI-DL/SB  -0.16 (0.21) 0.6040 -0.28 (1.56) 0.5165 -0.50 (1.79) 0.6225 
BGI-DL/MB  0.0015 (0.16)  0.88 (1.18)  1.50 (1.44)  
BGI-DL/LB  0.15 (0.24)  2.38 (1.56)  1.75 (2.15)  
BGI-G  0.12 (0.16)  0.91 (1.22)  -0.75 (1.40)  
BGI-DL/SB x Time  0.45 (0.27) 0.5655 0.55 (1.14) 0.7636 -0.96 (1.17) 0.2173 
BGI-DL/MB x Time  0.23 (0.22)  -0.33 (0.96)  -1.36 (1.00)  
GI-DL/LB x Time  0.10 (0.29)  0.12 (1.32)  -2.18 (1.45)  
BGI-G x Time  0.22 (0.22)  -0.64 (0.99)  0.17 (0.98)  
        
Number of teeth1 558       
Time (F/U vs. Baseline) -0.67 (0.23) 0.0048 -3.38 (0.86) 0.0001 -2.72 (0.90) 0.0028 
1-tooth increase  0.0031 (0.0086) 0.7129 0.046 (0.056) 0.3959 -0.0071 (0.073) 0.9233 
1-tooth increase x Time -0.0053 (0.01) 0.6109 -0.0094 (0.039) 0.8071 0.035 (0.0042) 0.4100 
b , regression coefficient; SE, standard error; BGI, Biofilm -Gingival Interface  
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP). 
BGI-DL/SB (deep lesion/severe bleeding), BGI-DL/MB (deep lesion/moderate bleeding), BGI-DL/LB (deep lesion/low bleeding), BGI-
G (gingivitis), and BGI-H (healthy).  In regression models, BGI-H was the reference group.  
1Adjusting for  age, gender,  race-center, education, income, smoking, alcohol use, and diabetes 
2Digit symbol substitution: Adjusting for age, gender, race-center, education, income, smoking, alcohol use, diabetes, hypertension, 
hyperlipidemia, body mass index, and APOE ε4 
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I. Figures 
 
Figure 5-1. Crude and adjusted means with 95% confidence intervals for the Delayed Word Recall 
test scores at baseline and follow-up comparing edentulous with dentate participants (n = 911) 
 
 
Figure 5-2. Crude and adjusted means and 95% confidences intervals for the Delayed Word Recall 
test scores at baseline and follow-up in relation to five levels of periodontal conditions (n = 558) 
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Figure 5-3. Crude and adjusted means and 95% confidences intervals for the Digit Symbol 
Substitution test scores at baseline and follow-up comparing edentulous with dentate participants          
(n = 911) 
 
Figure 5-4. Crude and adjusted means and 95% confidences intervals of Digit Symbol Substitution 
test scores at baseline and follow up in relation to five levels of periodontal conditions (n = 558)  
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Figure 5-5. Crude and adjusted means and 95% confidences intervals of Word Fluency test scores at 
baseline and follow up comparing edentulous with dentate participants (n = 911) 
 
 
Figure 5-6. Crude and adjusted means and 95% confidences intervals of Word Fluency test scores at 
baseline and follow up in relation to five levels of periodontal conditions (n = 558)  
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J. Supplemental materials 
Covariates  
Diabetic status was determined by fasting plasma glucose ≥ 126 mg/dL, non-fasting plasma 
glucose ≥ 200 mg/dL, self-reported- history of physician-diagnosed diabetes or current medication for 
diabetes. Hypertension was defined as a previous diagnosis of hypertension, taking hypertensive 
medication, or having a current systolic blood pressure of 140 mmHg or higher or a diastolic blood 
pressure 90 mmHg. Stroke was defined as a self-reported history of physician-diagnosed stroke or 
stroke validated by an ARIC clinician through a review of medical records. Coronary heart disease 
was defined as adjudicated myocardial infraction on the electrocardiogram at baseline, or prior self-
reported history of myocardial infarction, coronary artery bypass surgery or angioplasty.  
Additional analyses and results 
Effect measure modification 
We also tested whether diabetes and APOE ε4 were the effect measure modifiers by 
examining likelihood ratio for type 3 analysis of the interaction terms between presumed effect 
modifiers, oral health measures, and time. If the p-value is less than 0.10, the interaction term is 
included in the regression model. In this study sample, no effect measure modification by diabetes 
and APOE ε4 was observed. 
Secondary analyses 
The present longitudinal analysis included a substudy sample (~10%) of our previous cross-
sectional study (Study #1), and differences in study characteristics between the cross-sectional and 
longitudinal study participants were evident. Therefore, the cross-sectional analysis, examining the 
association between oral health measures and all three cognitive tests at Visit 4, was repeated  in the 
present study sample.  
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Complete tooth loss was significantly associated with only low DWR and WF scores. 
Periodontal disease and the number of teeth were not associated with all Visit 4 cognitive scores 
(Table 5-4).These results were consistent with the longitudinal analysis using GEE models. However, 
these cross-sectional findings differed from our prior cross-sectional study, which comprised of all 
available Visit 4 ARIC cohort members. The previous study found that complete tooth loss was 
related with all three cognitive performance. Furthermore, the associations of periodontal disease and 
the number of teeth with DSS and WF scores were observed.  
Differences in socio-demographic backgrounds as well as cognitive function at baseline 
between participants from Forsyth County and Jackson were also noticeable. Therefore, we 
performed a stratified analysis by study sites to investigate whether the associations between oral 
health measures and cognitive performance differed across the study sties. The sites-specific 
estimates were shown in Table 5-6. Overall, the effect of oral health measures on cognitive profile 
was more pronounced in Forsyth County than that in Jackson. 
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K. Supplemental Tables 
Table 5-4. Regression coefficients for the associations between oral health measures and Visit 4 
cognitive scores: A cross-sectional analysis 
    Delayed word recall Digit symbol substitution Word fluency 
  n  b (SE) P-value b (SE) P-value b (SE) P-value 
Dental status1,2 911             
  Edentulous   -0.44 (0.15) 0.0026 -1.40 (1.00) 0.1136 -3.16 (1.12) 0.0049 
  Dentate   Ref   Ref   Ref   
                  
Periodontal disease1 558             
Had periodontal pockets       
  BOP > 50%   -0.22 (0.21) 0.6788 -0.20 (1.44) 0.6173 -0.058 (1.76) 0.2981 
  BOP 10- ≤ 50%   0.0069 (0.17)   0.89 (1.14)   1.82 (1.40)   
  BOP < 10%   0.13 (0.25)   2.33 (1.69)   1.74 (2.06)   
No periodontal pockets       
  BOP ≥ 10%   0.11 (0.17)   0.76 (1.17)   -0.65 (1.44)   
  BOP < 10%    Ref   Ref   Ref   
                  
Number of teeth1 558             
  1-tooth increase   0.007 (0.009) 0.4261 0.031(0.06) 0.5961 0.018 (0.07) 0.7997 
b , regression coefficient; SE, standard error; BGI; Biofilm-Gingival Interface   
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP). Five levels of 
BGI were the followings: BGI-DL/SB (deep lesion/severe bleeding), BGI-DL/MB (deep lesion/moderate bleeding), BGI-DL/LB 
(deep lesion/low bleeding), BGI-G (gingivitis), and BGI-H (healthy). 
1Adjusting for age, gender, race-center, income, smoking, alcohol use, and diabetes 
2Digit symbol substitution: Adjusting for age, gender, race-center, education, income, smoking, alcohol use, diabetes, hypertension, 
hyperlipidemia, body mass index, and APOE ε4 
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Table 5-5. Comparison of cognitive scores at baseline and follow-up of participants who were from 
Forsyth County NC and Jackson MS  
 
 
 
 
 
 
 
 
  Study sites   
  
P-value 
  
All (n = 911) 
  
  Cognitive tests 
Forsyth County 
n = 518 (56.9%) 
Jackson 
n = 393 (43.1%) 
   Mean SD Mean SD   Mean SD 
Delayed word recall         
1996-1998  7.0 1.4 6.2 1.6  <0.0001 6.7 1.6 
2004-2006  6.3 1.6 5.5 1.7 
 
<0.0001 6.0 1.7 
Change  -0.7 1.7 -0.7 1.8 
 
0.7733 -0.7 1.7 
         Digit symbol substitution         
1996-1998  47.1 11.4 31.9 12.4 
 
<0.0001 40.5 14.0 
2004-2006  43.1 10.9 28.7 11.5 
 
<0.0001 36.9 13.2 
Change -4.0 6.7 -3.2 8.7 
 
0.0905 -3.6 7.6 
         Word fluency         
1996-1998  36.0 12.0 29.6 13.0 
 
<0.0001 33.3 12.9 
2004-2660  34.8 11.6 27.0 11.7 
 
<0.0001 31.4 12.3 
Change -1.2 7.4 -2.7 7.9   0.0034 -1.9 7.6 
Change = (Scores at 2004-2006 – Scores at 1996-1998) 
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Table 5-6. Study site-specific estimates for associations between time, dental status, and their on three 
measures of cognitive function  
 
  
  Forsyth County (n = 518)   Jackson (n = 393)   All (n = 911) 
  b	  	   SE P-value   b	  	   SE P-value 
 
b	  	   SE P-value 
Delayed word recall1 
       Time (F/U vs. Baseline) -0.74 0.08 0.0001 
 
-0.73 0.10 <0.0001 
 
-0.74 0.061 <0.0001 
Edentulous -0.68 0.24 0.0250 
 
-0.29 0.21 0.3028 
 
-0.42 0.16 0.0357 
Edentulous x Time 0.37 0.25 0.1500 
 
0.25 0.23 0.2827 
 
0.29 0.17 0.0855 
            Digit symbol substitution2 
           Time (F/U vs. Baseline) -4.18 0.30 <0.0001 
 
-3.14 0.45 <0.0001 
 
-3.76 0.26 <0.0001 
Edentulous -3.75 1.73 0.0638 
 
-0.13 1.38 0.8908 
 
-1.47 1.08 0.2438 
Edentulous x Time 1.86 1.24 0.1416 
 
-0.04 1.30 0.9729 
 
0.89 0.93 0.3389 
            Word fluency1 
           Time (F/U vs. Baseline) -1.28 0.35 0.0543 
 
-2.86 0.46 <0.0001 
 
-1.91 0.28 <0.0001 
Edentulous -4.74 1.40 0.0045 
 
-2.34 1.20 0.0677 
 
-3.03 0.92 0.0014 
Edentulous x Time 0.93 0.82 0.2645   0.79 0.85 0.3524   0.46 0.60 0.4512 
b , regression coefficient; SE, standard error 
1Adjusting for age, gender, education, income, smoking, alcohol use, and diabetes 
2Adjusting for age, gender, education, income, smoking,, alcohol use, and diabetes, hypertension, hyperlipidemia, body mass index,  
and APOE ε4 
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Table 5-7. Regression coefficients for the effects of time, oral health measures, and their interaction 
on three cognitive scores, excluding subjects with stroke at baseline 
  
 n 
Delayed word recall Digit symbol substitution Word fluency 
 b (SE) P-value b (SE) P-value b (SE) P-value 
Dental status1,2 894       
Time (F/U vs. Baseline) -0.74 (0.06) <0.0001 -3.74 (0.26) <0.0001 -1.83 (0.28)  < 0.0001 
Edentulous  -0.45 (0.16) 0.0261 -1.35 (1.08) 0.2810 -3.32 (0.93) 0.0004 
Edentulous x Time  0.31 (0.17) 0.0719 0.83 (0.95) 0.3859 0.42 (0.61) 0.5000 
        
Periodontal 
disease1 550       
Time (F/U vs. Baseline) -1.01 (0.18) <0.0001 -3.59 (0.83) <0.0001 -1.12 (0.81) <0.0001 
BGI-DL/SB  -0.20 (0.21) 0.6331 -0.14 (1.56) 0.3609 -0.31 (1.78) 0.5021 
BGI-DL/MB  0.0029 (0.16)  1.28 (1.17)  2.00 (1.43)  
BGI-DL/LB  0.12 (0.24)  2.62 (1.56)  2.12 (2.14)  
BGI-G  0.092 (0.16)  1.24 (1.21)  -0.33 (1.39)  
BGI-DL/SB x 
Time  0.48 (0.28) 0.4935 0.77 (1.13) 0.7867 -1.17 (1.18) 0.2133 
BGI-DL/MB x 
Time  0.27 (0.22)  -0.086 (0.95)  -1.47 (1.01)  
GI-DL/LB x Time  0.13 (0.29)  0.33 (1.32)  -2.38 (1.46)  
BGI-G x Time  0.25 (0.22)  -0.41 (0.99)  -0.024 (0.99)  
        
Number of teeth1 550       
Time (F/U vs. Baseline) -0.68 (0.23) 0.0047 -3.24 (0.88) 0.0003 -2.55 (0.92) 0.0060 
1-tooth increase  0.0017 (0.0086) 0.8458 0.052 (0.056) 0.3471 -0.0085 (0.074) 0.9098 
1-tooth increase x Time -0.0046 (0.01) 0.6581 -0.018 (0.039) 0.6507 0.030 (0.043) 0.4870 
b , regression coefficient; SE, standard error; BGI, Biofilm -Gingival Interface  
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP). 
BGI-DL/SB (deep lesion/severe bleeding), BGI-DL/MB (deep lesion/moderate bleeding), BGI-DL/LB (deep lesion/low bleeding), 
BGI-G (gingivitis), and BGI-H (healthy). 
1Adjusting for  age, gender,  race-center, education, income, smoking, alcohol use, and diabetes 
2Digit symbol substitution: Adjusting for age, gender, race-center, education, income, smoking, alcohol use, diabetes, hypertension, 
hyperlipidemia, body mass index, and APOE ε4 
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Table 5-8. Regression coefficients for effects oral health measures on cognitive function changes: 
Change score models  
 n 
Delayed word recall Digit symbol substitution Word fluency 
 b (SE) P-value b (SE) P-value b (SE) P-value 
Dental status1,2 991       
Edentulous  0.33 (0.17) 0.0536 0.75 (0.77) 0.3297 0.71 (0.77) 0.3571 
Dentate  Ref  Ref  Ref  
        
Periodontal disease1 558       
Had periodontal pockets       
BOP ≥ 50%  0.50 (0.26) 0.4392 0.39 (1.06) 0.9255 -1.83 (1.18) 0.0603 
BOP 10- <50%  0.22 (0.21)  -0.35 (0.84)  -2.00 (0.93)  
BOP < 10%  0.15 (0.31)  0.21 (1.23)  -2.17 (1.37)  
No periodontal pockets       
BOP ≥ 10%  0.24 (0.21)  -0.34 (0.86)  -0.021 (0.96)  
BOP < 10%  Ref  Ref  Ref  
        
Number of teeth1 558      0.7364 
1-tooth increase  -0.013 (0.011) 0.2291 0.024 (0.043) 0.5732 -0.016 (0.049)  
b, regression coefficient; SE, standard error; BGI, Biofilm -Gingival Interface  
Change scores = (Scores at follow-up) – (Scores at baseline) 
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP). 
BGI-DL/SB (deep lesion/severe bleeding), BGI-DL/MB (deep lesion/moderate bleeding), BGI-DL/LB (deep lesion/low bleeding), 
BGI-G (gingivitis), and BGI-H (healthy). 
1Adjusting for  age, gender,  race-center, education, income, smoking, alcohol use, and diabetes 
2Digit symbol substitution: Adjusting for age, gender, race-center, education, income, smoking, alcohol use, diabetes, hypertension, 
hyperlipidemia, body mass index, and APOE ε4 
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Table 5-9. Baseline characteristics and repeated measures (1996-1998 and 2004-2006) of the three 
cognitive test scores (n = 911)   
Characteristics Col 
% 
Delayed word recall Digit symbol substitution Word fluency 
  b (SE) P-value b (SE) P-value b (SE) P-value 
Age categories        
 ≥ 65 48.3 -0.44 (0.14) 0.0017 -5.05 (1.43) 0.0005 -2.54 (1.28) 0.1457 
 60-64 39.6 -0.19 (0.14)  -2.48 (1.46)  -2.03 (1.28)  
 51-59 12.1 Ref  Ref  Ref  
Gender        
 Male 38.6 -0.48 (0.094) <0.0001 -3.13 (0.89) 0.0005 -1.01 (0.82) 0.2244 
 Female 61.4 Ref  Ref  Ref  
Race        
 African American 48.5 -0.75 (0.088) <0.0001 -14.48 (0.72) <0.0001 -6.7 (0.76) <0.0001 
 White 51.5 Ref  Ref  Ref  
Study sites        
 Forsyth 56.9 0.79 (0.088) <0.0001 14.76 (0.73) <0.0001 7.10 (0.77) <0.0001 
 Jackson 43.1 Ref  Ref  Ref  
Education        
 Less than high 
school 20.0 -0.87 (0.12) <0.0001 -17.35 (0.95) <0.0001 -15.53 (0.87) <0.0001 
 High school 
completion 34.8 -0.21 (0.098)  -3.84 (0.86)  6.66 (0.79)  
 Post-secondary 
education 45.2 
 
Ref  Ref  Ref 
 
Income        
 Refused  2.4 0.024 (0.26) <0.0001 -7.13 (2.93) <0.0001 -5.15 (2.36) <0.0001 
 <25000 38.5 -0.64 (0.11)  -14.37 (0.95)  -10.94 (0.91)  
 25-<50000 31.4 -0.26 (0.12)  -5.58 (0.97)  -3.53 (0.96)  
 50000 or more 27.7 Ref  Ref  Ref  
Cigarette use        
 Current 13.0 -0.095 (0.13) 0.6417 -3.26 (1.26) 0.0232 -1.40 (1.23) <0.2513 
 Former 38.9 -0.079 (0.10)  0.17 (0.94)  0.73 (0.86)  
 Never 48.1 Ref  Ref  Ref  
Alcohol use        
 Current 35.8 0.34 (0.11) 0.0002 7.86 (1.04) <0.0001 6.08 (0.96) <0.001 
 Former 34.0 -0.092 (0.11)  0.29 (1.02)  0.42 (0.94)  
 Never 30.2 Ref  Ref  Ref  
Diabetes mellitus        
 Yes 16.7 -0.30 (0.13) 0.0193 -6.12 (1.15) <0.0001 -4.82 (0.97) <0.0001 
 No 83.3 Ref  Ref  Ref  
Hypertension        
 Yes 48.4 -0.36 (0.09) <0.0001 -6.68 (0.84) <0.0001 -3.84 (0.78) <0.0001 
 No 51.6 Ref  Ref  Ref  
CHD        
 Yes 4.6 -0.17 (0.24) 0.4998 -0.048 (1.73) 0.9778 0.76 (1.79) 0.6727 
 No 93.6 Ref  Ref  Ref  
 Missing  1.8       
Stroke        
 Yes 1.9 -0.98 (0.31) 0.0120 -5.59 (3.08) 0.0956 -1.21 (3.09) 0.6969 
 No 98.1 Ref  Ref  Ref  
 Missing 0.11       
Hyperlipidemia        
 Yes 34.8 0.13 (0.095) 0.1738 0.18 (0.93) 0.8454 -0.32 (0.81) 0.6965 
 No 65.2 Ref  Ref  Ref  
BMI (kg/m2)        
 ≥ 30  31.5 -0.32 (0.82) 0.6965 -0.24 (0.097) 0.0139 -5.54 (0.89) <0.0001 
 < 30 68.5 Ref  Ref   Ref  
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APOE ε4        
 Yes 30.6 -0.21 (0.10) 0.0427 -2.97 (0.96) 0.0023 -1.20 (0.87) 0.1718 
 No 69.4 Ref  Ref  Ref  
Oral health conditions       
Edentulous        
 Yes 13.8 -0.62 (0.13) <0.0001 -9.08 (1.17) <0.0001 -8.30 (0.99) <0.0001 
 No 86.2 Ref  Ref  Ref  
Number of teeth1        
 1-24 57.5 -0.36 (0.11) 0.0016 -7.28 (1.02) <0.0001 -4.73 (1.00) <0.0001 
 ≥ 25 42.5 Ref  Ref  Ref  
Periodontal disease1         
Had periodontal pockets       
 BOP  > 50% 13.3 -0.26 (0.19) 0.0577 -4.14 (1.98) 0.0047 -3.86 (1.85) 0.1249 
 BOP 10- ≤ 50% 31.9 0.051 (0.16)  0.45 (1.57)  0.083 (1.42)  
 BOP < 10% 7.5 0.17 (0.24)  3.62 (2.26)  1.98 (2.01)  
No periodontal pockets       
 BOP ≥ 10% 28.3 0.27 (0.16)  2.37 (1.58)  -0.32 (1.39)  
 BOP < 10%  19.0 Ref  Ref  Ref  
n, total number of study group; CHD, coronary heart disease; BMI, body mass index; BGI, Biofilm-Gingival Interface 
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP).  
1Only among dentate participants who received periodontal examination (n = 558) 
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Table 5-10. Regression coefficients for effects of time, dental status, and their interaction (n = 911) 
  
  
Models 
  
Delayed word recall Digit symbol substitution Word fluency 
b  SE P-value b  SE P-value b  SE P-value 
Crude           
 Time (F/U vs. Baseline) -0.74 0.06 <0.0001 -3.76 0.26 <0.0001 -1.91 0.28 <0.0001 
 
Edentulous -0.76 0.15 <0.0001 -9.52 1.34 <0.0001 -8.53 1.05 <0.0001 
 
Edentulous x Time 0.29 0.17 0.0855 0.89 0.93 0.3389 0.46 0.60 0.4512 
Model A1          
 Time (F/U vs. Baseline) -0.74 0.06 <0.0001 -3.76 0.26 <0.0001 -1.91 0.28 <0.0001 
 
Edentulous -0.44 0.16 0.0241 -2.24 1.10 0.4601 -3.20 0.92 0.0007 
 
Edentulous x Time 0.29 0.17 0.0855 0.89 0.93 0.3389 0.46 0.60 0.4512 
Model B2          
 Time (F/U vs. Baseline) -0.74 0.06 <0.0001 -3.76 0.26 <0.0001 -1.91 0.28 <0.0001 
 
Edentulous -0.42 0.16 0.0357 -1.74 1.08 0.1438 -3.03 0.92 0.0014 
 
Edentulous x Time 0.29 0.17 0.0828 0.89 0.93 0.3389 0.46 0.60 0.4512 
Model C3          
 Time (F/U vs. Baseline) -0.74 0.06 <0.0001 -3.76 0.26 <0.0001 -1.91 0.28 <0.0001 
 
Edentulous -0.41 0.16 0.0487 -1.47 1.08 0.2438 -2.94 0.93 0.0021 
 
Edentulous x Time 0.29 0.17 0.0828 0.89 0.93 0.3389 0.46 0.60 0.4512 
b, regression coefficient; SE, standard error 
1Adjusting for age, gender, race-center, education, and income 
2Adjusting for covariates in model A, smoking,, alcohol use, and diabetes (minimally sufficient adjustment set) 
3Adjusting for covariates in model B, hypertension, hyperlipidemia, body mass index, and APOE ε4 
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Table 5-11. Stratum-specific estimates for associations between dental status and cognitive scores     
(n = 911) 
 
Models Visit Delayed word recall  Digit symbol substitution  Word fluency 
 b  SE  b  SE  b  SE 
Model B1         
Edentulous  1996-1998 -0.42 0.16  -1.74 1.08  -3.03 0.92 
Edentulous 2004-2006 -0.13 0.15 
 
-0.85 0.90 
 
-2.58 0.87 
Model C2         
Edentulous 1996-1998 -0.41 0.16  -1.47 1.08  -2.94 0.93 
Edentulous 2004-2006 -0.11 0.15  -0.58 0.90  -2.49 0.88 
Change %3         
 1996-1998 -1.7   -27.3   -9.0  
 2004-2006 -1.7   -27.3   -9.0  
b, regression coefficient; SE, standard error 
1Adjusting for age, gender, race-center, education, income, smoking, alcohol use, and diabetes (a minimally sufficient adjustment set) 
2Adjusting for covariates in model B, hypertension, hyperlipidemia, body mass index, and APOE ε4 
3Changes in estimates = (b model B – b model C) x 100 
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Table 5-12. Regression coefficients for effects of time, periodontal disease, and their interaction on 
cognitive scores (n = 558) 
Models 
Delayed word recall Digit symbol substitution Word fluency  
b	  	   SE P-value b  SE P-value b  SE P-value 
Crude          
 Time (F/U vs. Baseline) -0.98 0.18 <0.0001 -3.38 0.84 <0.0001 -1.32 0.80 <0.0001 
 BGI-DL/SB  -0.49 0.21 0.0577 -4.42 2.12 0.0047 -3.38 2.00 0.1249 
 BGI-DL/MB -0.06 0.17  0.62 1.70  0.77 1.54  
 BGI-DL/LB 0.12 0.27  3.56 2.41  3.07 2.14  
 
BGI-G 0.17 0.16  2.69 1.72  -0.41 1.50  
 BGI-DL/SB x Time 0.45 0.27 0.5655 0.55 1.14 0.7636 -0.96 1.17 0.2173 
 BGI-DL/MB x Time 0.23 0.22  -0.33 0.96  -1.36 1.00  
 BGI-DL/LB x Time 0.10 0.29  0.12 1.32  -2.18 1.45  
 BGI-G x Time 0.22 0.22  -0.64 0.99  0.17 0.98  
Model A1          
 Time (F/U vs. Baseline) -0.98 0.18 <0.0001 -3.38 0.84 <0.0001 -1.32 0.80 <0.0001 
 BGI-DL/SB1 -0.17 0.21 0.5895 -0.42 1.60 0.6229 -0.63 1.79 0.6179 
 BGI-DL/MB 0.14 0.24  2.20 1.64  1.67 2.15  
 BGI-DL/LB -0.01 0.16  0.65 1.20  1.28 1.42  
 BGI-G 0.12 0.16  0.73 1.23  -1.00 1.37  
 BGI-DL/SB x Time 0.45 0.27 0.5655 0.55 1.14 0.7673 -0.96 1.17 0.2173 
 BGI-DL/MB x Time 0.10 0.29  0.12 1.32  -2.18 1.45  
 BGI-DL/LB x Time 0.23 0.22  -0.33 0.96  -1.36 1.00  
 BGI-G x Time 0.22 0.22  -0.64 0.99  0.17 0.98  
Model B2          
 Time (F/U vs. Baseline) -0.98 0.18 <0.001 -3.38 0.84 <0.0001 -1.32 0.80 <0.0001 
 BGI-DL/SB1 -0.16 0.21 0.6040 -0.28 1.56 0.5165 -0.50 1.79 0.6225 
 BGI-DL/MB 0.0015 0.16  0.88 1.18  1.50 1.44  
 BGI-DL/LB 0.15 0.24  2.38 1.56  1.75 2.15  
 BGI-G 0.12 0.16  0.91 1.22  -0.75 1.40  
 BGI-DL/SB x Time 0.45 0.27 0.5655 0.55 1.14 0.7636 -0.96 1.17 0.2173 
 BGI-DL/MB x Time 0.23 0.22  -0.33 0.96  -1.36 1.00  
 BGI-DL/LB x Time 0.10 0.29  0.12 1.32  -2.18 1.45  
 BGI-G x Time 0.22 0.22  -0.64 0.99  0.17 0.98  
Model C3          
 Time (F/U vs. Baseline) -0.98 0.18 <0.0001 -3.38 0.84 <0.0001 -1.32 0.80 <0.0001 
 BGI-DL/SB1 -0.14 0.21 0.6173 -0.31 1.55 0.5316 -0.40 1.79 0.6577 
 BGI-DL/MB 0.0039 0.16  0.92 1.17  1.51 1.43  
 BGI-DL/LB 0.14 0.24  2.32 1.56  1.75 2.17  
 BGI-G 0.12 0.16  0.97 1.21  -0.70 1.40  
 BGI-DL/SB x Time 0.45 0.27 0.5655 0.55 1.14 0.7636 -0.96 1.17 0.2173 
 BGI-DL/MB x Time 0.23 0.22  -0.33 0.96  -1.36 1.00  
 BGI-DL/LB x Time 0.10 0.29  0.12 1.32  -2.18 1.45  
 BGI-G x Time 0.22 0.22  -0.64 0.99  0.17 0.98  
b, regression coefficient; SE, standard error; BGI, Biofilm-Gingival Interface 
1Adjusting for age, gender, race-center, education, and income 
2Adjusting for covariates in model A, smoking,, alcohol use, and diabetes (a minimally sufficient adjustment set) 
3Adjusting for covariates in model B, hypertension, hyperlipidemia, body mass index, and APOE ε4 
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Table 5-13. Stratum-specific estimates for associations between periodontal disease and cognitive 
scores (n = 558) 
  
Models Visit Delayed word recall  Digit symbol substitution  Word fluency 
 b	  	   SE  b	  	   SE  b	  	   SE 
Model B1          
BGI-DL/SB 1996-1998 -0.16 0.21  -0.28 1.56  -0.50 1.79 
BGI-DL/MB  0.002 0.16  0.88 1.18  1.50 1.44 
BGI-DL/LB  0.15 0.24  2.38 1.56  1.75 2.15 
BGI-G  0.15 0.16  2.38 1.22  1.75 1.40 
BGI-DL/SB 2004-2006 0.30 0.24  0.28 1.55  -1.46 1.58 
GI-DL/MB  0.23 0.21  0.55 1.14  0.14 1.33 
BGI-DL/LB  0.25 0.28  2.50 1.58  -0.43 2.01 
BGI-G  0.34 0.21  0.27 1.15  -0.58 1.29 
Model C1          
BGI-DL/SB 1996-1998 -0.14 0.21  -0.31 1.55  -0.40 1.79 
BGI-DL/MB  0.004 0.16  0.92 1.17  1.51 1.43 
BGI-DL/LB  0.14 0.24  2.32 1.56  1.75 2.17 
BGI-G  0.14 0.16  2.32 1.21  1.75 1.40 
BGI-DL/SB 2004-2006 0.32 0.24  0.25 1.53  -1.37 1.58 
BGI-DL/MB  0.23 0.21  0.59 1.13  0.15 1.33 
BGI-DL/LB  0.24 0.28  2.43 1.55  -0.43 2.02 
BGI-G  0.34 0.21  0.33 1.14  -0.53 1.35 
Change %3          
BGI-DL/SB 1996-1998 -1.6   3.0   -9.3  
BGI-DL/MB  -0.2   -4.1   -0.7  
BGI-DL/LB  0.9   6.4   -0.1  
BGI-G  0.9   6.4   -0.1  
BGI-DL/SB 2004-2006 -1.6   3.0   -9.3  
BGI-DL/MB  -0.2   -4.1   -0.7  
BGI-DL/LB  0.9   6.4   -0.1  
BGI-G  -0.03   -5.8   -5.0  
b, regression coefficient; SE, standard error; BGI, Biofilm-Gingival Interface 
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP). 
BGI-DL/SB (deep lesion/severe bleeding), BGI-DL/MB (deep lesion/moderate bleeding), BGI-DL/LB (deep lesion/low bleeding), BGI-
G (gingivitis), and BGI-H (healthy). 
1Adjusting for age, gender, race-center, education, income, smoking, alcohol use, and diabetes (a minimally sufficient adjustment set) 
2Adjusting for covariates in model B, hypertension, hyperlipidemia, body mass index, and APOE ε4 
3Changes in estimates = (b model B – b model C) x 100 
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Table 5-14. Regression coefficients for effects of time, number of teeth, and their interaction  on 
cognitive scores (n = 558)
Models Delayed word recall Digit symbol substitution Word fluency 
b	  	   SE P-value b  SE P-value b  SE P-value 
Crude           
 Time (F/U vs. Baseline) -0.67 0.23 0.0048 -3.38 0.86 <0.0001 -2.72 0.90 0.0028 
 
1-tooth increase  0.028 0.008 0.0011 0.55 0.073 <0.0001 0.30 0.075 <0.0001 
 
1-tooth increase  x Time -0.0053 0.010 0.6109 -0.0094 0.039 0.8071 0.035 0.042 0.4100 
Model A1          
 Time (F/U vs. Baseline) -0.67 0.23 0.0048 -3.38 0.86 0.0001 -2.72 0.90 0.0028 
 
1-tooth increase  0.0052 0.0086 0.5455 0.072 0.058 0.2168 0.017 0.073 0.8209 
 
1-tooth increase x Time -0.0053 0.010 0.6109 -0.0094 0.039 0.8071 0.035 0.042 0.4100 
Model B2          
 Time (F/U vs. Baseline) -0.67 0.23 0.0048 -3.38 0.86 0.0001 -2.72 0.90 0.0028 
 
1-tooth increase  0.0031 0.0086 0.7129 0.046 0.056 0.3959 -0.0071 0.073 0.9233 
 
1-tooth increase x Time -0.0053 0.010 0.6109 -0.0094 0.039 0.8071 0.035 0.042 0.4100 
Model C3          
 Time (F/U vs. Baseline) -0.67 0.23 0.0048 -3.38 0.86 0.0001 -2.72 0.90 0.0028 
 
1-tooth increase  0.0027 0.0087 0.7568 0.040 0.057 0.4825 -0.017 0.073 0.8157 
 
1-tooth increase x Time -0.0053 0.0104 0.6109 -0.0094 0.039 0.8071 0.035 0.042 0.4100 
b, coefficient; SE, standard error 
1Adjusting for age, gender, race-center, education, and income 
2Adjusting for covariates in model A, smoking, alcohol use, and diabetes (a minimally sufficient adjustment set) 
3Adjusting for covariates in model B, hypertension, hyperlipidemia, body mass index, and APOE ε4 
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Table 5-15. Stratum-specific estimates for the association between number of teeth and cognitive 
scores (n = 558)  
Model Visit Delayed word recall  Digit symbol substitution  Word fluency 
 b	  	   SE  b	  	   SE  b	  	   SE 
Model B1          
1-tooth increase 1996-1998 0.0032 0.0086  0.048 0.057  -0.0071 0.073 
1-tooth increase 2004-2006 -0.0021 0.0095  0.039 0.055  0.028 0.066 
Model C2          
1-tooth increase 1996-1998 0.0027 0.0087  0.040 0.057  -0.017 0.073 
1-tooth increase 2004-2006 -0.0026 0.0095  0.031 0.055  0.018 0.066 
Change %3          
 1996-1998 0.05   0.8   1.0  
 2004-2006 0.05   0.8   1.0  
 b, regression coefficient; SE, standard error 
1Adjusting for age, gender, race-center, education, income, smoking, alcohol use, and diabetes (a minimally sufficient adjustment set) 
2Adjusting for covariates in model B, hypertension, hyperlipidemia, body mass index, and APOE ε4 
3Changes in estimates = (b model B – b model C) x 100 
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L. Supplemental figures 
 
1Covariates: age, race, gender, study sites, education, income, smoking, alcohol use, body mass index, hyperlipidemia, 
diabetes, and APOE ε4.  
Figure 5-7. Flow chart of ARIC participants who completed two cognitive function assessments 
(1996-1998 and 2004-2006) and participated in the Dental ARIC Study
  
 
 
Figure 5-8. Scatterplots for the association between baseline cognitive scores and change in the Delayed Word Recall by race, study sites, and 
dental status (n = 911) 
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Figure 5-9. Scatterplots for the association between baseline cognitive scores and change in the Digit Symbol Substitution scores by race, 
study sites, and dental status dental status (n = 911) 
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Figure 5-10. Scatterplots for the association between baseline cognitive scores and change in the Word Fluency scores by race, study sites, and 
dental status dental status (n = 911)
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DISCUSSION AND CONCLUSIONS 
A. Summary of major findings 
The present study was based on a conceptual framework that periodontal infection and 
inflammation in midlife are potential biological pathways for inducing or accelerating cognitive 
decline. Periodontal infection was assessed through a clinical periodontal examination, number of 
missing teeth, and also edentulism, since loss of teeth is an outcome of severe periodontal disease. 
In this subset of the Atherosclerosis Risk in Communities (ARIC) cohort, baseline 
distributions for all three cognitive test scores were approximately normal (Gaussian). In general, 
cognitive ability was more strongly correlated with socio-demographic factors than medical health 
conditions. White participants tended to have better cognitive performance on all tests than African 
Americans, corresponding to the marked disparities in educational attainment and income. 
In our cross-sectional study, complete tooth loss was consistently associated with lower 
performance on three measures of cognitive function whereas few teeth and periodontal disease were 
correlated only with low DSS and WF scores. The net differences in adjusted mean scores between 
dentate and edentulous participants were 0.16, 2.18, and 1.87 for the DWR, DSS, and WF tests, 
respectively. Although there was no clear dose-response relationship among the five levels of 
periodontal conditions, cognitive scores of participants with a greater extent of bleeding on probing 
(gingivitis and periodontitis with severe bleeding) were lower, on average, than scores of subjects 
who had  less bleeding on probing, regardless of pocket depth.
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These findings suggest that cognitive function was correlated with the host inflammatory 
response. Although the duration of having periodontal disease was not taken into account, it has been 
shown that the BGI index is correlated with a cumulative burden of periodontal disease and, indeed, 
the severe periodontitis group exhibited a greater extent of attachment loss (1). According to my 
conceptual model, the severe periodontitis group should have the lowest cognitive scores, given that 
participants in this subgroup had both chronic destructive periodontal disease and an active 
inflammatory state. However, the shallow lesions with bleeding that are classified as gingivitis may 
reflect deep lesions that have been treated and so now remain stable with gingival recession but with 
active inflammation.  
To investigate the relation of cognitive scores to different components of the BGI, we 
conducted additional analyses using bleeding on probing, pocket depth, attachment loss, plaque score, 
and the CDC/AAP classification, which is based on a combination of probing pocket depth and 
attachment loss levels and has been used in NHANES. Our results (Supplemental Table 4-8) 
confirmed that poor performance in executive function tests was strongly correlated with the extent of 
bleeding on probing rather than with pocket depth, which means that the observed associations were 
mostly driven by BOP. In addition, poor performance in both memory and executive function tests 
was associated with attachment loss. Given the differences of underlying bacterial components and 
levels of periodontal tissue destruction between people who had periodontitis (severe, moderate, or 
low bleeding) and those who did not (gingivitis or healthy), in this case, we would see cognitive 
scores of gingivitis < healthy and severe < moderate < low bleeding among participants with 
periodontitis. But, it was not necessary that people with periodontitis/ severe bleeding scored lower 
than those with gingivitis  or people with periodontitis/ low bleeding group scored lower than 
gingivitis group.  
We also found that plaque deposits were negatively correlated with all cognitive function 
tests. The association between active periodontal disease and reduced cognitive function is consistent 
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with the concept that periodontal bacteria are involved in the pathophysiology of cognitive function 
changes and also the concept that low cognitive ability or cognitive decline taking place before oral 
health status assessments may lead to poorer oral hygiene, thereby increasing plaque deposits and 
gingival bleeding in shallow lesions or, perhaps, early gingivitis.  
In our longitudinal study, a subset of study participants (n = 911) from two study sites 
(Forsyth County NC and Jackson MS) were available for the analysis. Over the eight-year follow-up, 
mean scores from all three cognitive measures decreased slightly. Overall declines in cognitive scores 
were 0.7, 3.6, and 1.8 points for the DWR, DSS, and WF tests, respectively. Although we found that 
complete tooth loss was associated with low performance on two cognitive tests, the DWR and WF, 
our data did not support the hypothesis that poor oral health predicted greater cognitive decline. 
Moreover, edentulous participants seemed to exhibit less cognitive decline than did dentate subjects, 
especially for the DWR test. Number of teeth and periodontal disease were not associated with 
cognitive performance nor with a steeper age-related cognitive decline over the eight years of follow-
up. 
Although our cross-sectional and longitudinal findings appear inconsistent, the longitudinal 
study (drawn from the brain MRI subcohort) had a relatively small sample size, and the two study 
populations differed in socio-demographic characteristics, cognitive performance at baseline, and oral 
health status (Table 7-12). For example, participants in the longitudinal study were more likely to be 
African American (48.5%), female, and older, and had lower incomes but higher educational 
attainment. DWR and WF scores at baseline were similar for the two studies, but the longitudinal 
study subjects had DSS scores that were approximately three points lower than subjects in the cross-
sectional study. The prevalence of complete tooth loss (13.4 % in cross-sectional vs. 13.8% in cohort) 
and severe periodontal disease (periodontitis with severe bleeding, 12.3 % vs. 13.3 %) did not differ. 
However, the prevalence of gingivitis (gingivitis) in the longitudinal study (28.3 %) was 
approximately twice that in the cross-sectional study (14.9 %). We also acknowledge that the 
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longitudinal study, with only 911 participants, may have been underpowered to detect weak 
associations of number of teeth and periodontal disease with cognitive function. 
B. Strengths 
Although the longitudinal study population was small, the cross-sectional study analyzed a 
large population-based sample that included predominantly late middle-aged adults receiving a 
comprehensive evaluation of periodontal disease status. Prior studies reporting associations between 
oral health and cognitive function have almost exclusively investigated older populations, where 
severe cognitive decline may already be present (2-5). With older participants poor oral health is 
more likely to reflect functional disability, poor oral self-care, and less frequent use of dental services 
(6,7). The fact that we found cross-sectional associations between oral health (i.e., complete tooth 
loss) and cognitive function in midlife makes it less likely that these associations can be attributed 
primarily to adverse effects of severe cognitive dysfunction on oral health. If the mechanism behind 
the association begins with cognitive impairment, an extended interval would be needed for the 
subsequent decline in oral health to translate into tooth loss and edentulism. In addition, almost half 
of our edentulous participants reported initial diagnosis of gum disease in mid-thirties. 
To our knowledge, our study is the first to examine the association between periodontal 
disease, as classified by the BGI index, and cognitive function. A primary advantage of using the BGI 
index is that we are able to study the association between natural gradients of periodontal disease 
severity and cognitive function. The five levels of the BGI differ in their underlying biological 
processes, which include the microbial, inflammatory, and acquired immune response. For example, 
BGI-G, BGI-DL/MB, and BGI-DL/SB subjects were more likely to have increased titers of C. rectus 
IgG. The two latter groups were more likely to show elevated titers of P. gingivali IgG. Importantly, 
the BGI index was developed using biospecimens from and clinical evaluation conducted on Dental 
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ARIC participants (1). Thus, the applicability of the BGI definition to our study sample is not an 
issue.  
Other strengths of the present study include high quality control for periodontal and cognitive 
data. All comprehensive dental examinations and cognitive function tests were carried out by well-
trained examiners using standard protocols. A high percentage of agreement between examiners was  
achieved (8,9). Periodontal probing was performed at six sites per tooth for all remaining teeth. 
Therefore, misclassification of periodontal disease condition is unlikely. In addition, since Dental 
ARIC provided extensive data on the clinical signs of periodontal disease, we were able to explore a 
variety of clinical definitions that may be predictive of cognitive function and change.  
In our study, directed acyclic graphs (DAGs) and the change-in-estimate procedures were 
used for adjustment-variable selection. DAGs were created based on assumptions about the exposure-
outcome relationship to identify variables to adjust for confounding and other biases. Nonetheless, 
there is uncertainty that the a priori DAG fits with the confounding pattern of the dataset. For 
instance, body mass index in the ARIC data was a significant confounder for oral health measures and 
cognitive outcome associations in the bivariate analyses, but was not included in the minimally 
sufficient adjustment variables set. In this case, model selection based on the change-in-estimate, 
which allows patterns in the data to decide the final adjustment variables, may include BMI in the 
final adjustment set. However, this approach has drawbacks if variables are measured with errors and 
variables associated only with the outcome alone may be selected. The combination of these two 
approaches leads to a more parsimonious model when compared to a selection based on the change-
in-estimate only since the model chooses variables by relevance to the exposure-outcome 
relationship. However, the change-in-estimate procedures allows us to check uncertainties underlying 
the a priori assumptions. 
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C. Limitations 
Four limitations of the present study deserve consideration. The primary limitation of our 
study is generalizability. Although we used data from a large population-based study, the 
generalizability of our research findings to the U.S. population is limited since study participants were 
sampled from only four geographic areas in the U.S. (i.e., Forsyth County, NC; Jackson, MS; the 
Northwest suburbs of Minneapolis, MN; and Washington County, MD) and the analytical samples 
were confined to only white and African American participants. Furthermore, only ARIC participants 
from the Forsyth County and Jackson study centers were available for our prospective study. 
Second, measures of cognitive function included three tests, which assessed only two 
cognitive domains, memory (DWR) and executive function (DSS and WF). Our prospective study 
was based on cognitive function assessments at two time points. It has been acknowledged that the 
most effective way to characterize real cognitive decline is by analyzing change over several 
assessments. Assessments at two time points provide limited ability to differentiate true change from 
changes due to random variation, such as learning effects, random fluctuations, and measurement 
error. In ARIC, the correlation coefficient between two measurements with an average interval of 
490.75 days for DWR test (R2 = 0.55) was moderate, whereas correlation coefficients of DSS (R2 = 
0.81) and WF tests (R2 = 0.84) were high (ARIC quality control report; unpublished data). 
Scatterplots displaying the difference in cognitive scores (scores at follow-up and scores at baseline) 
suggested that participants with higher cognitive scores at baseline tended to have greater cognitive 
declines. 
Third, the dental examination was restricted to participants who did not require antibiotics 
before dental procedures. This exclusion could lead to an underestimation of the association between 
periodontal disease and cognitive decline if people who require antibiotic prophylaxis have medical 
conditions that are associated with severe periodontal disease. Oral health measures in the data set 
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were available only at Visit 4. Therefore, we cannot assess the effects of cognitive function on tooth 
loss or periodontal disease status that may have occurred later in life. It is therefore possible that 
deterioration of oral health might be a result of impaired cognition. Furthermore, we were unable to 
take into account the duration of having periodontal disease or previous periodontal treatment. It is 
likely that subjects who periodically visit dentists will exhibit a lower level of periodontal 
inflammation, even if they have pocket lesions.  
Lastly, it has been acknowledged that poor oral health can be a result of severe adverse 
conditions, including compromised systemic health and low socio-demographic status, which are 
known risk factors for cognitive deficits. Although we carefully included all measured confounders 
and modifiers in the analyses, biased estimates from unmeasured confounders are still possible. In 
addition, we did not investigate whether tooth loss was also associated with dietary changes or 
nutritional status, which may play a role in the onset of cognitive decline. 
D. Public health significance 
Oral health is recognized to be an important determinant of general health and quality of life. 
Periodontal disease is a common oral disease and an important source of chronic infection and 
inflammation in adults. The estimated prevalence of periodontal disease in the U.S. ranges from 
24.4% in adults 30-34 years old to 70.1% in adults aged 65 years and older (10). Tooth loss secondary 
to poor oral health, including severe periodontal disease, may lead to worsening nutritional status. 
Both systemic infection and inflammation as well as nutritional deficiency have been implicated as 
possible causal pathways for cognitive decline and dementia. At present, these two chronic conditions 
are major public health concerns affecting older adults in the U.S. and worldwide because there is no 
currently effective treatment or prevention for cognitive impairment and dementia. The prevalence of 
all types of dementia ranges from approximately 2% in people aged 65-69 up to more than 30% in 
people over 90 years of age (11). In order to prevent or delay the clinical onset of cognitive 
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impairment and dementia, efforts to identify modifiable factors are, therefore, essential. The 
relationship between periodontal disease and cognitive function is potentially a critically public health 
problem due to the high prevalence of both conditions. If poor oral health in midlife has an important 
role in the pathophysiology of cognitive impairment and dementia, periodontal treatment or oral 
hygiene improvement would be a promising avenue to help reduce the burden of these chronic 
conditions.  
E. Future research direction 
Further investigation into a possible link of periodontal disease and/or tooth loss with 
cognitive function is warranted. Most current findings, including those from our studies, suggest that 
tooth loss is associated with cognitive function independent of known confounders. However, the 
nature of the association between periodontal status and cognitive function remains unclear. We have 
shown that the inflammatory state of periodontal disease is related to cognitive status, supporting the 
inflammatory model hypothesis. However, our cross-sectional study cannot demonstrate that 
periodontal disease is a cause of cognitive decline. Other potential mechanisms must still be 
considered. 
In fact, periodontal disease is a time-varying disease. To examine the temporal relationship 
and evaluate whether periodontal disease is independently associated with cognitive decline and 
dementia, a large population-based, prospective study that enrolls participants in midlife and obtains 
repeated measurements of cognitive function and periodontal status would be an appropriate design. 
Uniform criteria for periodontal disease case definition and disease severity would improve future 
studies. Since periodontal disease involves a complex interaction of biofilm with both the host 
inflammatory and immune responses, individuals vary in susceptibility to periodontal disease due to 
oral hygiene status and genetic backgrounds. It is, therefore, necessary to consider different clinical 
manifestations of periodontal disease together with systemic inflammatory markers and genetic 
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factors in response to periodontal infection. To our knowledge, there is only one pilot study that has 
examined an effect of oral care, specifically tooth brushing, on preventing subsequent cognitive 
degradation in demented patients (12), and none has investigated an effect of periodontal treatment. 
Further investigation in well-conducted controlled intervention studies is necessary to prove a benefit 
of periodontal intervention, i.e., that periodontal disease treatment and long-term maintenance have 
changed the levels of systemic inflammation and reduced the risk of cognitive impairment and 
dementia in later life. 
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Table A-1. Cardiovascular and other non-oral health risk factors for cognitive decline, dementia, and brain abnormalities identified                   
in the ARIC studies 
Studies Study design N Major risk factors Outcome Results  
Knopman et. al., 
2011 (1) 
Longitudinal 
Visit 3 (1993-
1994) to 2004-
2006 
1,112 Diabetes, hypertension, 
fasting blood sugars, 
systolic blood pressure, 
stroke, APOE genotype 
Infraction WMHs, 
VS, SW,  
Diabetes was associated with incident infarcts 
(OR 1.95, 95% 1.29-2.95) and worsening SW 
(OR 2.0, 95% 1.36-3.24). Hypertension was 
associated with incident infarcts (OR 1.73, 
95% CI 1.23-2.42). APOE ε4 allele was not 
associated with brain abnormalities. 
Christman et. al., 
2011 (2) 
Longitudinal 
Visit 2 (1990-
1992) to Visit 
4(1996-1998) 
8,958 Diabetes, 
Hyperglycemia;HbA1c 
DWR, DSS, WF, 
Dementia 
hospitalization 
Diagnosed diabetes was associated with 
cognitive decline on the DSS test (OR 1.42, 
95% CI 1.14-1.75) and dementia incidence 
(HR 2.82, 95% CI 1.83-4.30). HbA1c was a 
significant predictor for cognitive decline 
among people with diabetes.  
Knopman et. al., 
2009 (3) 
Longitudinal 
Visit 2(1990-
1992) to 2004-
2006 
1,130 Diabetes, hypertension, 
stroke, Plasma lipids, 
Lipoproteins, APOE 
genotype, metabolic 
syndrome2 
DWR, DSS, WF 
 
Diabetes and APOE genotype were 
associated with a decline in performance on 
the DSS test, whereas hypertension and 
stroke were not. For DWR, stroke and APOE 
genotype predicted cognitive decline. For the 
WF, metabolic syndrome, hypertension, and 
stroke were associated with decline.  
Alonso et. al., 2009 
(4) 
Longitudinal 
Visit 2(1990-
1992) to 2004 
11,151 Smoking, hypertension, 
diabetes, BMI, 
hypercholesterolemia, 
APOE genotype 
Dementia There were 203 cases of hospitalization with 
dementia. Smoking (HR 1.7, 95% CI 1.2-2.5), 
hypertension (HR 1.6, 95% CI 1.2-2.2), 
diabetes (HR 2.2, 95% 1.6-3.0), and APOE 
genotype (HR 1.8, 95% CI 1.4- 2.4) were risk 
factors for dementia. The associations of BMI 
and hypercholesterolemia with dementia were 
not significant. 
Young et.al, 2006 
(5) 
Longitudinal 
Visit 2(1990-
1992) to Visit 
4(1996-1998) 
7,148 Hyperinsulinemia DWR, DSS, WF 
(DWR < 3, 
dementia) 
Hyperinsulinemia was associated with lower 
DWR, DSS, and WF scores at baseline and a 
greater decline over 6 years in DWR and WF. 
Blair et.al., 2005  
(6) 
Longitudinal 
Visit 2(1990-
1992) to Visit 
4(1996-1998) 
7,895 APOE genotype, diabetes, 
hypercholesterolemia 
DWR, DSS, WF 
 
The association between APOE genotype 
groups with all cognitive function tests was 
observed among Caucasian individuals, while 
the result was inconsistent among African-
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American individuals. People with APOE ε4 
had greater cognitive decline for DWR and 
DSS. The combination APOE ε4 with 
hypercholesterolemia or diabetes showed the 
greatest cognitive decline.  
Knopman et.al., 
2001 (7) 
Longitudinal 
Visit 2(1990-
1992) to Visit 
4(1996-1998) 
10,963 Hypertension, diabetes, 
hyperlipidemia, 
smoking, carotid artery 
IMT, NSAID 
DWR, DSS, WF 
 
Decline in cognitive function was greater in 
participants with hypertension, diabetes, or 
incident stroke. The strong associations were 
observed between cardiovascular risk factors 
and DSS test. 
Knopman et.al., 
2005 (8) 
Cross-sectional 
Visit 3(1993-
1995) 
1,812 Diabetes, fasting blood 
sugar, BMI, APOE 
genotype, 
hypertension, blood 
pressure,  smoking, 
alcohol intake 
VS, SW Diabetes and increased fasting blood sugar 
were associated with high grade VS (OR 
1.07, 95% CI 1.19-2.24 and OR 1.07, 95% CI 
1.19-2.24, respectively) 
Mosley et.al., 2005 
(9) 
Cross-sectional 
Visit 3(1993-
1995)  
1,528 WMHs, SW, VS DWR, DSS, WF 
 
The presence of two or more high-grade 
abnormalities was associated with increased 
risks of impaired functioning on the DWR 
(OR 2.23, 95% CI 1.40-3.55); DSS (OR 2.06, 
95% CI 1.13-3.76); and WF (OR 2.07, 95% 
CI 1.23-3.49). 
Ding et.al., 2003 
(10) 
Cross-sectional 
Visit 3(1993-
1995) 
1,909 Alcohol intake WMHs, VS, SW 
infraction 
There was no association between alcohol 
intake and the presence of MRI infraction. 
Alcohol intake was not associated with 
WMHs grades, but with higher grades of VS 
and SW. 
Cerhan et.al., 1998 
(11) 
Cross-sectional 
Visit 2(1990-
1992) 
13,913 Depressive symptoms, 
current smoker, sport 
index, pulmonary 
function, alcohol drink, 
pulmonary function, 
fibrinogen, carotid 
artery IMT, diabetes, 
hypertension 
DWR, DSS, WF The DWR was negatively associated with 
depressive symptoms, diabetes, and 
fibrinogen. The DSS was negatively 
associated with depressive symptom, 
smoking, fibrinogen, and carotid IMT, and 
positively associated with alcohol drinking 
and pulmonary function. The WF was 
positively associated with alcohol drinking 
and sports participation. 
DWR, Delayed word recall; DSS, Digit symbol substitution; HbA1c, Glycated haemoglobin;  IMT, Carotid artery intima-media thickness;  NSAID, Non-steroidal anti-
inflammatory drug; WF, Word fluency; WMHs, White matter hyperintensities; VS, Ventricular size; SW, Sulcal width. 
1Study participants aged 45-64 at inception (1987-1989; Visit 1). 
2Metabolic syndrome was defined as any three of the following: fasting blood sugar > 110 mg/dL or the use of an antidiabetic agent; triglycerides > 150 mg/d; high-density 
lipoprotein (HDL) cholesterol level < 40 mg/dL in men or < 50 mg/dL in women; hypertension (systolic blood pressure > 130 mm Hg or diastolic blood pressure >85 mm Hg or 
current use of an antihypertensive agent); or waist circumference > 88 cm in women, or > 102 cm in men. 
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Table A-2. Cognitive decline and dementia are associated with an increased likelihood of poor oral health
Authors Study design N Age 
 
Cognitive assessment Oral health measures Results 
Syrjala et.al., 2012 
(12) 
Cross-sectional  354 ≥75 
 
Dementia types Caries, PPD > 4 mm, 
edentulousness, oral 
hygiene, denture hygiene 
Participants with AD and other 
dementia had an increased risk of poor 
oral health (more dental caries, less 
teeth, more teeth with deep PPD) and 
oral hygiene.  
Ellefsen et.al., 
2009 (13) 
Longitudinal  
(1-yr F/U) 
106 81.9  MMSE  
Dementia  
IADL 
Caries increment  Compared with non-demented group, 
individuals with AD and other 
dementia had higher adjusted caries 
increments (3.3 surfaces for non-
demented; 4.7 and 5.8 surfaces for AD 
and other dementia, respectively). 
Chalmers et.al., 
2005 (14) 
Longitudinal  
(1-yr F/U) 
 
224 ≥75 
 
MMSE 
ADL 
 
Caries incidence 
Caries increment 
The coronal (64.4%) and root caries 
(48.5%) incidence were high. The 
adjusted coronal and root caries 
increments were 2.5 and 1.0 surfaces, 
respectively. 
Chalmers et.al., 
2003 (15) 
Longitudinal  
(1-yr F/U) 
132 ≤ 79 
≥ 80 
MMSE 
IADL, ADL 
 
Coronal and root caries 
attack rate1, oral mucosal 
lesions, retained root, 
tooth loss, use of dentures, 
plaque index  
Participants with dementia had poorer 
oral conditions than those without 
dementia. Coronal and root surface 
caries as well as plaque score were 
higher in participants with moderate-
severe dementia and functionally 
impairment.  
Yu et.al., 2008 (16) 
 
Cross-sectional 
(NHANE 2001-
02) 
803 ≥60 DSS2 
(Individual standard 
deviation score) 
PD3 Higher cognitive function were 
associate with lower odd of PD (OR  
0.69, 95% CI 0.51-0.94). 
Adam et.al., 2006 
(17) 
Cross-sectional 135 ≥65 AMT  Caries, tooth loss, plaque 
deposit, denture 
The number of caries and missing teeth 
as well as mean dental plaque and 
calculus were similar for both no/mild 
and moderate/ sever dementia. Mean 
number of missing teeth was 28.22 and 
27.88 for no/mild and moderate/severe 
dementia, respectively. 
AD, Alzheimer’s disease; ADL, Activities of daily living scale; AMT, Abbreviated  mental test; DDST, Digit symbol substitution; IADL, Instrumental activities of daily living; MMSE, 
Mini-mental state examination; PD, Periodontal disease; PPD, periodontal  pocket depth 
1Coronal and root caries attack rate were the number of tooth surfaces affected by caries as a percentage of the total number of surface at risk. 
2Participants were asked to copy symbols that were paired with numbers within 2 minutes. 
3Periodontal disease was defined as at least 10% of sites with clinical attachment loss of more than 4 mm and at least 10% sites with probing depth greater than 3 mm. 
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Table A-3. Possible causal relationships of periodontal disease or tooth loss with cognitive decline  
Authors Study design N Age  
 
Markers/ 
Genotypes 
Oral health 
measures 
Outcomes Results 
Arrive et.al., 2012 
(18) 
Longitudinal 
(15-yr F/U) 
405 66-80  DMFT, 
POP, CPI 
Alzheimer 
Dementia 
Seventy-two persons developed a dementia 
during a median follow-up of 10 years. 
Among people with low school level, missing 
teeth ≥11 was associated with the lower risk 
of dementia (HR 0.40, 95% CI 0.17-0.94). 
The periodontal condition and masticatory 
function measured by POP were not 
associated with the risk of dementia. 
Batty et.al., 2011 
(19) 
Longitudinal in 
type 2 diabetes 
patients (5-yr 
F/U) 
 
11,140 55-88  Self-
reported 
number of 
teeth, 
number of 
days of 
bleeding 
gums 
MMSE 
Dementia 
 
Having no teeth was associated with the 
highest risk of both dementia (HR 1.48, 95% 
CI 1.24-1.78) and cognitive decline (HR 
1.39, 95% CI 1.21-1.59). Number of days of 
bleeding gums was unrelated to the 
outcomes. 
Kaye et.al., 2010 
(20) 
Longitudinal 
(32-yr F/U) 
597 28-70  Rates of 
tooth loss, 
caries 
incidence, 
probing 
depth, 
alveolar 
bone loss 
MMSE  
SCT 
 
Higher rates of tooth loss and periodontal 
disease progression during adulthood 
predicted performance on the MMSE and 
SCT. 
Sein et.al., 2010 
(21) 
Longitudinal 
“The Nun 
study” 
144 75-98 APOE Number of 
teeth 
DWR Individuals with both APOE and fewer teeth 
had lower DWR at baseline and declined 
more quickly compared with participants 
with neither of these risk factors or with 
either risk factor alone. 
Starr et.al., 2008 
(22) 
Longitudinal 
“The Healthy 
Old People in 
Edinburgh” 
(9-yr F/U) 
201 ≥70  Complete 
tooth loss 
MMSE, 
NART, RPM, 
LM 
 
Being edentulous was associated with lower 
MMSE (p = 0.006), RPM (p = 0.028), and 
LM (p = 0.015). These associations all 
became non-significant after adjusting for 
NART and age. 
139 
  
Stein et.al., 2007 
(23) 
Longitudinal 
“The Nun 
Study” 
144 75-98 APOE Number of 
teeth, 
alveolar 
bone loss 
MMSE, 
DWR, others1 
 
A low number of teeth increased a 
prevalence (OR 4.30, 95% CI 1.16-15.60) 
and an incidence of dementia (HR 2.2, 95% 
1.10, 4.50). 
Shimazaki et.al., 
2001 (24) 
Longitudinal  
(6-yr F/U) 
1,929 ≥ 65  Number of 
teeth 
Mental health 
status2 
The OR for mental impairment of edentulous 
subjects not using dentures to the subjects 
with 20 or more teeth was 2.4 (95% CI 0.9- 
6.5). 
Matthews et.al., 
2011 (25) 
Cross-sectional 9,583 45- ≥85 Serum CRP Self-
reported 
tooth loss 
WLL Higher number of tooth loss (> 16 teeth) was 
associated with poorer cognitive function. 
However, the association was not significant 
after adjusting for demographic factors, 
socio-economic status, and other risk factors 
(i.e. BMI, CRP). 
Kamer et.al., 2012 
(26) 
Cross-sectional 152 70  MCPI, 
number of 
missing 
teeth 
WAIS3 Periodontal inflammation (MCPI ≥ 3) and 
high number of missing teeth (≥ 11) were 
associated with lower cognitive scores. 
Education and cognitive scores at age 50 
were important confounders. 
Rai et.al., 2012 
(27)  
Cross-sectional 55:PD 
20:Dementia 
32:Controls 
60-69 
59-69 
58-69 
WBCs, 
neutrophils, 
thrombocytes, 
CRP, MMP-8, 
MMP-9, IGF-I, 
TNF-α, GCF 
MMP-8 and 
MMP-9 
Plaque, GI, 
PPD, CAL, 
horizontal 
bone loss, 
number of 
teeth 
Dementia Dementia and periodontitis patients had 
poorer oral health than healthy controls. 
Total WBCs, neutrophil, thrombocytes, CRP, 
serum and GCF MMP-8 and MMP-9 levels 
were higher in dementia and periodontitis 
patients compared to controls. 
Okamoto et.al., 
2010 (28) 
Cross-sectional 4,206 ≥ 65  Number of 
teeth, 
length of 
edentulous 
period, 
CPI4 
MMSE 
GDS 
ORs of 0-10 vs. 22-32 remaining teeth were 
1.68 (95% CI 1.07-2.63) for mild memory 
impairment, and 2.17 (95% CI 1.51-3.14) for 
a low MMSE. ORs of ≥ 15 vs. < 15 years 
edentulous period for low MMSE was 3.10 
(95% CI 1.43-6.7). 
Grabe et.al., 2009 
(29) 
Cross-sectional  1,336 60-79   Number of 
teeth 
MMSE A decreased number of teeth was associated 
with lower MMSE scores in female (p = 
0.002) but not in males (p = 0.825).  
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Noble et.al., 2009 
(30) 
Cross-sectional: 
NHANES III 
2,355 ≥60  P. gingivalis  
Ig G 
 Logical verbal 
memory test5, 
serial 
subtraction 
Individuals with the highest P. gingivalis IgG 
had significantly greater odds of poor DWR 
(OR 3.01, 95%CI 1.06-8.53) and impaired 
subtraction (OR 2.00, 95% CI 1.19-3.36). 
Stewart et.al., 
2008 (31)  
Cross-sectional: 
NHANE III 
 
5,138 
1,555 
20-59 
≥70  
 Gingival 
bleeding, 
CAL ≥ 3 
mm, number 
of missing 
teeth  
SDST, SDLT,  
A story recall 
test 
Gingival bleeding and CAL were associated 
with SDST (ß = 0.003), and gingival 
bleeding was associated with SDLT (ß = 
0.017). 
Stewart et.al., 
2007 (32) 
Cross-sectional 4,032 ≥65  Complete 
tooth loss 
AMTS Lack of teeth was associated with cognitive 
impairment (OR 3.59, 95% CI 2.36-5.47). 
Kim et.al., 2007 
(33) 
Cross-sectional 686 ≥65  Number of 
teeth 
MMSE 
Dementia 
diagnosis 
The prevalence of dementia increased for 
each decreasing quintile of tooth loss (OR 
1.4, 95% CI 1.1-1.7). 
Gatz et.al., 2006 
(34) 
Case-control 310 cases 
3,063 
controls 
(106 
identical 
twins) 
≥65  Tooth loss 
before age 
35 
Dementia 
diagnosis 
History of tooth loss before age 35 and low 
educational attainment were significant risk 
factors for AD. 
AMTS, The abbreviated mental test score; CAL, Clinical attachment level; CPI, Community periodontal index; CRP, Serum C-reactive protein; DMFT, Number of decayed (D), 
missing (M), or filled (F) teeth (T) index; GI, Gingival index; PPD, probing pocket depth; DWR, Delayed word recall; GCF, Gingival crevicular fluid; GDS, Geriatric depression 
scale; IGF, Insulin-like growth factor; LM, Logical memory test; MCPI, Modified community periodontal index; MMP, Matrix metalloproteinase; MMSE, Mini-mental state 
examination; NART, the national adult  reading test; POP, Number of posterior occluding pair; RPM, Ravens progressive matrices; SCT, Spatial copying task; SDLT, The serial digit 
leaning test; SDST, The symbol digit substitution test; TNF, Tumor necrotic factor; WBCs, Total count of white blood cells; WLL, Word list learning. 
1The Boston naming test, the verbal fluency test, and constructional praxis test. 
2Mental health status was classified into three categories according to subject’s symptoms of dementia and degree of cognition: good, fair, and poor.  
3Four subsets of the Wechsler Adult Intelligence Scale (WAIS) were measured: digit span, digit symbol (DST), picture completion, and block design (BDT). 
4Community periodontal index (CPI); 0 = healthy, 1 = gingival bleeding after probing; 2 = calculus present in the periodontal pocket; 3 = periodontal pocket 4-5 mm; 4 = periodontal 
pocket at least 6 mm. 
5An immediate and delayed logical verbal memory test from the East Boston memory test. 
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Table A-4. Clinical measures, inflammatory biomarkers, and microbiology components of periodontal diseases: Dental ARIC 
 
Author N Exposure Outcome Covariates  Results 
Zhong et.al., 
2007 (35) 
6,277 Maximum PPD 
Maximum CAL 
BOP 
GCF IL-1β, PGE2 
 
Age, gender, race, BMI, dental visit, 
tooth brushing, NSAID, BOP, 
smoking, diabetes, 
GCF IL-1β, PGE2 were more strongly 
associated with maximum PPD and BOP than 
CAL. 
Offenbacher 
et.al., 2007 (36)  
6,768 GCF IL-1β, PGE2,  
IgG levels to P. 
gingivalis, C. rectus 
 
BGI index (BOP, 
PPD) 
Age, gender, race, education, 
smoking, diabetes, BMI, brushing, 
flossing, dental visit 
BGI-Deep lesion/ severe bleeding had an 
excessive IL-1β and PGE2, and increased 
levels of IgG to P. gingivalis and C. rectus.  
Beck et.al., 
2005 (37) 
4,846 IgG to 17 oral 
microorganisms 
CDC/AAP 
classification 
CHD Age, gender, diabetes, hypertension, 
waist-to-hip ratio, HDL, LDL, 
education, smoking 
Clinical signs of PD were not associated with 
CHD, while systemic antibody response was 
associated with CHD. 
Kshirsagar et.al, 
2005 (38) 
5,537 CDC/AAP 
classification 
GFR 
Serum creatinine 
Age, gender, race, diabetes, 
hypertension, BMI, education, 
smoking, and serum CRP 
 
Initial and severe PD were associated with 
higher odds of GFR less than 60 ml/min/1.73 
m2 after adjusting for all covariates (OR 2.00; 
95% CI 1.23-3.24 for initial PD; OR 2.14; 
95% CI 1.19-3.85 for severe PD). 
Slade et.al., 
2003 (39) 
5,552 PPD ≥ 4mm (0-30% 
and > 30%) 
Serum CRP  
 
Age, gender, diabetes, smoking, 
NSAID, BMI 
The association between PPD and serum 
CRP was modified by BMI level; when BMI 
was 35, the difference of serum CRP level 
between two groups of PPD was negligible.  
Beck et.al., 
2002 (40) 
5,400 PPD 
BOP 
CAL 
Serum CRP, ICAM1 Age, gender, race, triglyceride, 
diabetes, BMI, number of teeth, 
cholesterol medications, smoking,  
study sites, income, NSAID, arthritis, 
kidney infection, bronchitis, and 
sinus infection 
PPD and BOP were strongly associated with 
systemic inflammation. 
BGI, Biofilm-Gingival Interface; BOP, bleeding on probing; BMI, body mass index; CAL, clinical attachment level; CDC/AAP, The Centers for Disease Control and Prevention/ The 
American academy of Periodontology; CRP, C-reactive protein; CHD, Coronary heart disease; GCF, Gingival crevicular fluid; GFR, Glomerular filtration rate; HDL, High density 
lipoprotein; ICAM, Intracellular adhesion molecule; IgG, Immunoglobulin G; IL- Interleukin-1b ; LDL, Low density lipoprotein; NSAID, Non-steroidal anti-inflammatory drug; PD, 
Periodontal disease; PGE2, Prostaglandin E2; PPD, Probing pocket depth. 
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Appendix B: Directed acyclic graphs (DAGs) 
 
 
Figure B-1. Directed acyclic graph for associations between periodontal disease and cognitive 
function1 
                                                      
1EDU = education, INC = income, SITE = study site, APOE = apolipoprotein E, HT = hypertension, BMI = body mass index, LDL = low 
density lipoprotein, DM = diabetes mellitus, SMK = smoking, ALC = alcohol, CHD = coronary heart disease, STK = stroke, INF = 
inflammatory markers, CF = cognitive function, PD = periodontal disease 
A minimal sufficient adjustment set for estimating the effect of periodontal disease on cognitive function is {AGE, RACE, 
SEX, SITE, EDU, INC, DM, SMK, ALC}. 
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Figure B-2 Directed acyclic graph for associations between tooth loss and cognitive function1 
                                                      
1EDU = education, INC = income, SITE = study site, APOE = apolipoprotein E, HT = hypertension, BMI = body mass index, LDL = low 
density lipoprotein, DM = diabetes mellitus, SMK = smoking, ALC = alcohol, CHD = coronary heart disease, STK = stroke, INF = 
inflammatory markers, CF = cognitive function 
A minimal sufficient adjustment set for estimating the effect of tooth loss on cognitive function is {AGE, RACE, SEX, SITE, 
EDU, INC, DM, SMK, ALC}. 
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Appendix C: Oral health measures 
Dental status 
 
Table C-1. Selected baseline characteristics of ARIC study samples in relation to dental status  
Characteristics Cross-sectional study 
n = 9,9091 
Longitudinal study 
n = 9112 
Prevalence (row %) P-value3 Prevalence (row %) P-value3 
Edentulous Dentate  Edentulous Dentate  
Age at Visit 4 (years)       
 > 65  17.2 82.8 <0.0001 14.8 85.2 0.6030 
 60 - 65 12.4 87.6  12.7 87.3  
 51 - 59 9.7 90.3  13.6 86.4  
Race       
 African American 19.4 80.6 <0.0001 20.6 79.4 <0.0001 
 White 11.8 88.2  7.5 92.5  
Gender       
 Male 13.0 87.0 0.3111 11.1 88.9 0.0563 
 Female 13.7 86.3  15.6 84.4  
Study sites       
 Forsyth 11.9 88.1 <0.0001 8.7 91.3 <0.0001 
 Jackson 19.9 80.1  20.6 79.4  
 Minneapolis 5.4 94.6  0 0  
 Washington 19.0 81.0  0 0  
Education       
 Less than high school 33.0 67.0 <0.0001 29.7 70.3 <0.0001 
 High school completion 12.7 87.3  14.2 85.8  
 Post-secondary education 5.2 94.8  6.6 93.4  
Income       
 Refused 12.8 87.2 <0.0001 13.6 86.4 <0.0001 
 <$25,000 25.0 75.0  24.8 75.2  
 $25-<$50,000 11.5 88.5  9.8 90.2  
 $50,000 or more 4.6 95.4  3.2 96.8  
Cigarette use       
 Current 23.1 76.9 <0.0001 26.9 73.1 <0.0001 
 Former 13.2 86.8  11.9 88.1  
 Never 10.2 89.8  11.9 88.1  
Alcohol use       
 Current 8.0 92.0 <0.0001 7.7 92.3 0.0002 
 Former 18.4 81.6  18.4 81.6  
 Never 19.4 80.6  16.0 84.0  
Diabetes mellitus       
 Yes 22.4 77.6 <0.0001 21.0 79.0 0.0047 
 No 11.7 88.3  12.4 87.6  
Hypertension       
 Yes 16.1 83.9 <0.0001 20.0 80.0 <0.0001 
 No 11.0 89.0  9.1 91.9  
Coronary heart disease       
 Yes 21.0 79.0 <0.0001 14.3 85.7 0.9340 
 No 12.7 87.3  13.8 86.2  
Stroke       
 Yes 20.7 79.3 0.0017 17.6 82.4 0.6469 
 No 13.2 86.8  13.8 86.2  
Hyperlipidemia       
 Yes 14.8 85.2 0.0005 13.2 86.8 0.7102 
 No 12.4 87.6  14.1 85.9  
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Body mass index (km/m2)       
 ≥ 30 16.7 83.3 <0.0001 19.9 80.1 0.0003 
 < 30 11.6 88.4  11.1 88.9  
APOE ε4       
 Yes 13.2 86.8 0.6907 17.6 82.4 0.0302 
 No 13.5 86.5  12.1 87.8  
1Participants were from all four study sites. In the final analysis, African Americans from Washington and Minneapolis study sites (n 
=35) were excluded, leaving an analytical sample of 9,874. 
2Paticipants were from two study sites (Forsyth County, NC and Jackson, MS). 
3Chi-square test 
 147 
Periodontal disease 
Table C-2. Prevalence of periodontal diseases in Dental ARIC study, classified by CDC/AAP1 index 
and Biofilm-Gingival Interface classification (n = 6,700)2 
 
 
CDC/AAP 
classification 
 
Biofilm-Gingival Interface (BGI) classification3 (n, row %) All 
No periodontal pockets Had periodontal pockets 
BOP <10% ≥ 10% BOP < 10% 10- < 50% ≥ 50%  
Healthy/Mild 786 28.4 823 29.7 405 14.6 696 25.1 62 2.2 2772 41.4 
Moderate 171 6.2 189 6.9 645 23.4 1390 50.5 359 13.0 2754 41.1 
Severe 0 0 0 0 149 12.7 576 49.1 449 38.2 1174 17.5 
1CDC/AAP: The Centers for Disease Control and Prevention/The American Academy of Periodontology  
2A total of 6,700 participants completed periodontal examination at Visit 4 ARIC. 
3Five levels of BGI were the followings: BGI-DL/SB (deep lesion/severe bleeding), BGI-DL/MB (deep lesion/moderate bleeding), 
BGI-DL/LB (deep lesion/low bleeding), or BGI-G (gingivitis), and BGI-H (healthy).  
0 
20 
40 
60 
80 
100 
PPD >=3 mm PPD >=4 mm PPD >=5 mm PPD >=6 mm 
BGI, Biofilm-Gingival Interface  
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP). Five 
levels of BGI were the followings: BGI-DL/SB (deep lesion/severe bleeding), BGI-DL/MB (deep lesion/moderate bleeding), 
BGI-DL/LB (deep lesion/low bleeding), or BGI-G (gingivitis), and BGI-H (healthy). 
BGI- H                      BGI-G                       BGI-DL/LB                  BGI-DL/MB                 BGI-DL/SB 
Percent 
Figure C-1. Extent of probing pocket depth among Dental ARIC participants, by five levels of 
Biofilm-Gingival Interface classification (n = 6,700) 
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Figure C-2. Extent of attachment loss of Dental ARIC participants by five levels of Biofilm-Gingival 
Interface classification (n = 6,700)  
0 
20 
40 
60 
80 
100 
AL >= 3 mm AL >= 4 mm AL >= 5 mm AL >= 6 mm AL >= 7 mm AL >= 8 mm 
AL, attachment loss; BGI, Biofilm-Gingival Interface. 
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP). Five 
levels of BGI were the followings: BGI-DL/SB (deep lesion/severe bleeding), BGI-DL/MB (deep lesion/moderate bleeding), 
BGI-DL/LB (deep lesion/low bleeding), or BGI-G (gingivitis), and BGI-H (healthy). 
 
Percent 
     BGI-H            BGI-G           BGI-DL/LB              BGI-DL/MB                 BGI-DL/SB 
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Table C-3. Selected characteristics of ARIC study participants at Visit 4 in relation to periodontal 
disease prevalence: A cross-sectional study (n = 5,966)  
Characteristics (row %) No periodontal pockets Had periodontal pockets P-value 
BOP <10% ≥ 10% BOP < 10% 10- < 50% ≥ 50% 
Age at Visit 4 (years)       
 > 65  12.7 15.2 18.0 40.1 14.0 0.0070 
 60 - 65 15.5 13.3 19.5 40.5 11.2  
 51 - 59 14.8 15.9 17.9 39.4 12.0  
Race       
 African American 24.7 19.9 10.2 24.4 20.8 <0.0001 
 White 12.1 13.8 20.2 43.3 10.6  
Gender       
 Male 8.2 12.0 19.3 44.6 15.9 <0.0001 
 Female 19.5 17.3 17.7 36.0 9.5  
Study sites       
 Forsyth 15.7 29.1 7.1 32.6 15.5 <0.0001 
 Jackson 26.6 21.2 10.4 23.6 18.1  
 Minneapolis 14.3 2.5 40.6 41.1 1.6  
 Washington 5.8 12.5 5.9 55.8 20.0  
Education       
 Less than high school 16.1 17.7 9.5 33.5 23.2 <0.0001 
 High school completion 13.7 15.0 17.0 43.0 11.3  
 Post-secondary education 14.6 13.8 22.3 38.8 10.4  
Income       
 Refused 22.0 14.0 27.0 30.7 6.3 <0.0001 
 <$25,000 16.1 18.7 12.7 34.6 17.8  
 $25-<$50,000 14.2 14.6 18.0 41.2 12.0  
 $50,000 or more 12.9 12.7 22.0 42.7 9.7  
Cigarette use       
 Current 12.2 10.7 21.0 38.3 17.8 <0.0001 
 Former 13.2 12.3 20.2 42.7 11.6  
 Never 16.1 18.5 16.0 37.7 11.7  
Alcohol use       
 Current 13.0 10.9 23.4 43.0 9.7 <0.0001 
 Former 15.1 16.2 15.1 38.4 15.1  
 Never 17.4 24.4 8.6 33.0 16.6  
Diabetes mellitus       
 Yes 10.5 18.5 13.5 38.8 18.7 <0.0001 
 No 14.9 14.3 19.2 40.1 11.4  
Hypertension       
 Yes 15.8 15.6 14.7 39.0 14.9 <0.0001 
 No 13.3 14.3 21.2 40.7 10.5  
Coronary heart disease       
 Yes 12.4 13.0 17.3 40.5 16.8 0.1041 
 No 14.5 15.0 18.5 39.9 12.1  
Stroke       
 Yes 18.2 13.1 17.2 34.3 17.2 0.4135 
 No 14.3 14.9 18.4 40.1 12.3  
Hyperlipidemia       
 Yes 13.5 12.9 18.7 42.1 12.8 0.0020 
 No 14.9 16.1 18.2 38.5 12.2  
Body mass index (km/m2)       
 ≥ 30 13.3 15.4 14.7 41.9 14.7 <0.0001 
 < 30 14.9 14.6 20.2 39.0 11.3  
APOE ε4       
 Yes 14.0 14.0 18.3 40.1 13.6 0.3155 
 No 14.5 15.2 18.5 39.9 11.9  
BGI, Biofilm-Gingival Interface 
In the final analysis, African Americans from Washington and Minneapolis study sites (n = 24) were excluded, leaving an analytical 
sample of 5,942.  
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Table C-4. Selected characteristics at Visit 4 of ARIC study participants from Jackson and Forsyth 
County study sites in relation to periodontal disease: A longitudinal study (n = 558)  
  
Characteristics (row %) No periodontal pockets Had periodontal pockets P-value 
BOP <10% ≥ 10% BOP < 10% 10- < 50% ≥ 50% 
Age at Visit 4 (years)       
 > 65  17.9 33.0 6.8 28.6 13.7 0.4364 
 60 - 65 19.7 24.6 9.2 34.2 12.3  
 51 - 59 20.3 26.6 3.1 34.4 15.6  
Race       
 African American 22.6 20.8 7.5 31.4 17.7 0.0033 
 White 16.6 33.4 7.6 32.2 10.2  
Gender       
 Male 12.7 21.3 7.2 36.6 22.2 <0.0001 
 Female 23.2 32.9 7.7 28.8 7.4  
Study sites       
 Forsyth 16.2 33.0 7.3 31.8 11.7 0.0088 
 Jackson 24.0 20.0 8.0 32.0 16.0  
Education       
 Less than high school 17.1 19.7 2.6 38.2 22.4 0.0429 
 High school completion 17.8 33.7 6.7 31.2 10.6  
 Post-secondary education 20.4 26.6 9.5 30.7 12.8  
Income       
 Refused 36.3 27.3 9.1 18.2 9.1  
 <$25,000 20.5 26.7 4.5 29.5 18.8 0.3594 
 $25-<$50,000 18.7 29.0 9.3 33.2 9.8  
 $50,000 or more 16.9 29.2 8.4 33.7 11.8  
Cigarette use       
 Current 19.1 15.9 9.5 36.5 19.0 0.0290 
 Former 18.4 23.6 7.5 34.0 16.5  
 Never 19.4 34.6 7.1 29.3 9.6  
Alcohol use       
 Current 19.6 24.8 8.9 32.7 14.0 0.2838 
 Former 18.1 26.6 7.3 31.1 16.9  
 Never 19.2 34.7 6.0 31.7 8.4  
Diabetes mellitus       
 Yes 16.0 29.3 4.0 36.0 14.7 0.6520 
 No 19.5 28.2 8.1 31.3 13.0  
Hypertension       
 Yes 19.2 28.5 5.1 32.3 14.9 0.4046 
 No 18.9 28.2 9.3 31.5 12.1  
Hyperlipidemia       
 Yes 19.2 30.3 7.6 32.8 10.1 0.5866 
 No 18.9 27.2 7.5 31.4 15.0  
Body mass index (km/m2)       
 ≥ 30 18.8 25.9 9.4 33.0 12.9 0.7778 
 < 30 19.1 29.4 6.7 31.4 13.4  
APOE ε4       
 Yes 19.6 28.6 6.5 36.3 9.0 0.2642 
 No 18.7 28.2 8.0 30.0 15.1  
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Number of teeth 
Figure C-3. Density plot for a distribution of number of teeth for Dental ARIC participants                           
(n = 6,700) 
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1 = BGI-Healthy; 2= BGI-Gingivitis; 3 = BGI-Deep lesion/low bleeding; 4 = BGI-Deep lesion/moderate bleeding; 5= BGI-
Deep lesion/severe bleeding 
Figure C-4. Boxplots for number of teeth by five levels of Biofilm-Gingival Interface (BGI) 
classification for ARIC participants: A cross-sectional study (n = 5,966)1 
1 = BGI-Healthy; 2= BGI-Gingivitis; 3 = BGI-Deep lesion/low bleeding; 4 = BGI-Deep lesion/moderate bleeding; 5= BGI-
Deep lesion/severe bleeding 
Figure C-5. Boxplots for number of teeth by five levels of Biofilm-Gingival Interface (BGI) 
classification for ARIC participants: A cohort study (n = 558)  
                                                      
1In the final analysis, African Americans from Washington and Minneapolis study sites (n = 24) were excluded, leaving an analytical 
sample of 5,942. 
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Table C-5. Selected characteristics of ARIC study participants in relation to number of teeth   
Characteristics A cross-sectional study 
n = 5,9661 
A cohort study 
n = 5582 
Col % Mean (95% CI) Col % Mean (95% CI) 
Age at Visit 4 (years)     
 > 65  
31.6 
69.09 20.71, 
21.34)* 
41.9 20.48 (19.52, 21.43)¥ 
 60 – 65 32.1 21.77 (21.45, 22.08) 46.6 20.72 (19.81, 21.63) 
 51 – 59 36.3 22.90 (22.60, 23.19) 11.5 21.76 (19.94, 23.59) 
Race     
 African American 17.6 17.59 (17.18, 18.00)* 40.5 17.28 (16.48, 18.28)* 
 White 82.4 22.87 (22.68, 23.06) 59.5 23.03 (22.28, 23.77) 
Gender     
 Male 45.8 22.10 (21.84, 22.37)¥ 39.6 21.23 (20.25, 22.22¥) 
 Female 54.2 21.81 (21.56, 22.05) 60.4 20.41 (19.62, 21.21) 
Study sites     
 Forsyth 26.3 22.44 (22.11, 22.78)* 64.2 22.59 (21.86, 23.32)* 
 Jackson 15.1 17.59 (17.15, 18.03) 35.8 17.42 (16.44, 18.40) 
 Minneapolis 33.3 24.13 (23.83, 24.42) 0 0 
 Washington 25.3 21.15 (20.81, 21.49) 0 0 
Education     
 Less than school 12.5 17.59 (17.10, 18.08)* 13.6 16.83 (25.19, 18.47)* 
 High school completion 43.3 21.50 (21.24, 21.76) 37.3 20.94 (19.95, 21.93) 
 Post-secondary education 44.2 23.60 (23.34, 23.87) 49.1 21.67 (20.81, 22.54) 
Income     
 Refused 2.1 22.82 (21.64, 23.99)* 2.0 22.00 (17.82, 26.16)* 
 <$25,000 24.0 18.67 (18.32, 19.02) 31.5 17.89 (16.85, 18.94) 
 25-<$50,000 36.2 21.71 (21.43, 22.00) 34.6 20.35 (19.35, 21.35) 
 $50,000 or more 37.7 24.19 (23.91, 24.47) 31.9 23.89 (22.85, 24.93) 
Cigarette use     
 Current 12.3 19.27 (18.77, 19.78)* 11.3 18.59 (16.75, 20.42)§ 
 Former 43.9 21.82 (21.55, 22.08) 38.0 20.78 (19.78, 21.78) 
 Never 43.8 22.82 (22.55, 23.09) 50.7 21.19 (20.32, 22.05) 
Alcohol use     
 Current 55.0 23.12 (22.88, 23.36)* 38.4 22.97 (22.00, 23.94)* 
 Former 26.3 20.69 (20.34, 21.03) 31.7 19.65 (18.58, 20.72) 
 Never 18.7 20.25 (19.84, 20.66) 29.9 19.04 (17.93, 20.14) 
Diabetes mellitus     
 Yes 13.3 19.86 (19.27, 20.35)* 13.4 18.69 (17.01, 20.37)§ 
 No 86.7 22.26 (22.07, 22.45) 86.6 21.06 (20.40, 21.72) 
Hypertension     
 Yes 42.5 20.94 (20.66, 21.21)* 42.1 19.44 (18.49, 20.38)* 
 No 57.5 22.69 (22.45, 22.92) 57.9 21.69 (20.88, 22.49) 
Hyperlipidemia     
 Yes 39.0 21.77 (21.48, 22.06)¥ 35.5 20.64 (19.60, 21.68)¥ 
 No 61.0 22.05 (21.82, 22.28) 64.5 20.79 (20.02, 21.57) 
Body mass index (km/m2)     
 ≥ 30 32.6 22.42 (22.20, 22.64)* 30.5 18.15 (17.05, 19.24)* 
 < 30 67.4 20.96 (20.64, 21.27) 69.5 21.88 (21.15, 22.60) 
APOE ε4     
 Yes 30.1 21.59 (21.26, 21.92)§ 30.1 19.59 (18.47, 20.72)§ 
 No 69.9 22.09 (21.88, 22.31) 69.9  
1Participants were from all four study sites. In the final analysis, African Americans from Washington and Minneapolis study 
sites (n = 24) were excluded, leaving an analytical sample of 5,942. 
2Paticipants were from two study sites (Jackson MS and Forsyth County NC). 
*p < 0.0001 
§p < 0.05 
¥ p > 0.05 
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Appendix D: Cognitive function assessment in ARIC study 
Over a 14-year follow-up in the ARIC study, cognitive scores of ARIC participants slightly 
decreased for both whites and African Americans (Table 7-10).The latter had lower scores at each 
time point, consistent with racial difference in education attainment. The present study used 
cognitive scores measured at Visit 4 as baseline scores.  
 Table D-1. Means, standard deviations, and median scores of three cognitive tests for African 
American and white participants at each ARIC visit  
 
 
  Visit African American  White 
n Mean ± SD Median  n Mean ± SD Median 
1990-1992 (Visit 2)      
 Delayed word recall 3,389 6.1 ± 1.7 6  10,626 6.8 ± 1.4 7 
 Digit symbol substitution 3,352 31.1 ±  13.4 30  10,614 48.9 ± 11.6 49 
 Word fluency 3,375 27.7 ± 13.1 27  10,620 34.9 ± 11.8 34 
1993-1995 (Visit 3)      
 Delayed word recall 995 6.0 ± 1.8 6  1,052 6.7 ± 1.5 7 
 Digit symbol substitution 972 28.8 ± 13.0 28  1,048 46.3 ± 11.3 46 
 Word fluency 985 27.6 ± 13.3 26  1,053 33.8 ± 11.6 33 
1996-1998 (Visit 4)      
 Delayed word recall 2,324 6.0 ± 1.7 6  8,846 6.7 ± 1.5 7 
 Digit symbol substitution 2,293 30.6 ± 13.4 30  8,825 46.8 ± 11.3 47 
 Word fluency 2,309 27.9 ± 13.3 27  8,839 34.8 ± 12.0 34 
2004-2006 (Brain MRI)       
 Delayed word recall 541 5.4 ± 1.8 6  536 6.3 ± 1.6 6 
 Digit symbol substitution 529 28.8 ± 12.0 27  533 43.7 ± 10.5 43 
 Word fluency 538 26.9 ± 12.4 25  537 34.9 ± 11.4 34 
n, total number of participants who completed each cognitive function tests; SD, Standard deviation  
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Figure D-1. Pearson correlation coefficients among three cognitive scores at 1996-1998 for ARIC 
participants (n = 11,097) 
  
R = 0.40 DSS 
WF 
DWR 
R = 0.29 
R = 0.50 
R = 0.50 
R = 0.29 R = 0.40 
DWR, Delayed Word Recall; DSS, Digit Symbol Substitution; WF, Word Fluency test;  
R = Rho (Pearson correlation coefficient) 
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Figure D-2. Pearson correlation coefficients among three cognitive function scores at 2004-2006 for 
ARIC participants (n = 1,101)
DWR, Delayed word recall; DSS, Digit symbol substitution; WF, Word fluency test;  
R = Rho (Pearson correlation coefficient) 
DSS 
WF 
DWR 
R = 0.41 
R = 0.33 
R = 0.41 
R = 0.33 
R = 0.57 
R = 0.57 
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Table D-2. Cognitive scores at Visit 4 in relation to selected study characteristics (n = 9,909)1 
Characteristics Col 
% 
 Mean (95% CI) 
 
 
 Delayed word recall  Digit symbol 
substitution 
 Word fluency 
Age at Visit 4 (years)        
 > 65 34.3  6.17 (6.12, 6.22)*  39.70 (39.27, 40.14)*  32.44 (32.02, 32.86)* 
 60-65 31.8  6.66 (6.60, 6.71)  44.48 (44.03, 44.93)  33.50 (33.06, 33.93) 
 51-59 33.9  6.90 (6.85, 6.95)  47.21 (46.77, 47.65)  34.94 (34.52, 35.36) 
Gender        
 Male 44.3  6.20 (6.15, 6.24)*  41.45 (41.06, 41.84)*  32.57 (32.20, 32.94)* 
 Female 55.7  6.87 (6.83, 6.91)  45.60 (45.26, 45.95)  34.46 (34.13, 34.79) 
Race        
 African American 20.5  6.06 (5.99, 6.12)*  31.21 (30.70, 31.72)*  28.57 (28.04, 29.10)* 
 White 79.5  6.70 (6.67, 6.74)  47.00 (46.74, 47.26)  34.92 (34.66, 35.20) 
Study sites        
 Forsyth 25.2  6.77 (6.71, 6.83)*  45.51 (45.05, 45.96)*  33.52 (33.04, 34.00)* 
 Jackson 17.8  6.02 (5.95, 6.10)  30.32 (29.77, 30.86)  28.28 (27.71, 28.85) 
 Minneapolis 29.2  6.74 (6.68, 6.79)  49.06 (48.64, 49.48)  36.60 (36.15, 37.04) 
 Washington 27.8  6.56 (6.50, 6.62)  45.21 (44.77, 45.64)  34.01 (33.55, 34.46) 
Education        
 Less than high 
school 17.7  5.91 (5.84, 5.98)*  31.81 (31.25, 32.37)*  24.39 (23.86, 24.92)* 
 High school 
completion 42.6  6.62 (6.57, 6.66)  44.33 (43.97, 44.69)  32.58 (32.23, 32.92) 
 Post-secondary 
education 39.7  6.82 (6.77, 6.86)  48.50 (48.12, 48.87)  38.87 (38.52, 39.23) 
Income        
 Refused 2.2  6.27 (6.06, 6.47)*  40.63 (39.01, 42.24)*  31.33 (29.74, 32.92)* 
 <$25,000 30.2  6.18 (6.12, 6.23)  36.30 (35.87, 36.74)  28.72 (28.29, 29.15) 
 $25-<$50,000 35.0  6.60 (6.55, 6.65)  44.70 (44.30, 45.11)  34.16 (33.76, 34.56) 
 $50,000 or more 32.6  6.92 (6.87, 6.97)  49.88 (49.46, 50.30)  37.74 (37.33, 38.15) 
Cigarette use        
 Current 14.4  6.45 (6.36, 6.53)*  40.46 (39.77, 41.14)*  31.82 (31.18, 32.47)* 
 Former 43.9  6.50 (6.45, 6.55)  44.04 (43.64, 44.43)  34.12 (33.75, 34.49) 
 Never 41.6  6.69 (6.64, 6.74)  44.63 (44.22, 45.03)  33.73 (33.35, 34.11) 
Alcohol use        
 Current 50.3  6.71 (6.67, 6.76)*  47.31 (46.95, 47.66)*  36.12 (35.78, 36.46)* 
 Former 29.5  6.42 (6.36, 6.48)  40.74 (40.28, 41.21)  31.71 (31.27, 32.16) 
 Never 20.1  6.44 (6.37, 6.50)  39.34 (38.79, 39.91)  30.18 (29.64, 30.71) 
Diabetes mellitus        
 Yes 15.8  6.19 (6.11, 6.27)*  38.51 (37.86, 39.16)*  30.41 (29.80, 31.03)* 
 No 84.2  6.64 (6.61, 6.68)  44.75 (44.47, 45.03)  34.22 (33.96, 34.49) 
Hypertension        
 Yes 46.6  6.40 (6.36, 6.45)*  40.92 (40.55, 41.30)*  32.26 (31.89, 32.61)* 
 No 53.4  6.72 (6.68, 6.76)  46.25 (45.90, 46.60)  34.82 (34.49, 35.16) 
Coronary heart disease        
 Yes 8.4  6.10 (6.00, 6.21)*  39.48 (38.57, 40.38)*  31.17 (30.32, 32.02)* 
 No 91.6  6.61 (6.58, 6.65)  44.16 (43.88, 44.43)  33.85 (33.59, 34.10) 
Stroke        
 Yes 2.1  5.56 (5.34, 5.77)*  33.18 (31.38, 34.98)*  28.65 (26.96, 30.35)* 
 No 97.9  6.59 (6.56, 6.62)  43.99 (43.73, 44.26)  33.73 (33.48, 33.98) 
Hyperlipidemia        
 Yes 40.0  6.54 (6.49, 6.59)¥  43.55 (43.14, 43.97)¥  33.30 (32.91, 33.69)§ 
 No 60.0  6.59 (6.55, 6.63)  43.91 (43.57, 44.25)  33.84 (33.52, 34.16) 
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Body mass index (kg/m2)        
 ≥ 30  34.4  6.52 (6.46, 6.57)§  42.09 (41.64, 42.53)*  32.55 (32.13, 32.97)* 
 < 30 65.6  6.60 (6.56, 6.64)  44.64 (44.32, 45.97)  34.19 (33.89, 34.49) 
APOE ε4        
 Yes 29.9  6.45 (6.39, 6.51)*  42.16 (41.69, 42.64)*  33.23 (32.78, 33.68)§ 
 No 70.1  6.62 (6.58, 6.66)  44.45 (44.14, 44.76)  33.79 (33.50, 34.08) 
Oral health conditions        
Edentulous        
 Yes 13.4  6.07 (5.99, 6.16)*  35.63 (34.93, 36.32)*  27.68 (27.02, 28.34)* 
 No 86.6  6.65 (6.61, 6.68)  45.02 (44.75, 45.29)  34.28 (34.28, 34.80) 
Number of teeth2        
 1-24 50.5  6.48 (6.42, 6.53)*  42.34 (41.91, 42.77)*  32.71 (32.27, 33.14)* 
 ≥ 25 49.5  6.86 (6.81, 6.92)  49.00 (48.57, 49.44)  36.99 (36.55, 37.42) 
Periodontal disease2         
Had periodontal pockets        
 BOP ≥ 50% 12.4  6.39 (6.28, 6.50)*  41.20 (40.30, 42.07)*  31.80 (30.92, 32.68)* 
 BOP 10- <50% 40.0  6.68 (6.61, 6.74)  46.88 (46.38, 47.37)  35.32 (34.83, 35.81) 
 BOP < 10% 18.4  6.72 (6.63, 6.81)  48.08 (47.35, 48.80)  37.40 (36.67, 38.12) 
No periodontal pockets        
 BOP ≥ 10% 14.8  6.79 (6.68, 6.89)  43.72 (42.91, 44.53)  33.06 (32.26, 33.87) 
 BOP < 10% 14.4  6.69 (6.59, 6.80)  44.92 (44.09, 45.74)  34.58 (33.77, 35.40) 
n, total number of study group; BGI, Biofilm-Gingival Interface   
1Participants were from all four study sites. In the final analysis, African Americans from Washington and Minneapolis study sites (n =35) 
were excluded, leaving an analytical sample of  9,874. 
2A subset of dentate participants received periodontal examination (n = 5,966). In the final analysis, African Americans from Washington and 
Minneapolis study sites (n =24) were excluded, leaving an analytical sample of 5,942. 
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP).  
*p < 0.0001 
§ p < 0.05 
¥ p > 0.05 
  
 
 
 
 
 
 
  
 
 
Figure D-3. Race- and gender-specific density plots for three cognitive scores measured at Visit 4: A cross-sectional study (n = 9,909)1
                                                      
1Participants were from all four study sites. In the final analysis, African Americans from Washington and Minneapolis study sites (n =35) were excluded, leaving an analytical sample of 9,874. 
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Figure D-4. Density plots for a) Delayed Word Recall scores at 1996-1998 and 2004-2006; b) race- 
and gender-specific changes in Delayed Word Recall scores: A cohort study  (n = 911) 
 
  
b 
a 
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Figure D-5. Density plots for a) Digit Symbol Substitution scores at 1996-1998 and 2004-2006; b) 
race- and gender-specific changes in Digit Symbol Substitution scores: A cohort study (n = 911) 
  
b 
a 
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Figure D-6. Density plots for a) Word Fluency scores at 1996-1998 and 2004-2006; b) race- and 
gender-specific changes in Word Fluency scores: A cohort study (n = 911)  
b 
a 
  
 
Table E-1. Characteristics of ARIC cohort members who were included in or excluded from cross-sectional and cohort studies 
  
  
 Characteristics 
  
  
Aim 1: A Cross-sectional study Aim 2: A Longitudinal study 
ARIC Visit 4  
Excluding Study  sample Minneapolis  Forsyth & Jackson 
  
&Washington Excluding Study sample 
n = 1,568 n = 9,874 n = 6,319 n = 4,212 n = 911 n =11,4421 
Age at Visit 4 ( mean, SD) 62.9 5.7 62.8 5.7 63.0 5.5 62.1 6.0 64.7 4.3 62.8 5.7 
Race (n, %) 
            
 
African American 561 35.8 1,994 20.2 0 0.0 2,113 50.2 442 48.5 2,555 22.3 
 
White 1,007 64.2 7,880 79.8 6,319 100.0 2,099 49.8 469 51.5 8,887 77.7 
Gender (n, %) 
            
 
Female 874 55.7 5510 55.8 3,369 53.3 2,456 58.3 559 61.4 6,384 55.8 
 
Male 694 44.3 4364 44.2 2,950 46.7 1,756 41.7 352 38.6 5,058 44.2 
Study site (n, %) 
            
 
Forsyth 321 20.5 2,503 25.3 0 0 2,306 54.7 518 56.9 2,824 24.7 
 
Jackson 541 34.5 1,758 17.8 0 0 1,906 45.3 393 43.1 2,299 20.1 
 
Minneapolis 318 20.3 2,878 29.2 3,196 50.58 0 0 0 0 3,196 27.9 
 
Washington 388 24.7 2,735 27.7 3,123 49.42 0 0 0 0 3,123 27.3 
Education (n, %) 
 
           
 
Missing 16 1.0 0 0 5 0.1 11 0.3 0 0 16 0.1 
 
Less than high school 468 29.8 1,742 17.6 959 15.2 1,069 25.4 182 20.0 2,210 19.3 
 
High school completion 603 38.5 4,213 42.7 2,965 46.9 1,534 36.4 317 34.8 4,816 42.1 
 
Post-secondary education 481 30.7 3,919 39.7 2,390 37.8 1,598 37.9 412 45.2 4,400 38.5 
Income (n, %) 
            
 
Missing 310 19.8 0 0 68 1.1 242 5.7 0 0 310 2.7 
 Refused 39 2.5 217 2.2 114 1.8 120 2.8 22 2.4 256 2.2 
 
<$25,000 490 31.3 2,978 30.2 1,544 24.4 1,573 37.3 351 38.5 3,468 30.3 
 
$25-<$50,000 405 25.8 3,460 35.0 2,410 38.1 1,169 27.8 286 31.4 3,865 33.8 
 
$50,000 or more 324 20.7 3,219 32.6 2,183 34.5 1,108 26.3 252 27.7 3,543 31.0 
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A
ppendix E
: C
haracteristics of A
R
IC
 study participants 
ts 
  
 
Cigarette use (n, %) 
            
 
Missing 112 7.1 0 0 5 0.1 107 2.5 0 0 112 1.0 
 
Current 258 16.5 1,426 14.4 807 12.8 758 18.0 119 13.1 1,684 14.7 
 
Former 606 38.6 4,338 43.9 2,963 46.9 1,627 38.6 354 38.9 4,944 43.2 
 
Never 592 37.8 4,110 41.6 2,544 40.3 1,720 40.8 438 48.1 4,702 41.1 
Alcohol use (n, %) 
            
 
Missing 110 7.0 0 0 5 0.1 105 2.5 0 0 110 1.0 
 
Current 606 38.6 4,973 50.4 3,836 60.7 1,417 33.6 326 35.8 5,579 48.8 
 
Former 482 30.7 2,911 29.5 1,642 26.0 1,441 34.2 310 34.0 3,393 29.7 
 
Never 370 23.6 1,990 20.2 836 13.2 1,249 29.7 275 30.2 2,360 20.6 
Diabetes (n, %) 
            
 
Missing 143 9.1 0 0 19 0.3 124 2.9 0 0 143 1.3 
 
No 1,074 68.5 8,317 84.2 5,400 85.5 3,232 76.7 759 83.3 9,391 82.1 
 
Yes 351 22.4 1,557 15.8 900 14.2 856 20.3 152 16.7 1,908 16.7 
Hypertension (n, %) 
            
 
Missing 56 3.6 0 0 24 0.4 32 0.8 0 0 56 0.5 
 
No 671 42.8 5,270 53.4 3,535 55.9 1,936 46.0 470 51.6 5,941 51.9 
 
Yes 841 53.6 4,604 46.6 2,760 43.7 2,244 53.3 441 48.4 5,445 47.6 
Coronary heart disease (n, %) 
           
 
Missing 219 14.0 0 0 128 2.0 75 1.8 16 1.8 219 1.9 
 
No 1,200 76.5 9,047 91.6 5,620 88.9 3,774 89.6 853 93.6 1,0247 89.6 
 
Yes 149 9.5 827 8.4 571 9.0 363 8.6 42 4.6 976 8.5 
Stroke (n, %) 
            
 
Missing 23 1.5 0 0 13 0.2 9 0.2 1 0.1 23 0.2 
 
No 1,483 94.6 9,667 97.9 6,182 97.8 4,075 96.7 893 98.0 11,150 97.4 
 
Yes 62 4.0 207 2.1 124 2.0 128 3.0 17 1.9 269 2.4 
Body mass index (n, %) 
            
 
Missing 38 2.4 0 0 13 0.2 25 0.6 0 0 38 0.3 
 
< 30 kg/m2 928 59.2 6,482 65.6 4,111 65.1 2,675 63.5 624 68.5 7,410 64.8 
 
≥ 30 kg/m2 602 38.4 3,392 34.4 2,195 34.7 1,512 35.9 287 31.5 3,994 34.9 
Hyperlipidemia (n, %) 
            
 
Missing 227 14.5 0 0 84 1.3 143 3.4 0 0 227 2.0 
 
No 798 50.9 5,925 60.0 3,582 56.7 2,547 60.5 594 65.2 6,723 58.8 
 
Yes 543 34.6 3,949 40.0 2,653 42.0 1,522 36.1 317 34.8 4,492 39.3 
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APOE ε4 (n, %) 
            
 
Missing 439 28.0 0 0 253 4.0 186 4.4 0 0 439 3.8 
 
No 745 47.5 6,924 70.1 4,370 69.2 2,667 63.3 632 69.4 7,669 67.0 
 
Yes 384 24.5 2,950 29.9 1,696 26.8 1,359 32.3 279 30.6 3,334 29.1 
Oral health conditions 
            Dental status (n, %) 
            
 
Missing 126 8.0 0 0 72 1.1 54 1.3 0 0 126 1.1 
 
Edentulous 270 17.2 1,320 13.4 766 12.1 698 16.6 126 13.8 1,590 13.9 
 
Dentate 1,172 74.7 8,554 86.6 5,481 86.7 3,460 82.1 785 86.2 9,726 85.0 
No. of teeth, (mean, SD) 20.3 7.4 22 7.1 22.7 6.7 20.4 7.5 20.7 7.5 21.8 7.1 
 
N/A 835 
 
3,931 
 
2,491 
 
1,992 
 
353 
 
4,766 
 BGI index (n, %) 
            
 
N/A 835 53.3 3,932 39.8 2,491 39.4 1,923 45.7 353 38.7 4,767 41.7 
Had periodontal pockets             
 BOP ≥ 50% 130 8.3 733 7.4 370 5.9 419 9.9 74 8.1 863 7.5 
 BOP 10- <50% 278 17.7 2,374 24.0 1,824 28.9 650 15.4 178 19.5 2,652 23.2 
 
BOP < 10% 99 6.3 1,097 11.1 957 15.1 197 4.7 42 4.6 1,196 10.5 
No periodontal pockets             
 
BOP ≥ 10% 126 8.0 884 9.0 277 4.4 575 13.7 158 17.3 1,010 8.8 
 
BOP < 10% 100 6.4 854 8.6 400 6.3 448 10.6 106 11.6 954 8.3 
CDC/AAP (n, %) 
            
 
N/A 835 53.3 3,931 39.8 2,491 39.4 1,922 45.6 353 38.7 4,766 41.7 
 
Healthy/Mild 293 18.7 2,475 25.1 1,357 21.5 1,133 26.9 278 30.5 2,768 24.2 
 
Moderate 309 19.7 2,434 24.7 1,730 27.4 808 19.2 205 22.5 2,743 24.0 
 
Severe 131 8.4 1,034 10.5 741 11.7 349 8.3 75 8.2 1,165 10.2 
Cognitive function 
            
 
DWR (mean, SD) 6.4 1.7 6.6 1.6 6.6 1.5 6.4 1.7 6.7 1.6 6.5 1.6 
 
Missing 310 
 
0 
 
22 
 
228 
 
0 
 
310 
 
 
DSS (mean, SD) 41.2 14.5 43.8 13.3 47.0 11.2 38.5 14.9 40.5 14.0 43.5 13.5 
 
Missing 362 
 
0 
 
37 
 
325 
 
0 
 
362 
 
 
WF (mean, SD) 31.2 12.8 33.6 12.5 35.2 11.8 30.5 13.1 33.3 12.9 33.4 12.6 
  Missing 332   0   28   304   0   332   
SD, standard deviation; CDC/AAP, The  Centers for  Disease Control and Prevention/The American Academy of Periodontology; BGI, Biofilm-Gingival classification; DWR,  
Delayed Word Recall; DSS, Digit Symbol Substitution; WF, Word Fluency; BGI, Biofilm-Gingival Interface 
BGI classified periodontal disease based on probing pocket depth (PPD) and the extent of bleeding on probing (BOP).  
1African Americans from Washington and Minneapolis sties (n = 38) were excluded. 
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Table E-2. Selected characteristics of ARIC study participants by study sites: A cross-sectional study  
 Characteristics  
 
Forsyth County Jackson Minneapolis Washington County 
n = 2,503 n = 1,758 n = 2,878 n = 2,735  
Age at Visit 4, (mean, SD) 63.3 5.9 61.4 5.6 62.7 5.5 63.4 5.5 
African American (n, %) 236 9.4 1,758 100.0 0 0 0 0 
Male (n, %) 1,138 45.5 609 34.6 1,359 47.2 1,258 46.0 
Education 
        
 
Less than high school 324 12.9 595 33.8 163 5.7 660 24.1 
 
High school completion 1,060 42.3 515 29.3 1,318 45.8 1,320 48.3 
 
Post-secondary education 1,119 44.7 648 36.9 1,397 48.5 755 27.6 
Income (n, %) 
        
 
Refused 68 2.7 49 2.8 60 2.1 40 1.5 
 < $25,000 573 22.9 1042 59.3 448 15.6 915 33.5 
 
$25-<$50,000 891 35.6 405 23.0 1,127 39.2 1,037 37.9 
 
$50,000 or more 971 38.8 262 14.9 1,243 43.2 743 27.2 
Cigarette use (n, %) 
        
 
Current 437 17.5 280 15.9 368 12.8 341 12.5 
 
Former 1,072 42.8 627 35.7 1,443 50.1 1,196 43.7 
 
Never 994 39.7 851 48.4 1,067 37.1 1,198 43.8 
Alcohol use (n, %) 
        
 
Current 1,056 42.2 457 26.0 2,134 74.1 1,326 48.5 
 
Former 809 32.3 674 38.3 604 21.0 824 30.1 
 
Never 638 25.5 627 35.7 140 4.9 585 21.4 
Diabetes mellitus (n, %) 349 13.9 449 25.5 305 10.6 454 16.6 
Hypertension (n, %) 1,000 40.0 1,179 67.1 1,142 39.7 1,283 46.9 
Coronary heart disease (n, %) 222 8.9 105 6.0 210 7.3 290 10.6 
Stroke (n, %) 50 2.0 52 3.0 49 1.7 56 2.0 
Hyperlipidemia (n, %) 921 36.8 642 36.5 1,170 40.7 1,216 44.5 
Body mass index ≥ 30 kg /cm2 609 24.3 854 48.6 921 32.0 1,008 36.9 
APOE ε 4 (n, %) 676 27.0 713 40.6 825 28.7 736 26.9 
Edentulous (n, %) 297 11.9 350 19.9 156 5.4 517 18.9 
Number of teeth1 (mean, SD) 22.4 6.8 17.6 7.6 24.1 5.7 21.2 7.3 
Periodontal disease1 (n, %) 
        Had periodontal pockets         
 
BOP ≥ 50% 243 15.5 163 18.1 30 1.5 297 19.8 
 BOP 10- < 50% 511 32.6 213 23.6 811 41.1 839 56.0 
 BOP < 10% 112 7.1 94 10.4 802 40.6 89 5.9 
No periodontal pockets         
 
BOP ≥ 10% 456 29.1 191 21.2 49 2.5 188 12.5 
 
BOP < 10% 246 15.7 240 26.6 282 14.3 86 5.7 
Delayed Word Recall (mean, SD) 6.8 1.6 6 1.7 6.7 1.5 6.6 1.5 
Digit Symbol Substitution (mean , SD) 45.5 11.9 30.3 13.2 49.1 10.7 45.3 11.3 
Word fluency (mean, SD) 33.5 12.4 28.3 13.2 36.6 11.3 34.1 12.3 
SD, standard deviation; BGI, Biofilm-Gingival Interface 
1A subset of dentate participants received dental examination (n = 5,942) 
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